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Abstract
The overall objectives of the current dissertation were to 1) establish the neural
coding principles employed by the sympathetic nervous system (SNS) in response to acute
physiological stress; and 2) to determine the various mechanisms of control underlying these
sympathetic neural recruitment strategies. This research tested the working hypothesis that
efferent post-ganglionic muscle sympathetic nerve activity exhibits neural coding patterns
reflecting increased firing of lower-threshold axons, recruitment of latent sub-populations of
higher-threshold axons, as well as malleable synaptic delays, and further, that these strategies
are governed by factors such as reflex-specificity, stress severity, perception of effort or
stress, age, and cardiovascular disease. Specifically, we utilized a novel signal processing
approach to study sympathetic action potential discharge patterning during periods of acute
reflex-mediated sympathoexcitation. Overall, these studies support the working hypothesis
and confirm that neural coding principles operate within the SNS. Specifically, in response to
acute homeostatic perturbation, the SNS has options to increase the firing rate of alreadyactive, lower-threshold axons, recruit sub-populations of previously silent (i.e., not present at
baseline), larger-sized and faster conducting sympathetic axons, as well as modify acutely
synaptic delays. Study 1 demonstrated that the ability to recruit latent neural sub-populations
represents a fixed, reflex-independent recruitment strategy, as this pattern was observed
during chemoreflex- and baroreflex-mediated sympathoexcitation. In turn, this option
appears reserved for severe stress scenarios. Furthermore, study 2 suggests that central,
perceptual features may play a specific role in modifying the synaptic delay aspect of efferent
discharge timing, whereas peripheral-reflex mechanisms mediate the recruitment of latent
axons. Study 3 demonstrates that, while the ability to acutely modify synaptic delays appears
i

preserved, the ability to increase firing frequency of already-active axons, and importantly,
the capacity of the SNS to recruit latent sub-populations of higher-threshold axons are
reduced with healthy aging and perhaps lost altogether with cardiovascular disease. Finally,
study 4 suggests that the lack of ventilation itself, rather than the ever-increasing chemical
drive, mediates the robust sympathetic neural recruitment observed during apnea. In
conclusion, the series of studies contained herein confirm the presence of neural coding
patterns in human efferent post-ganglionic sympathetic nerve activity.
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Chapter 1

1

Introduction

1.1 Overview
The foundation of ‘integrative physiology’ as we know it today may well be
rooted in the seminal workings of Claude Bernard (1813-1878), a French physiologist
who noted, “…all of the vital mechanisms, however varied they may be, have always
one goal, to maintain the uniformity of the conditions of life in the internal environment
[milieu intérieur]…the constancy of the internal environment is the condition for free
and independent life…” (Bernard, 1974). In this sense, the concept of ‘homeostasis’, a
fundamental principle of physiology, was born, the term being devised sometime later
by Walter B. Cannon (1871-1945), an American physiologist (Cannon, 1929).
Homeostasis, therefore, represents the tendency of an organism to regulate its internal
stability, owing largely to a coordinated system of feedback controls, so as to stabilize
its health and functioning in the face of external challenge. As such, the concept of
‘homeostasis’ has become somewhat synonymous with the domain of ‘physiology’. In
this regard, a full understanding of, and appreciation for, the integrative regulation and
functioning (i.e., physiology) of the human body, requires that integrative physiologists
break down the individual phenomena, or ‘parts’, that together constitute the existence
of living beings.
Certainly, the autonomic nervous system (ANS), and especially, its sympathetic
division, is of fundamental importance in both the short- and long-term regulation and
maintenance of the cardiovascular system in humans. Indeed, the bidirectional

2

relationship that exists between autonomic dysregulation and numerous cardiovascular
disease-related pathologies represents perhaps the best evidence for the fundamental
role played by the ANS in maintaining cardiovascular homeostasis (Esler, 2010;
Malpas, 2010). For example, sympathetic nervous system (SNS) dysregulation
represents a hallmark of, among others, essential hypertension (Grassi et al. 2010;
Parati & Esler, 2012), coronary artery disease (CAD) (Graham et al. 2002; Graham et
al. 2004), heart failure (Floras, 2009; Triposkiadis et al. 2009), obstructive sleep apnea
(Somers et al. 1995; Narkiewicz & Somers, 2003), and even, increasing age (Seals &
Esler, 2000). Therefore, as mentioned above, a thorough understanding of the
pathophysiology of these (or any) disease and/or aging process requires the careful
study of the individual ‘parts’ that together comprise the dysfunctional system. But
first, one must understand the ‘normal’ processes in health.
The SNS represents a major medium through which homeostatic adjustments to
stress are achieved, occurring mostly as a result of its vasoconstrictor actions, and thus,
control of blood pressure and distribution of blood flow (Shoemaker et al. 2016). This
process has been largely referred to as sympathetic neural control of the circulation. In
brief, sympathetic neural control involves central integration of sensory afferent and
cortical/subcortical signals within the brainstem autonomic nuclei and spinal cord
(Barman & Gebber, 2000), synapses at peripheral sympathetic ganglia (Jänig &
McLachlan, 1992), efferent post-ganglionic nerve activity, neurotransmitter release, and
ultimately, the end-organ effect (Shoemaker et al. 2016). As such, each of these
individual junctures, or ‘parts’, offer unique sites of control in which sympathetic
outflow can be coded and modified in response to homeostatic challenge. The focus of
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the series of studies in this dissertation is on the patterns of sympathetic neural coding
and the recruitment strategies used by the efferent SNS to increase sympathetic drive in
the face of physiological stress.
Indeed, patterns of neural coding form the basis of all stimulus-response
processes requiring exchange and processing of neural information. Specifically, these
can include variations in the frequency or rate of neuron firing (i.e., rate coding),
recruitment of additional, higher-threshold neurons (i.e., population coding), as well as
variations in the timing of activity amongst neurons (i.e., temporal coding). To date,
limited access to direct neural recordings in humans, as well as technological
limitations, have precluded a definitive understanding of the neural coding principles
used by the ANS, as opposed to more well-known and defined patterns in other
peripheral organ systems. For example, rate- and population coding patterns exist in the
somatic nervous system during the generation of ever-increasing muscular contraction
force (i.e., Henneman’s size principle) (Henneman et al. 1965). However, whether the
SNS operates in a similar manner remains largely unknown.
With the introduction of the microneurographic technique (Hagbarth & Vallbo,
1968; Vallbo et al. 2004), direct neural recordings from the populations of postganglionic sympathetic axons innervating the skeletal muscle vasculature (i.e., muscle
sympathetic nerve activity; MSNA) are possible in humans. Indeed, this tool has proven
instrumental in understanding sympathetic neural control of the circulation in both
health and disease (Wallin & Charkoudian, 2007; Charkoudian & Rabbitts, 2009;
Shoemaker et al. 2016; Joyner et al. 2015). Traditionally, due to an inherently noisy
signal, analysis of this multi-fibre MSNA signal has been largely constrained to the
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integrated neurogram that exposes the timing and location of sympathetic ‘bursts’ that,
in turn, reflect periods of efferent action potential (AP) synchronization (i.e.,
sympathetic APs firing more or less at the same time) (Delius et al. 1972). Nonetheless,
inferences regarding central neural recruitment strategies have been drawn from the
integrated MSNA neurogram. That is, early observations that larger integrated
sympathetic bursts expressed shorter reflex latencies (i.e., faster neural conduction
rates) led Wallin et al. (1994) to hypothesize that potential may exist for malleable
synaptic delays and/or the ability to recruit sub-populations of neurons with varying
recruitment thresholds and conduction velocities. Indeed, the strength of any given
burst reflects both the number (Ninomiya et al. 1993) and size (Salmanpour et al.
2011a) of axons recruited within that burst. Therefore, variations in the strength (i.e.,
size) of sympathetic bursts represent the discharge patterns used by the SNS to elevate
efferent neural drive. In this regard, these axonal recruitment patterns ultimately
represent the strategies used by the central nervous system (CNS) to fine-tune efferent
sympathetic nerve activity and control the cardiovascular system, and, by extension,
maintain homeostasis.
With the use of these features, the concept of neural coding in the SNS was
advanced by Macefield et al. (1994) with the introduction of single-axon sympathetic
recordings. These data indicated that, when active, a given axon will fire generally once
per integrated sympathetic burst at rest (Macefield et al. 1994; Macefield & Wallin,
1999), but perhaps more (i.e., two to three times) during periods of acute (Macefield &
Wallin, 1999; Elam & Macefield, 2001; Murai et al. 2006) or chronic (Elam et al. 2002;
Ashley et al. 2010) sympathoexcitation. However, information regarding the
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populations of axons available for recruitment, and therefore, the neural recruitment
strategies available to the SNS to alter efferent outflow, cannot be extracted from
single-unit recordings, but instead require a multi-unit approach.
Recently, technological advancements have been made that allow for the
extraction, quantification, and morphological classification of the populations of
sympathetic APs comprising each integrated MSNA burst (Salmanpour et al. 2010).
With the use of this approach, Steinback et al. (2010b) reported increased firing rates of
axons already-active at baseline, as well as recruitment of previously silent (i.e., not
active at baseline) sub-populations of larger-sized, faster conducting sympathetic axons
during voluntary apnea-induced sympathoexcitation. In contrast, recruitment of latent
neural sub-populations was not observed during baroreceptor unloading induced via
−60 mmHg lower body negative pressure (LBNP) (Salmanpour et al. 2011a). In this
scenario, increases in sympathetic outflow were achieved through increased firing rate
of axons already-active at baseline. The reasons for the observed difference in
recruitment patterns between studies are unknown, but could involve varying thresholds
for recruitment of these latent axons (i.e., stress severity), interindividual variability,
and/or reflex-specific neural recruitment strategies. Therefore, additional data are
needed, in the same individuals, on the reflex-specific neural recruitment strategies
available to the SNS to alter efferent post-ganglionic outflow in response to physiologic
stress. This background formed the rationale for Study 1 of this dissertation. Briefly,
sympathetic neural recruitment strategies were studied during both chemoreflex- (i.e.,
as inferred from voluntary apnea) and baroreflex- (i.e., −80 mmHg LBNP) mediated
sympathoexcitation in the same individuals.
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Furthermore, in preliminary studies, Salmanpour et al. (2011b) demonstrated an
acute downward shift in the AP cluster size-latency relationship during reflex-mediated
stress. That is, all APs at baseline displayed shorter reflex latency during a subsequent
Valsalva maneuver, providing evidence perhaps for the possibility of acute synaptic
delay modifications somewhere within the reflex pathway, as previously hypothesized
(Wallin et al. 1994). However, in addition to reflex-specific recruitment strategies, a
persistent question remains, particularly with the apnea data (Steinback et al. 2010b;
Breskovic et al. 2011), as to whether or not these neural coding patterns are influenced
by a central (i.e., perception of effort or stress) phenomena, or by the reflex stress itself
(i.e., a peripheral-reflex mechanism). Specifically, voluntary apnea and the Valsalva
maneuver, as opposed to lower body suction, exhibit a certain level of volitional stress
that is likely related to perception of effort or stress and/or individual tolerance for the
maneuver. As such, the exact central versus peripheral elements of these sympathetic
neural coding principles requires investigation. This background formed the rationale
for Study 2 of this dissertation, in which sympathetic neural recruitment patterns were
investigated during fatiguing static handgrip (SHG) exercise and a subsequent period of
post-exercise circulatory occlusion (PECO). Specifically, this model (i.e., exercise
pressor reflex) was used as the physiologic response to fatiguing exercise (and PECO)
represents a unique scenario in which the central and peripheral features of the reflex
can be studied separately as they occur over time.
Furthermore, the majority of studies to date have investigated young, healthy
populations, and therefore, the malleability of these recruitment strategies with
increasing age and cardiovascular disease remains unknown. As such, this formed the
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rationale for Study 3 of this dissertation. Briefly, CAD patients completed maximal
voluntary apneas, which served as a stimulus for sympathoexcitation, and neural
recruitment patterns were compared to that of young healthy and older healthy
individuals to account for the concurrent effect of age.
Finally, while voluntary apnea appears to provide the most powerful stimulus
for sympathetic axonal recruitment (Steinback et al. 2010b), the exact mechanisms
mediating this robust sympathetic response are uncertain and appear diverse.
Specifically, the roles played by ventilation (or the lack thereof in the case of apnea)
versus the chemoreflex activation itself in eliciting the recruitment response are
unknown. This formed the rationale for Study 4 of this dissertation, in which
sympathetic neural discharge patterns were studied during prolonged voluntary apnea
(i.e., absence of ventilation) and during asphyxic rebreathing (i.e., presence of
ventilation) in trained breath-hold divers. In this sense, we studied the dissociated
influences of chemoreceptor stimuli (i.e., hypoxia and hypercapnia) and ventilation on
sympathetic AP recruitment patterns during varying levels of high chemoreflex stress.
As such, the overall objectives of the research contained herein are to 1)
Establish the neural coding principles employed by the SNS in response to acute
physiological (i.e., homeostatic) stress; and 2) To determine the various mechanisms of
control underlying these sympathetic neural recruitment strategies. The working
hypothesis to be tested is that efferent post-ganglionic MSNA exhibits neural coding
patterns reflecting increased firing rates of lower-threshold axons, latent subpopulations of higher-threshold axons, as well as malleable synaptic delays and/or
central processing times, and further, that these are modified by factors such as reflex-

8

specificity, stress severity, perception of effort or stress, age, and cardiovascular
disease.
Study 1. Sympathetic neural recruitment strategies: responses to severe
chemoreflex and baroreflex stress
Objective: To test the hypothesis that neural coding strategies exist within the SNS
and to determine reflex-specific neural recruitment strategies during severe
chemoreflex- and baroreflex-mediated stress.
Study 2. Central vs. peripheral determinants of sympathetic neural recruitment:
insights from static handgrip exercise and postexercise circulatory occlusion
Objective: To investigate the varying roles played by central versus peripheral
elements in the control of sympathetic neural recruitment during acute physiological
stress.
Study 3. Effects of aging and coronary artery disease on sympathetic neural
recruitment strategies during end-inspiratory and end-expiratory apnea
Objective: To test the hypothesis that cardiovascular disease impairs sympathetic
neural recruitment.
Study 4. Ventilation inhibits sympathetic action potential recruitment even during
severe chemoreflex stress
Objective: To determine the influence of ventilation on sympathetic neural
recruitment during varying levels of high chemoreflex stress.
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1.2

Autonomic Nervous System

The ANS represents a highly complex, multi-faceted neural network that, in an
involuntary manner (i.e., without conscious control), maintains and controls most
visceral organs within the body’s internal environment. In this sense, the ANS
coordinates numerous bodily functions and is critical to the maintenance of physiologic
homeostasis, and by extension, many life-sustaining outcomes. Of great importance,
and a focus of this dissertation, is the ANS control of the cardiovascular system,
occurring largely through the reflexive regulation of blood pressure and distribution of
blood flow (Shoemaker et al. 2016). In this sense, these variables are tonically, and
reflexively, regulated to ensure adequate perfusion and delivery of oxygen throughout
the body in an attempt to meet the metabolic demands of all organs and tissues.
Specifically, the ANS is comprised of two main branches; that is, the parasympathetic
nervous system (PNS) and the SNS. The PNS and SNS function antagonistically,
synergistically, and/or independently to regulate cardiovascular function, among other
effector systems, both at rest and in the face of physiological perturbation. Importantly,
dysregulation of the ANS represents the basis for, or a consequence of, many chronic
cardiovascular disease-related pathologies (Somers et al. 1995; Narkiewicz & Somers,
2003; Floras, 2009; Esler, 2010; Grassi et al. 2010; Malpas, 2010; Parati & Esler,
2012), highlighting its fundamental role in homeostatic cardiovascular control. Thus, an
appreciation for, and thorough understanding of, the intricate nature of autonomic
neural control in both health and disease represents a critical endeavor in the
understanding of ‘normal’ homeostatic mechanisms, as well as the pathophysiological
basis of many chronic disease states.
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1.2.1

Parasympathetic Nervous System
The PNS involves a two-neuron efferent system with pre-ganglionic neurons

situated in the CNS and post-ganglionic neurons located at peripheral ganglia (Shields,
1993). The PNS consists of long, myelinated or unmyelinated pre-ganglionic fibres that
synapse onto unmyelinated post-ganglionic fibres near or within the target organ
(Wehrwein et al. 2016). In general, cell bodies of PNS pre-ganglionic fibres originate
within regions of the brainstem, as well as in the sacral spinal cord (Wehrwein et al.
2016). Within these regions, the oculomotor (CN III), facial (CN VII),
glossopharyngeal (CN IX), and vagus (CN X) nerves form the pre-ganglionic
parasympathetic nerves which, in turn, synapse with post-ganglionic neurons through
the binding of acetylcholine (ACh) onto nicotinic cholinergic receptors (Shields, 1993;
Wehrwein et al. 2016). With respect to cardiac function, PNS control is mediated via
the vagus nerve through the binding of ACh onto muscarinic receptors located within
the heart (Brodde & Michel, 1999). Although several subtypes of muscarinic receptors
have been identified (Brodde & Michel, 1999), the predominant receptor found in the
human heart is the M2 receptor subtype (Peralta et al. 1987; Hulme et al. 1990). In
brief, activation of M2 receptors via ACh binding, coupling to an inhibitory G-protein,
leads to inhibition of adenylate cyclase activity, which subsequently inhibits
intracellular cyclic adenosine monophosphate (cAMP), resulting in decreased
intracellular calcium (Ca2+) levels. Furthermore, binding of ACh to M2 receptors causes
increased outward, hyperpolarizing potassium (K+) currents, which decreases sinoatrial
node firing rate and slows conduction within the atrioventricular node. Therefore, the
net result of vagal (i.e., PNS) stimulation of the heart is reduced cardiac contractility

11

and conduction velocity, and importantly, decreased heart rate. While the importance of
parasympathetic neural control of the circulation cannot be understated, its effects are
limited to the heart, and therefore, cardiac function, whereas the SNS innervates the
heart, blood vessels, and other visceral organs to provide widespread control of cardiac
and vascular function. In this sense, the SNS exerts considerable control over
cardiovascular homeostasis. Thus, neuro-circulatory control in the context of the SNS,
and more specifically, sympathetic neural control of the vasculature, represents the
focus of this dissertation.

1.2.2

Sympathetic Nervous System
Similar to the PNS, the peripheral elements of the SNS also operate via a two-

neuron efferent system to effectively modulate homeostatic cardiovascular control; that
is, short, myelinated pre-ganglionic neurons originating in the CNS synapse with postganglionic neurons located at peripheral ganglia, whose long, unmyelinated axons
travel to visceral targets within the periphery to exert appropriate end-organ responses
(Shields, 1993; Wehrwein et al. 2016). Specifically, the cell bodies of SNS preganglionic neurons lie in the intermediolateral (IML) cell column within the first
thoracic to the first two lumbar regions of the spinal cord (i.e., T1-L2) (Shields, 1993).
Here, the SNS pre-ganglionic fibres exit via the ventral root to form the white rami,
where they synapse with post-ganglionic neurons within prevertebral ganglia and/or
paravertebral ganglia located at the sympathetic chains (Wehrwein et al. 2016). At
these peripheral ganglia, pre-ganglionic neurons release ACh, which binds to nicotinic
cholinergic receptors located on post-ganglionic neuron cell-bodies which, in turn,
stimulates an AP in the post-ganglionic neuron. The AP descends along the axon until it
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reaches the distal end of the neuron. Sympathetic post-ganglionic axons that innervate
cardiovascular tissue (i.e., cardiac and vascular smooth muscle) branch extensively,
coming into close contact with several regional effector cells. Here, sympathetic postganglionic fibres become beaded with enlargements known as varicosities, in which
they release their neurotransmitters from. Specifically, once the AP arrives at the
varicosity, the ensuing depolarization initiates the opening of voltage-gated Ca2+
channels, resulting in an influx of Ca2+ and the exocytosis of synaptic vesicles
containing neurotransmitters. Sympathetic post-ganglionic neurons release several
neurotransmitters, including norepinephrine (NE), neuropeptide Y (NPY), and
adenosine triphosphate (ATP) (Burnstock, 1990; Lundberg et al. 1990) that, in turn,
stimulate receptors located on the effector organs and tissues, as described below.
Additionally, sympathetic pre-ganglionic fibres can also travel to the medullary portion
of the adrenal gland, where they release ACh onto nicotinic cholinergic receptors
located on chromaffin cells. In this scenario, the adrenal medulla releases NE and
epinephrine, in an approximate 1:4 ratio (Jänig, 2008), into the circulation, where they
can bind to receptors located on effector targets.
Of importance to neuro-cardiovascular control are receptors located at the heart,
and perhaps more importantly, on smooth muscle cells of the vasculature within
skeletal muscle and other visceral organs. Briefly, at the heart, NE and epinephrine bind
to β1- and β2-adrenergic receptors, which, through a stimulatory G-protein, activates
adenylate cyclase, thereby catalyzing the conversion of ATP to cAMP. This causes
increases in cAMP-dependent protein-kinase A activity, thus activating L-type Ca2+
channels. The net result is increased intracellular Ca2+ levels, and thus, increased heart
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rate and cardiac contractility. Within blood vessels, neurally released NE and
epinephrine bind to α1-adrenergic receptors which, through a Gq-protein, stimulates
phospholipase C, leading to the formation of inositol triphosphate and diacylglycerol,
and, in turn, increased intracellular Ca2+ and protein kinase C activation, respectively.
The rise in Ca2+ activates calmodulin-dependent myosin light chain kinase to increase
myosin ATPase activity, causing myosin and actin binding, and therefore, vascular
smooth muscle contraction. Therefore, the net result is overall vasoconstriction.
Similarly, activation of α2-adrenergic receptors via NE binding is coupled to an
inhibitory G-protein which inhibits adenylate cyclase and decreases cAMP levels.
Briefly, this causes less myosin light chain kinase inhibition and greater intracellular
Ca2+ levels. Again, the net result is vasoconstriction. In addition to NE, as mentioned
above, vascular sympathetic nerves also co-release NPY and ATP (Burnstock, 1990;
Lundberg et al. 1990). Both neurotransmitters can cause net vasoconstriction through
the activation of NPY Y1 receptors, via NPY, and purinergic P2X1 receptors, via ATP,
which act to increase intracellular Ca2+ levels, and therefore, vascular smooth muscle
contraction. The release of these co-transmitters and the subsequent contribution to the
functional sympathetic vasoconstrictor response may ultimately depend on the
patterning and rate of sympathetic discharge that, in turn, likely exerts important
influences on end-organ homeostatic stress responses (Huidobro-Toro & Donoso,
2004). In this sense, technological advancements allowing for direct recordings of
sympathetic post-ganglionic vasoconstrictor discharge (i.e., microneurography;
described in detail later) has initiated an exciting era of research with respect to
sympathetic neurovascular control.
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1.3 Sympathetic Neural Control of the Circulation
Overall, the concept of sympathetic neurovascular control represents a highly
integrative and multi-faceted process of regulation that involves central integration of
sensory signals within the brainstem and spinal cord (Barman & Gebber, 2000),
synapses at peripheral ganglia (Jänig & McLachlan, 1992), recruitable efferent postganglionic sympathetic nerve traffic, neurotransmitter release, and finally, the endorgan response (Shoemaker et al. 2016). Ultimately, each of these elements offer
unique and complex levels of regulation, that combined, represent a key mechanism of
control over cardiovascular homeostasis. Therefore, to fully appreciate the complexity
and integrative nature of sympathetic neuro-circulatory control in health, and perhaps
more importantly, in disease, a thorough and systematic understanding of each
individual element of control, or ‘part’, is critical. In line with this, recruitment patterns
in efferent sympathetic nerve activity form the scope of this dissertation. For detailed
information on other regulatory segments within the sympathetic neural control
complex, such as the central and ganglionic features (McAllen & Malpas, 1997; Jänig
& Häbler, 2003; McLachlan, 2003), or the efferent nerve activity–vascular contraction
integration (Shoemaker et al. 2016), the reader is referred to existing comprehensive
reviews. Nonetheless, the concept of sympathetic neurovascular control has been wellstudied in three fundamental reflexes; that is, the baroreflex, chemoreflex, and exercise
pressor reflex. These efforts are described briefly in the sections below.

1.3.1

Baroreflex
The arterial baroreflex provides short-term regulation of arterial blood pressure

around a set-point (determined by the state of the individual), via a negative feedback
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control system that responds to beat-to-beat changes in blood pressure by reflexively
altering ANS (i.e., PNS and SNS) activity. The arterial baroreflex consists of
baroreceptors located in the carotid sinus, at the bifurcation of the internal and external
carotid artery, as well as the aortic arch (Dampney, 1994). The carotid and aortic
baroreceptors are composed of mechanosensitive afferent neurons located within the
medial-adventitial wall of the vessel that respond to stretch or distortion of the arterial
wall due to changes in blood pressure, or more specifically, transmural pressure
(Dampney, 1994). Afferent baroreceptor discharge is relayed from the carotid sinus (via
the glossopharyngeal nerve) and the aortic arch (via the vagus nerve) to the nucleus
tractus solitarius (NTS) in the medulla oblongata region of the brainstem (Dampney,
1994; Aicher et al. 2000). Here, NTS neurons project to and excite (via the release of
glutamate) the caudal ventrolateral medulla (CVLM). CVLM neurons are interneurons
in the baroreflex pathway and project to the rostral ventrolateral medulla (RVLM), and
through the release of ɣ-aminobutyric-acid (GABA), inhibit the RVLM. The RVLM
represents the primary regulator of the SNS, sending excitatory messages to
sympathetic pre-ganglionic neurons located in the IML of the spinal cord, as mentioned
above. As such, when baroreceptors are activated (i.e., by increased blood pressure), the
NTS activates the CVLM, thus inhibiting the RVLM, which, in turn, inhibits
sympathetic nerve activity to decrease blood pressure (i.e., vasodilation) back to its setpoint. In this scenario, PNS activity is simultaneously increased to cause reductions in
heart rate and cardiac contractility. On the other hand, when blood pressure levels
decrease, less afferent baroreceptor discharge causes less excitation of the NTS, less
activation of the CVLM, and therefore, disinhibition (i.e., activation) of the RVLM.
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This, in turn, causes increases in efferent sympathetic nerve activity to the periphery,
and therefore, vasoconstriction (i.e., to increase blood pressure).
Orthostatic (i.e., postural) stress represents a common method of studying
baroreflex-mediated neuro-circulatory control due to reductions in venous return,
cardiac output, and thus, blood pressure. This results in baroreceptor ‘unloading’,
reductions in afferent discharge to central sympathetic sites, and therefore, as described
above, increases in sympathetic nerve activity and peripheral vascular resistance to
maintain arterial blood pressure (Sundlöf & Wallin, 1978a; Victor & Leimbach, 1987).
In a laboratory setting, orthostatic stress is often simulated using LBNP, although other
methods are often utilized. In brief, during LBNP, participants lie supine with their
lower body sealed within a chamber at the level of the iliac crest. Next, negative suction
is created, such that blood is shunted away from the thoracic cavity and into the
capacitance vessels of the lower body, thereby unloading the baroreceptors. Indeed,
LBNP elicits robust and graded (i.e., with severity) increases in efferent sympathetic
nerve outflow, vasoconstriction, and, by extension, total vascular resistance (Rea &
Wallin, 1989; Taylor et al. 1992; Ryan et al. 2011). Furthermore, the patterning of
sympathetic discharge may differ with LBNP stress severity, such that both rate and
strength of firing increase at lower levels of suction (i.e., up to approximately −30
mmHg), whereas, at higher levels of LBNP, the strength of sympathetic discharge
appears emphasized (Ichinose et al. 2004; Ichinose et al. 2006).

1.3.2

Chemoreflex
The chemoreflex represents a highly complex and coordinated homeostatic

response to systemic hypoxia and/or hypercapnia that ultimately serves to regulate
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cardiorespiratory function to maintain and defend perfusion to the body’s critical organs
and tissues. Briefly, the chemoreflex includes peripheral chemoreceptors, located
primarily in the carotid bodies, but also, the aortic bodies, as well as the central
chemoreceptors, located within the brainstem. In general, peripheral chemoreceptors
respond primarily to hypoxia, but also to hypercapnia/H+ concentration (Marshall,
1994), while central chemoreceptors respond to increased brain interstitial
hypercapnia/H+ concentration (Nattie & Li, 2012). The net result of peripheral and/or
central chemoreceptor activation is reflex-induced increases in respiration, as well as
autonomic circulatory arousal. Indeed, the homeostatic response to chemoreflex
activation involves large increases in post-ganglionic sympathetic nerve activity (Saito
et al. 1988; Morgan et al. 1995; Leuenberger et al. 2005), mediated through an
excitatory NTS to RVLM to IML neural reflex arc (Koshiya et al. 1993), to influence
systemic vascular resistance and distribution of blood flow, and ultimately, maintain
brain perfusion.
Importantly, when the effects of hypoxia and hypercapnia are combined, such as
occurs during asphyxic rebreathing or breathing a hypoxic-hypercapnic gas mixture, a
synergistic effect occurs, such that the sympathoexcitatory response is potentiated
(Somers et al. 1989a; Jouett et al. 2015). Furthermore, voluntary apnea (i.e., absence of
active ventilation) appears to elicit an even more robust sympathetic response (Somers
et al. 1989b; Steinback et al. 2010a), reflecting increases in both frequency and strength
of sympathetic discharge.
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1.3.3

Exercise Pressor Reflex
The exercise pressor reflex is of fundamental importance in mediating the

necessary neural cardiovascular adjustments to fatiguing exercise, which include
increases in blood pressure and elevated sympathetic drive. In brief, mechanically- and
metabolically-sensitive sensory afferent fibres within active skeletal muscle provide
feedback to cardiovascular control centers within the brain stem in response to
mechanical and chemical stimuli, respectively (Alam & Smirk, 1937; McCloskey &
Mitchell, 1972; Kaufman et al. 1983; Mitchell et al. 1983). Specifically, muscle
mechanoreflex sensory afferents are comprised of Type III sensory neurons and
respond primarily to mechanical stretch and deformation induced by muscular
contraction (Mitchell et al. 1983). On the other hand, muscle metaboreflex sensory
afferents are comprised of Type IV sensory neurons and are stimulated via the build-up
of metabolites (i.e., chemical stimuli) produced by the working skeletal muscle
(Mitchell et al. 1983). However, this organization is not absolute, as some Type III
fibres respond to metabolic stimuli, whereas some Type IV fibres respond the
mechanical stimuli. Nonetheless, the exercise pressor reflex elicits large increases in
sympathetic nerve activity (Mark et al. 1985; Seals et al. 1988; Victor et al. 1988;
Wallin et al. 1989; Shoemaker et al. 2007), albeit after a delay (Mark et al. 1985), the
timing of which depends on exercise intensity (Hashimoto et al. 1998). Furthermore,
sympathetic outflow remains elevated during PECO, which serves to trap exerciseinduced metabolites within the previously-active skeletal muscle (thereby, isolating the
metaboreflex) (Alam & Smirk, 1937), suggesting a dominant role for the muscle
metaboreflex in eliciting the robust sympathetic response.
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1.4 Muscle Sympathetic Nerve Activity
In the late 1960s (Hagbarth & Vallbo, 1968), the study of sympathetic neurocirculatory control was greatly advanced in humans with the development of the
microneurographic technique by Hagbarth and Vallbo in Uppsala, Sweden (Vallbo et
al. 2004). Specifically, microneurography allows for direct real-time recordings from
the populations of post-ganglionic sympathetic axons innervating the skeletal muscle
vasculature (i.e., MSNA) in human peripheral nerves. The recordings are referred to as
“multi-unit” in that several axons are recorded from simultaneously. Sympathetic
outflow directed to skeletal muscle, as opposed to skin (Hagbarth et al. 1972), is related
to blood pressure and accurately reflects both age-related and pathological states
(Sundlöf & Wallin, 1978b; Wallin & Charkoudian, 2007); thus, MSNA represents the
neural signal of interest in this dissertation. Advantages of the microneurographic
technique versus other measures of sympathetic nerve activity (i.e., plasma
catecholamine levels, NE spillover, etc.) include its direct and continuous nature and its
excellent temporal resolution. Disadvantages include the technical demands of the skill
and its pseudo-invasive nature (thereby, limiting its practicality), its focus on one
regional vascular bed, as well as uncertainty over how best, and how accurately, to
interpret and analyze the recorded signal (White et al. 2015; Joyner, 2016). In general,
however, levels of MSNA reflect levels of sympathetic outflow to the heart and other
visceral beds (Wallin et al. 1992; Wallin et al. 1996; Lambert et al. 1997; Grassi &
Esler, 1999), reinforcing the relevance of this important neural signal. Indeed, over the
past 50 years or so, microneurography has proven an invaluable research tool in the
study of sympathetic neurovascular control at rest, and in response to physiological
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stress, in both health and disease (Wallin & Charkoudian, 2007; Charkoudian &
Rabbitts, 2009; Shoemaker et al. 2016; Joyner et al. 2015).
In theory, any accessible peripheral nerve can be used for microneurographic
recordings; however, the most widely used is likely the peroneal nerve at or just
proximal to the fibular head, as it is readily accessible and close to the skin, relatively
large, and fairly easy to stabilize (i.e., the lower limb) for long durations of time (White
et al. 2015). Certainly, the peroneal nerve, along with other human mixed nerves,
contains unmyelinated efferent sympathetic axons (i.e., C-fibers), albeit in a mix of
other sensory and motor fibres. Though limited data exist in humans on the anatomical
arrangement and distribution of these sympathetic fibres within peripheral nerves,
Tompkins et al. (2013) demonstrated, using immunohistochemical techniques, that
sympathetic fibres were dispersed throughout approximately 25 to 38 fascicles within
the human peroneal nerve. Throughout these fascicles, sympathetic fibres existed either
individually or in bundled groups of approximately two- to 44 axons, although the
distribution favoured smaller bundles (i.e., median value of five axons/bundle). Finally,
the axons also displayed variations in size, with diameters ranging from approximately
0.5 to 2 µm. Therefore, within the human peroneal nerve, post-ganglionic sympathetic
fibres exist in bundles of axons that vary both in number and size.
As such, microneurography involves the manual manipulation and positioning
of a recording electrode into an active bundle of efferent sympathetic axons within the
peroneal nerve. Specifically, the technique entails the use of two electrodes. First, a
‘reference’ electrode is positioned subcutaneously approximately 1-3 cm from the
recording site. Next, a tungsten ‘recording’ electrode (35 mm long, 200 µm in diameter,
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and tapered to a 1-5 µm uninsulated tip) is inserted percutaneously into the nerve and is
manually, and carefully, manipulated until an adequate MSNA recording site is located.
This is confirmed by the presence of a characteristic pulse-synchronous burst pattern,
absence of skin paresthesia, and a signal that increases in response to voluntary apnea,
but not during arousal to loud noise (Delius et al. 1972). The recorded raw neural signal
is first preamplified with a gain of 1000 (using preamplifier and isolation amplifier;
gain of 100 and 10, respectively) and further amplified with a gain of 75 (using a
variable gain amplifier; gain of 0.1-99). The neural activity is then band-pass filtered
(bandwidth of 700-2000 Hz) before being rectified and integrated (using a leaky
integrator; 0.1 s time constant) to obtain a mean voltage neurogram. These steps
ultimately reduce background noise to expose both the timing and location of
sympathetic ‘bursts’ that, in turn, reflect periods of efferent AP synchronization (Delius
et al. 1972). In this sense, variations in the size and number of APs within and between
sympathetic bursts is lost in the integration process. Nonetheless, MSNA is
characterized by spontaneously, and irregularly, occurring bursts of pulse-synchronous
impulses (i.e., APs) that are separated by periods of neural silence (Hagbarth & Vallbo,
1968). These integrated sympathetic bursts are entrained to the cardiac cycle via a
baroreflex mechanism, in that they are initiated during diastole and turned off during
systole (Sundlöf & Wallin, 1978b). Indeed, Fagius et al. (1985) demonstrated that
baroreceptor deafferentation via temporary bilateral block of the vagus and
glossopharyngeal nerves led to marked increases in muscle sympathetic outflow and a
loss of MSNA cardiac rhythmicity. Confirmation that these recorded bursts indeed
represent efferent post-ganglionic sympathetic outflow is evidenced by their conduction
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velocities (~1 m/s) (Hagbarth & Vallbo, 1968; Fagius & Wallin, 1980), as well as their
complete abolishment following ganglionic blockade (Delius et al. 1972).
Sympathetic bursts are identified from the integrated MSNA neurogram if: 1)
they exhibit pulse-synchrony; 2) they have a signal-to-noise ratio of at least 2:1 with
respect to the previous period of neural silence between bursts; 3) they present with
characteristic rising and falling slopes; and 4) APs are visible in the corresponding raw
and filtered neurograms. The level of integrated sympathetic nerve activity is most
commonly quantified using burst frequency and/or burst incidence. Burst frequency
gives an indication of overall firing frequency and is expressed as the number of bursts
per minute, whereas burst incidence involves the ‘normalization’ of burst frequency to
heart rate, and therefore, is expressed as the number of bursts per 100 heartbeats.
Furthermore, the level of total integrated activity (i.e., total MSNA) is often calculated
as the product of burst frequency and burst amplitude (or area), although interpretation
of the latter amplitude component is more complicated, as described below. Therefore,
integrated burst frequency represents the most-widely reported MSNA index in the
literature due to its relative ease of calculation and interpretation, and because it is
highly reproducible over time (Sundlöf & Wallin, 1977; Kimmerly et al. 2004). In
contrast, burst size demonstrates less test-retest reproducibility, presumably due to the
fact that absolute burst size voltages are influenced by proximity of the recording
electrode tip in relation to the active group of axons, a factor that is likely to differ
between individuals and between recording sites. In this sense, interindividual
comparisons of absolute burst amplitude are limited, and therefore, normalization
procedures are often utilized. A commonly used approach is to normalize all bursts
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within the recording period to the largest burst at baseline (or throughout the recording),
which is assigned a value of 100 arbitrary units, although other methods are often
employed (White et al. 2015). Another approach, developed by Sverrisdóttir and
colleagues (Sverrisdóttir et al. 1998; Sverrisdóttir et al. 2000), involves the
normalization of burst amplitude as above, followed by the creation of a relative burst
amplitude distribution spectra or plot that describes the relative proportion of ‘small’
versus ‘large’ bursts within the integrated neurogram. Importantly, this method has
demonstrated to be a more sensitive and specific indicator of altered MSNA
(Sverrisdóttir et al. 1998), is reproducible (Kimmerly et al. 2004), and furthermore, has
shown to independently discriminate clinical conditions (i.e., heart failure) with
elevated, but similar, burst frequency (Sverrisdóttir et al. 2000). Therefore, burst
amplitude offers unique insight into sympathetic neural control of the circulation above
and beyond that of burst frequency or burst incidence. In this sense, burst size
represents an important independent variable of interest, as outlined below.
Certainly, it has been hypothesized for some time that burst size is regulated in a
differential manner as compared to burst frequency, thereby representing its own level
of control (Malpas, 1995; Kienbaum et al. 2001). Highlighting this point, several
studies have observed alterations in burst amplitude, without accompanying changes in
burst frequency, in response to both baroreflex- (DiBona et al. 1997; Kimmerly &
Shoemaker, 2003) and chemoreflex- (Malpas & Ninomiya, 1992; Malpas et al. 1996)
induced stress. As such, changes in burst frequency alone may not adequately represent
reflex-mediated sympathetic vasomotor control. Furthermore, changes in burst
amplitude, reflecting altered AP discharge patterns, may be independently relevant for
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neurovascular control (Malpas, 1998). Indeed, Fairfax et al. (2013) demonstrated that
burst size alone, independent of burst pattern or frequency (i.e., single versus multiple
bursts), influences directly the magnitude of decrease in leg vascular conductance (i.e.,
vasoconstriction). The importance of the burst amplitude index likely lies in the fact
that the size of each integrated burst represents the true neural content of that burst; that
is, burst size is reflective of both the number (Ninomiya et al. 1993; Salmanpour et al.
2011a) and size (Salmanpour et al. 2011a) of axons recruited within that burst.
Therefore, the content and variability of APs within and between integrated bursts
reflect the recruitment patterns and strategies used by the CNS to fine-tune sympathetic
outflow, and ultimately, control systemic vascular resistance and blood pressure at rest
and in the face of physiological challenge. While the efforts outlined above for
normalizing burst amplitude have proven somewhat fruitful (Kimmerly & Shoemaker,
2003), considerable information is lost within the integrated neural signal. Specifically,
the integration process eliminates all AP information (i.e., number and morphology),
precluding the study of sympathetic neural discharge patterning. As such, investigation
into the neural coding patterns utilized by the SNS has been limited over the years due
to technical limitations in extracting AP information from raw MSNA recordings due to
high levels of background noise.
Nonetheless, early hypotheses regarding central recruitment strategies have been
inferred from the integrated MSNA neurogram. For instance, Wallin et al. (1994)
observed an inverse relationship between integrated burst amplitude and baroreflex
latency; that is, larger sympathetic bursts expressed shorter reflex latencies. Baroreflex
latency, as determined from the time-delay between the peak of the integrated burst and
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the preceding R-wave related to that burst (Fagius & Wallin, 1980), has been found to
be approximately 1.2 to 1.5 seconds in human peroneal nerve recordings (Fagius &
Wallin, 1980). In turn, this reflex latency reflects the sum of time of all conduction
components, including baroreceptor sensory afferent processing, central integration,
spinal conduction time, and pre- and post-ganglionic efferent nerve segments. In this
sense, the finding that larger sympathetic bursts expressed shorter conduction latencies
was hypothesized to be due to either malleability of synaptic delays between the brain
stem and peripheral nerve (i.e., ‘shortcuts’ in the neural pathway), and/or the presence
of sub-populations of sympathetic fibres with varying conduction velocities and
thresholds for recruitment (Wallin et al. 1994).
The question of neural coding in human efferent sympathetic nerve activity was
advanced by Macefield et al. (1994) with the introduction of single sympathetic fibre
recordings. The single-unit approach uses the same methodology as outlined above for
multi-unit recordings; however, the electrode has a much higher impedance and thus
limits the overall area from which the neural signal is recorded. Data from this work
indicates that, in general, when active at rest, a given axon will fire approximately once
per sympathetic burst (Macefield et al. 1994; Macefield & Wallin, 1999), but perhaps
more in certain pathological states (Elam et al. 2003; Lambert et al. 2008). Indeed, a
shift towards greater likelihood of multiple firing of individual axons per burst has been
demonstrated in hypertension (Lambert et al. 2007), obstructive sleep apnea syndrome
(Elam et al. 2002), and chronic obstructive pulmonary disease (Ashley et al. 2010), but
not in congestive heart failure (Macefield et al. 1999). Furthermore, multiple withinburst firing has been observed during acute states of autonomic arousal, such as the
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Valsalva maneuver (Murai et al. 2006), voluntary apnea (Macefield & Wallin, 1999),
and following cardiac dysrhythmia (Elam & Macefield, 2001). Therefore, these data
indicate that increased firing probability, and also, an increase in the within-burst firing
of single axons, represent mechanisms by which sympathetic drive is elevated during
physiological stress. However, given that only approximately 40% of bursts during
apnea were associated with multiple spikes, Macefield and colleagues hypothesized that
recruitment of additional neurons (along with increased firing probability) may be the
primary mechanism by which sympathetic activation is achieved (Macefield & Wallin,
1999). However, recruitment of new axons cannot be determined from single-fibre
recordings. As such, information regarding the several recruitment strategies available
to the SNS to alter efferent outflow in response to homeostatic challenge cannot be
extracted using single-unit analyses, but instead, require a multi-unit analysis approach.
Indeed, patterns of neural coding represent a fundamental feature of all neural
exchange and processing. These patterns, among others, can include variations in the
frequency, or rate, of individual spike firing (i.e., rate coding), varying thresholds for
recruitment of additional neurons (i.e., population coding), and also, variations in the
timing of neuronal activity (i.e., temporal coding). These coding patterns exist in the
control of many bodily systems. For example, the recruitment strategies used by the
skeletal motor system to respond to ever-increasing muscular contraction force follow
Henneman’s size principle, whereby smaller motor units are recruited first, followed by
recruitment of larger, faster conducting motor units as load intensity and force
production increase (Henneman et al. 1965). Furthermore, once active, these units
increase their firing rate (Westgaard & De Luca, 2001). Therefore, neural coding
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patterns exist in the control of muscular activation. Whether these principles operate in
the SNS, which regulates numerous homeostatic outcomes, is less clear in humans due
to limited access to direct neural recordings, and furthermore, limitations in extracting
multi-unit AP activity from the sympathetic neurogram.
More recently, the investigation of neural coding in efferent sympathetic nerve
activity has been furthered by technological advancements enabling the extraction and
morphological classification of multi-unit APs from raw MSNA recordings
(Salmanpour et al. 2010). One such method, developed by Salmanpour et al. (2010),
and used in many subsequent experiments (Steinback et al. 2010b; Breskovic et al.
2011; Salmanpour et al. 2011a,b; Maslov et al. 2012; Salmanpour & Shoemaker, 2012;
Maslov et al. 2014a,b), uses wavelet-base methodology to detect and extract
sympathetic APs from the noisy raw MSNA signal, thereby enabling the study of multiunit post-ganglionic neural discharge (Figure 1.1).
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Figure 1.1: Schematic representation of action potential (AP) detection and
classification.
MSNA, muscle sympathetic nerve activity. Reproduced with permission from the
American Physiological Society: “Badrov MB, Usselman CW & Shoemaker JK (2015).
Sympathetic neural recruitment strategies: responses to severe chemoreflex and
baroreflex stress. Am J Physiol Regul Integr Physiol 309: R160-168.”
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This technique has proven invaluable in the testing of early hypotheses proposed
by Wallin et al. (1994) and Macefield and colleagues (Macefield et al. 1994; Macefield
& Wallin, 1999), among others (Tsukahara & Mano, 1997; Xie et al. 1999). With the
use of this approach, an ordered pattern of recruitment was observed within the SNS
during baseline rest, whereby larger axons with faster conduction velocities (i.e., shorter
reflex latencies) are hierarchically recruited as integrated sympathetic bursts become
stronger (i.e., larger) (Steinback et al. 2010b; Salmanpour et al. 2011a). This pattern
was also observed during baroreflex- and chemoreflex-mediated sympathoexcitation
(Steinback et al. 2010b; Salmanpour et al. 2011a). Furthermore, in response to
prolonged voluntary apnea, Steinback et al. (2010b), and later, Breskovic et al. (2011),
observed increased firing rates of sympathetic fibres already-active at baseline, and
also, recruitment of previously silent (i.e., not present at baseline) sub-populations of
higher-threshold, faster conducting (therefore, larger) sympathetic axons. Importantly,
these larger, latent axons accounted for approximately 74% of the apnea-induced
increase in sympathetic nerve activity (Steinback et al. 2010b). Therefore, it appears
that increased sympathetic drive in response to physiological stress may be achieved
predominantly through the recruitment of additional, larger sympathetic neurons, as
previously hypothesized (Macefield & Wallin, 1999). However, in contrast to the
discharge patterns observed during apnea (Steinback et al. 2010b; Breskovic et al.
2011), recruitment of latent neural sub-populations was not observed during moderate
levels of baroreceptor unloading (i.e., −60 mmHg LBNP) in approximately 70% of
participants, whereby sympathetic activation was achieved primarily through increased
firing rates of those axons already recruited as baseline (Salmanpour et al. 2011a).
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Discrepancy in recruitment strategies between the two studies (or reflexes) may be due
to stress severity (i.e., varying thresholds for recruitment) and/or differences between
the reflexes themselves (i.e., ‘chemoreflex’ versus ‘baroreflex’). However, these two
studies were conducted in different samples of individuals, thereby limiting conclusions
as to the roles played by these factors. Therefore, reflex-specific neural recruitment
strategies within the SNS, as well as the issue of stress severity and threshold for
recruitment of these latent axons, require further investigation.
Furthermore, a consistent finding to date has been an inverse relationship
between AP size and AP latency; that is, larger APs express shorter reflex latencies
(i.e., faster conduction velocities) (Steinback et al. 2010b; Salmanpour et al. 2011a,b).
This finding forms the basis of the assumption that these larger APs reflect recruitment
of larger axons. While this relationship has been observed at rest and during
sympathoexcitatory stimuli (Steinback et al. 2010b; Salmanpour et al. 2011a),
Salmanpour et al. (2011b) demonstrated that all APs active at baseline were recruited
with a shorter reflex latency during a subsequent Valsalva maneuver, evidence perhaps
for acute malleability of synaptic delays within the neural reflex arc. In contrast, in a
preliminary manner, Salmanpour et al. (2011a) observed an acute upward-shift of the
AP size-latency profile during −60 mmHg LBNP, such that lower-threshold axons were
recruited with a slower latency during moderate levels of simulated orthostatic stress.
Nonetheless, these observations appear to support the concept, initially proposed by
Wallin et al. (1994), of acute synaptic delay variations, although additional data are
required. Furthermore, the exact mechanism(s) for the reduction in neural activation
latency during the Valsalva maneuver (Salmanpour et al. 2011b), but the increase
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during LBNP-induced baroreceptor unloading (Salmanpour et al. 2011a), are unknown,
but may reflect a central, perceptual component that is likely more pronounced during
the Valsalva maneuver. As such, in addition to the study of reflex-specific discharge
patterns, the exact roles played by central, perceptual components versus peripheralreflex mechanisms in mediating these sympathetic neural recruitment responses remain
to be determined.
Additionally, the majority of studies to date on sympathetic AP discharge
properties have been conducted in young, healthy populations, and therefore, whether
these neural coding strategies persist with increasing age and cardiovascular disease
remains largely uncertain. Preliminary work in healthy aged-individuals and chronic
heart failure patients suggests a comparable pattern, but perhaps slightly diminished in
heart failure, of sympathetic neural recruitment in response to voluntary apnea (Maslov
et al. 2014b) and premature ventricular contractions (Maslov et al. 2012). However,
direct comparisons to a young, healthy group were not made. Furthermore, AP latency
variations, reflecting synaptic delay modifications, were not studied in these
investigations. Therefore, the malleability of these sympathetic neural recruitment
strategies with increasing age and cardiovascular disease requires further study.
Finally, voluntary apnea appears to provide the most powerful stimulus for
sympathetic axonal recruitment (Steinback et al. 2010b). Yet, the exact mechanisms
mediating the robust sympathetic response are uncertain and appear diverse. Indeed,
one fundamental issue involves the roles played by ventilation (or the lack thereof)
versus chemoreceptor activation in eliciting the recruitment response. For example, the
chemoreflex stimulus to typical 20- to 30-second apneas in untrained breath-hold
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performers is rather ordinary (Leuenberger et al. 2005; Heusser et al. 2009; Seitz et al.
2013), raising the concern that additional factors are likely at play. Furthermore,
voluntary apnea has shown to potentiate the sympathetic response to isocapnic hypoxia
(Somers et al. 1989a,b), indicating the sympathoinhibitory nature of breathing.
Therefore, the influence of chemoreflex stress per se, as opposed to the absence of
ventilation itself, on sympathetic axonal discharge during apneic stress remains to be
determined.
Nonetheless, the existing multi-unit data, albeit limited, appear to support earlier
hypotheses (Wallin et al. 1994; Macefield & Wallin, 1999) that, in response to acute
homeostatic stress, the SNS has options to increase the firing rate of already-active,
lower-threshold axons, recruit latent, higher-threshold neural sub-populations, as well
as modify acutely synaptic delays and/or central processing times. In turn, it appears
that these strategies may differ across reflexes and/or with stress severity, which may
perhaps reflect a perceptual component. Therefore, as outlined above, many
questions/issues remain regarding the mechanisms of control underlying the neural
recruitment strategies used by the SNS, which include, among others: (1) the reflexspecific recruitment strategies in efferent sympathetic nerves, (2) the threshold for
recruitment of these neural sub-populations (i.e., stress severity), (3) the central,
perceptual versus peripheral-reflex elements of sympathetic neural coding, (4) the
effects of age and disease on neural discharge properties, and (5) the role of
chemoreflex stress versus ventilation (or the lack thereof) in the apneic neural response.
These important, but yet unanswered issues, form the basis of this dissertation.
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Therefore, the overall objectives of this dissertation are to 1) Establish the
neural recruitment strategies available to the SNS to respond to acute homeostatic
challenge; and 2) To determine the various mechanisms of control underlying these
neural coding patterns. The research contained herein tested the working hypothesis
that efferent post-ganglionic MSNA exhibits neural coding strategies reflecting
increased firing rates of lower-threshold axons, recruitment of latent, higher-threshold
axons, and acute synaptic delays modifications, and further, that these are modified by
factors such as reflex-specificity, stress severity, perception of effort or stress, age, and
cardiovascular disease.
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Chapter 2

2

Sympathetic neural recruitment strategies: responses
to severe chemoreflex and baroreflex stress

(Published in Am J Physiol Regul Integr Comp Physiol 309: R160-R168, 2015)

2.1 Introduction
Patterns of neural coding form the basis of all neural processes requiring
information exchange and processing. Neural coding patterns include variations in
firing rate of single neurons (rate coding), the timing of activity amongst synchronized
or pseudo-synchronized neurons (temporal coding), and varying thresholds for
recruitment of sub-populations (population coding). Although established largely in
intracerebral neural processing, these coding patterns exist in the control of peripheral
organs as well, such as during the generation of ever-increasing muscular force
(Henneman et al. 1965). Conversely, the neural strategies employed by the autonomic
nervous system, which regulates homeostatic and life-sustaining outcomes, remain
unclear, particularly in humans where access to direct neural recordings is limited. The
multiple sites of control through which efferent sympathetic outflow can be modified
include the brainstem autonomic nuclei (Barman & Gebber, 2000), spinal cord, and
paraspinal ganglia (Jänig & McLachlan, 1992; McAllen & Trevaks, 2003). These
junctures introduce opportunities for modifiable synaptic delays and latent neuronal
sub-populations.
Using microneurographic techniques (Hagbarth & Vallbo, 1968), direct
recordings are made from the populations of post-ganglionic sympathetic neurons
innervating the skeletal muscle vasculature (muscle sympathetic nerve activity; MSNA)
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in humans. The measured bursts of activity reflect periods of efferent action potential
synchronization (Delius et al. 1972b). The size of any given burst is determined by the
proximity of the recording electrode to the individual neurons within the respective
bundle of sympathetic axons (Tompkins et al. 2013), as well as the number (Ninomiya
et al. 1993) and size (Salmanpour et al. 2011a) of action potentials. With the use of
these features, the question of neural coding in efferent sympathetic nerve activity was
advanced by the introduction of single fibre recordings (Macefield et al. 1994), which
indicated that a given axon will fire approximately once per burst and perhaps two to
three times during states of elevated sympathetic drive (Macefield & Wallin, 1999;
Elam et al. 2002). To further study the existence of latent neuronal sub-populations
and/or modifiable synaptic delays, our laboratory developed a technique that quantifies
and classifies the populations of axons comprising each sympathetic burst (Salmanpour
et al. 2010). With the use of this approach, a fundamental pattern was exposed within
the sympathetic nervous system, whereby larger neurons with faster conduction
velocities are hierarchically recruited as sympathetic bursts become stronger (i.e.,
larger), an observation made under baseline conditions (Salmanpour et al. 2011a) and
during chemoreceptor activation (Steinback et al. 2010). Importantly, Steinback et al.
(2010) documented recruitment of latent sub-populations of larger neurons during
maximal end-inspiratory apnea, which were absent under baseline conditions. However,
in a preliminary study, recruitment of latent axons was not observed during moderate
baroreceptor unloading using −60 mmHg lower body negative pressure [LBNP;
(Salmanpour et al. 2011a)]. Discrepancy in neuronal recruitment patterns between
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studies may be due to reflex-specific strategies, varying thresholds for sub-population
recruitment, and/or interindividual variations.
To further understand rate and population coding within the efferent
sympathetic nervous system, this study tested the hypothesis of reflex-specific
sympathetic neural recruitment strategies during periods of high sympathetic stress in
the same individuals, and whether these recruitment patterns demonstrated test-retest
repeatability.

2.2

Methods

2.2.1 Participants
Eleven normotensive individuals (6 males, 5 females) participated in the current
investigation. Participants were aged 25 ± 3 years (mean ± SD) and were 173 ± 8 cm in
height and 70 ± 9 kg in weight (body mass index = 24 ± 2 kg/m2). Participants were
regular exercisers, non-smokers, and free of any overt cardiovascular or respiratory
disease (as assessed by a standardized health questionnaire). All protocols in the current
investigation were submitted to, and approved by, the Health Sciences Research Ethics
Board at Western University in Canada. All participants provided written informed
consent and were familiarized to all experimental procedures before study participation.

2.2.2 Experimental Protocol
All testing was conducted following at least a 3-hour fast and a 12-hour
abstinence from alcohol, caffeine, and other stimulants. Female participants were tested
during the early follicular menstrual cycle phase. Participants voided their bladder
immediately prior to testing commencement to minimize the effect of bladder distention
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on sympathetic nerve activity (Fagius & Karhuvaara, 1989). Experimentation entailed
two protocols as follows.
In the first protocol, the impact of progressive chemoreflex stress was studied in
which data were obtained in the supine position during a 5-minute period of baseline
(spontaneous breathing) and during a maximal end-inspiratory apnea, which was
preceded by a rebreathing period designed to maximize the severity of chemoreflex
stimulation through progressive hypoxia and hypercapnia [described previously in
detail; (Usselman et al. 2015)]. Briefly, participants were fitted with a mouthpiece
(series 9060, Hans Rudolph, Kansas City, MO) attached to a three-way valve allowing
them to breathe either room air, or through a Y-connector (VacuMed, Ventura, CA)
leading to two 3-liter breathing bags. Before the start of the protocol, participants
expired into the breathing bags to fill them with air for the ensuing rebreathing period.
After five minutes of baseline collection, the three-way valve was turned to initiate
rebreathing. Once end-tidal partial pressure of oxygen (PETO2) reached 70 Torr,
participants performed an end-inspiratory apnea of maximal voluntary duration. Upon
cessation, participants breathed twice into and out of the bags to allow for the
measurement of end-apnea PETO2 and end-tidal partial pressure of carbon dioxide
(PETCO2). Blood gases were analyzed using an infrared carbon dioxide sensor and
optical oxygen detector fed from a damped micro-vacuum sampling pump (ML206 Gas
Analyzer, ADInstruments, Colorado Springs, CO). Values were calibrated using
ambient air pressure values and converted to online measurements of PETO2 and
PETCO2.
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In the second protocol, the impact of severe baroreceptor unloading was studied.
Data were collected in the supine position during a 5-minute period of baseline
(spontaneous breathing) and during three minutes of −80 mmHg LBNP. One individual
exhibited presyncopal symptoms (i.e., systolic blood pressure <90 mmHg) during the
−80 mmHg LBNP protocol; however, data used for this participant included the first
170 seconds of LBNP, prior to the onset of presyncopal symptoms.
Heart rate was measured using a standard three-lead electrocardiogram.
Continuous beat-to-beat mean arterial blood pressure was obtained through finger
photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The
Netherlands). Finometer blood pressures were validated and calibrated to manual
sphygmomanometer blood pressure measurements taken throughout the protocol.
Stroke volume and cardiac output were obtained using the Finometer Modelflow
algorithm. Participant sex, age, height, and weight were input manually into the
Finometer to optimize estimation of stroke volume and cardiac output. Total peripheral
resistance was calculated as mean arterial pressure divided by cardiac output. Data were
collected using LabChart6 and PowerLab data acquisition system (ADInstruments).

2.2.3 Sympathetic Neural Recordings
Efferent post-ganglionic sympathetic outflow was measured in the fibular
(peroneal) nerve of the right leg by microneurography (Hagbarth & Vallbo, 1968).
Specifically, a tungsten microelectrode (35 mm long, 200 µm in diameter, and tapered
to a 1-5 µm uninsulated tip) was inserted percutaneously into the nerve just posterior to
the fibular head. A reference electrode was positioned subcutaneously 1-3 cm from the
recording site. A suitable recording site was searched for by manually manipulating the
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microelectrode until a characteristic pulse-synchronous burst pattern was observed.
Confirmation of an MSNA site was determined by the absence of skin paresthesia and a
signal that increased firing frequency in response to voluntary apnea, but not during
arousal to loud noise (Delius et al. 1972a). The MSNA neurogram was measured with a
nerve traffic analysis system (662C-3; Bioengineering of University of Iowa, Iowa City,
IA). The neural signal was first preamplified with a gain of 1,000 (using preamplifier
and isolation amplifier; gain of 100 and 10, respectively) and further amplified with a
gain of 75 (using a variable gain amplifier; gain of 0.1-99). The neural activity was then
band-pass filtered (bandwidth of 700-2,000 Hz) before being rectified and integrated
(using a leaky integrator; 0.1 s time constant) to obtain a mean voltage neurogram. The
raw, filtered, and integrated MSNA signals were sampled at a frequency of 10,000 Hz
and stored for further offline analysis (PowerLab Software, ADInstruments).

2.2.4 Integrated MSNA Analysis
Integrated bursts of MSNA were included in the analysis if they exhibited pulsesynchrony, had a signal-to-noise ratio of at least 2:1 with respect to the previous period
of neuronal silence between bursts, and had characteristic rising and falling slopes.
Occurrence of integrated sympathetic bursts was confirmed by visually inspecting the
corresponding raw and filtered neurograms.
Integrated sympathetic nerve activity was expressed both as burst frequency (the
number of bursts per minute) and burst incidence (the number of bursts per 100 heart
beats). Burst amplitudes during baseline and sympathoexcitatory maneuvers were
normalized to the largest recorded burst during each relevant baseline and maneuver
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period, which was given a value of 100. Total MSNA was quantified as the product of
mean normalized burst amplitude and burst frequency.

2.2.5 Action Potential Detection and Analysis
Action potentials were detected and extracted from the filtered raw MSNA
signal using the techniques developed in our laboratory and described previously in
detail [See Figure 2.1; (Salmanpour et al. 2010)]. Briefly, this approach detects
individual action potentials using a continuous wavelet transform (CWT). The CWT
uses a ‘mother wavelet’ that was adapted to an actual average action potential
waveform constructed from (and with the same morphology as) physiological
recordings of efferent post-ganglionic sympathetic action potentials (Salmanpour et al.
2010). The CWT was applied to the filtered raw MSNA signal to generate a
resemblance index (i.e., wavelet coefficient) between the signal of interest (i.e., an
action potential) and the mother wavelet, such that the wavelet coefficient was the
greatest in the presence of action potentials and negligible when applied to noise.
Wavelet coefficients related to action potentials and noise were separated based on
thresholding analysis (Johnstone & Silverman, 1997). The exact location of the
negative peak for each action potential was then detected by isolating the largest
suprathreshold wavelet coefficient. With the use of this location information, the action
potential waveforms were obtained from the original filtered raw MSNA signal by
setting the estimated location of action potentials in the center of a predefined window
(3.2 ms). As such, the amplitude and morphology of each extracted action potential
remained unaltered. Extracted action potentials were then ordered based on their peakto-peak amplitude, and histogram analysis was performed to separate action potentials
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into ‘clusters’ (i.e., bins or groups of action potentials with similar peak-to-peak
amplitudes) defined by Scott’s rule (Scott, 1979). Scott’s rule proposes the optimal
histogram bin width to minimize the integrated mean square error by defining bin width
based on the sample size and an estimate of the SD of the data. As such, the number of
total clusters varied by participant. To enable comparisons within maneuvers and
individuals, bin characteristics across conditions (i.e., baseline vs. apnea; baseline vs.
LBNP) were manipulated within each individual to ensure that minimum histogram bin
width, maximum bin center, and total number of bins would be identical across
conditions. This bin normalization ensured that corresponding clusters at baseline and
subsequent sympathoexcitatory maneuvers contained action potentials with similar
peak-to-peak amplitudes. As such, new clusters detected during sympathoexcitatory
maneuvers represent recruitment of new, larger action potentials not present during
baseline.
Action potential indices assessed include action potential frequency (the number
of action potentials per minute), action potential incidence (the number of action
potentials per 100 heart beats), and the mean action potential content per integrated
burst. Additionally, the number of total clusters detected and the number of active
clusters per integrated burst were assessed. The conduction latency of each individual
action potential was established as the time delay between the R-wave of the ECG of
the preceding cardiac cycle and the negative peak of the action potential waveform. As
such, action potential cluster latency was determined as the mean latency of all action
potentials contained within each cluster. As the number of total clusters varied by
individual, normalization procedures were completed when assessing action potential
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content and latency as a function of cluster number between individuals (i.e., Figures
2.4, 2.5, 2.8, and 2.9). Specifically, each participants’ number of total clusters was
normalized to 10 total clusters (i.e., bins), each containing a 10% range of the largest
detected cluster (i.e., 0-10%, 10-20%, etc.), which was given a value of 100%. For
example, cluster 0-10% contained an average of all cluster numbers that were 0-10% of
the largest cluster. This procedure was then repeated for the nine remaining clusters.

2.2.6 Test-Retest Repeatability of Action Potential Detection
To assess the test-retest repeatability of this technique to detect and extract
action potentials from the filtered raw MSNA signal, male participants (n = 6) were
studied a second time approximately one month following their initial testing day. All
repeat testing was conducted at the same time of day as initial testing. Successful
microneurographic recordings were obtained in both test dates in five participants, who
are thus included in the test-retest repeatability analysis (chemoreflex protocol; n = 4).
Test-retest repeatability of selected action potential variables (action potential
frequency and active clusters per burst) was assessed using the Bland-Altman method
of differences (Altman & Bland, 1983; Bland & Altman, 1986). To determine
systematic differences or biases between the two test dates, we assessed measures of
fixed bias and proportional bias. Fixed bias occurs when one test produces values that
are consistently greater or lesser than those from a second test by a constant amount,
whereas proportional bias occurs when one test produces values that are greater or
lesser than those from a second test by an amount proportional to the level of the
variable assessed (Ludbrook, 1997).
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2.2.7

Statistical Analysis
The effect of condition (baseline vs. apnea; baseline vs. LBNP) was assessed

using two-tailed, paired t-tests. Cohen’s d values are provided as an estimate of effect
size (Cohen, 1988). For test-retest repeatability analysis, fixed bias was tested using a
one-sample t-test, where the mean difference between test dates was tested against a
value of “0”. Proportional bias was determined to exist if the Pearson product-moment
correlation coefficient was significantly different than r = 0. Statistical significance was
set at P < 0.05 and all data are presented as means ± SD. All statistical analyses were
performed using SigmaPlot 12.0 (Systat Software Inc., San Jose, CA).

2.3

Results
Baseline versus End-Inspiratory Apnea. Data were obtained and analyzed for

297 ± 6 seconds at baseline and during 23 ± 10 seconds of a maximal end-inspiratory
apnea. A representative sample of data collected for one subject at baseline and during
chemoreflex conditions is shown in Figure 2.2. The rebreathe protocol and subsequent
apnea elicited severe chemoreflex stress, as evident by the significant end-apnea
decrease in PETO2 and increase in PETCO2 compared with baseline (all P < 0.0001;
Table 2.1). Results from the integrated MSNA analyses at baseline and during apnea
are presented in Table 2.2. Specifically, compared with baseline, burst frequency, burst
incidence, mean normalized burst amplitude, and total MSNA were significantly
increased during apnea (all P < 0.0001). The elevated sympathetic nerve activity during
apnea was concomitant with significant increases in mean arterial blood pressure and
total peripheral resistance (both P < 0.05; Table 2.1).
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When compared with baseline, both action potential frequency and action
potential incidence were elevated during apnea, yielding an increase in the mean action
potential content per burst during apnea (all P < 0.01; Table 2.2). When detected action
potentials were binned according to peak-to-peak amplitude, the number of total
clusters of action potentials detected (13 ± 4 to 20 ± 8 total clusters; P = 0.0009; d =
1.14; Figure 2.3a) increased during apnea. Moreover, the increased number of total
clusters was associated with a significant increase in the number of active clusters per
sympathetic burst (5 ± 2 to 8 ± 2 clusters/burst; P < 0.0001; d = 1.44; Figure 2.3b)
during apnea. When histogram analysis was conducted to represent action potential
content as a function of normalized cluster number (Figure 2.4), a shift in the median
occurred during apnea compared with baseline (P < 0.0001), indicating preferential
recruitment of larger-amplitude action potentials during apnea.
At baseline and during apnea, a pattern emerged whereby action potential
cluster latency decreased in each subject as cluster number increased (i.e., as peak-topeak cluster amplitude increased). The mean responses (Figure 2.5) were fitted using an
exponential function model at baseline (R2 = 0.91; P < 0.001) and during apnea (R2 =
0.98; P < 0.0001). Interestingly, the cluster latency profile was shifted downwards for
every corresponding cluster number during apnea versus baseline (range −15 to −99
ms; mean = −53 ± 27 ms), indicating that all action potentials with similar peak-to-peak
amplitudes were detected approximately 53 ms earlier during apnea versus baseline.
Baseline versus −80 mmHg LBNP. Data were obtained and analyzed for 274 ±
39 seconds at baseline and for 188 ± 15 seconds at −80 mmHg LBNP. A representative
sample of data collected for one subject at baseline and LBNP is shown in Figure 2.6.
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Hemodynamic parameters at baseline and during LBNP are displayed in Table 2.3.
Results from the integrated MSNA analyses during baseline and LBNP are presented in
Table 2.4. Specifically, compared with baseline, burst frequency, burst incidence, mean
normalized burst amplitude, and total MSNA were increased during LBNP (all P <
0.001). The increase in MSNA during LBNP was associated with a pronounced
tachycardia and reduction in stroke volume, as well as a significant increase in total
peripheral resistance (all P < 0.05; Table 2.3).
Action potential frequency, action potential incidence, and the mean action
potential content per burst were increased during LBNP versus baseline (all P < 0.01;
Table 2.4). When detected action potentials were binned according to their peak-topeak amplitude, the number of total action potential clusters increased from 15 ± 5 at
baseline to 26 ± 8 during LBNP (P = 0.0012, d = 1.66; Figure 2.7a), indicating
recruitment of approximately 11 additional, larger amplitude clusters of action
potentials during LBNP. This was associated with an increase in the number of active
clusters per sympathetic burst during LBNP (5 ± 1 to 8 ± 3 clusters/burst; P = 0.0076, d
= 1.44; Figure 2.7b). Histogram analysis representing action potential content as a
function of normalized cluster number (Figure 2.8) revealed a shift in the median value
during LBNP compared with the baseline period (P = 0.0011), indicating preferential
recruitment of larger amplitude action potentials during LBNP.
As with the apnea outcomes, action potential cluster latency decreased in each
participant as an inverse function of cluster number (i.e., as peak-to-peak amplitude
increased) at both baseline and LBNP. Mean responses (Figure 2.9) were fitted using an
exponential model at baseline (R2 = 0.97; P < 0.0001) and LBNP (R2 = 0.95; P <
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0.0001). However, in contrast to apnea, the cluster latency-size profile during LBNP
was shifted upwards relative to baseline for every corresponding cluster number (range
+2 to +45 ms; mean = +31 ± 12 ms), indicating that action potentials with similar peakto-peak amplitudes were detected approximately 31 ms later during LBNP.
Test-Retest Repeatability of Action Potential Detection. Results obtained from
the Bland-Altman method of differences for action potential detection at baseline and
during apnea and LBNP are summarized in Table 2.5. Specifically, action potential
frequency and the number of active clusters per burst were without significant
proportional or fixed bias during baseline, apnea, or LBNP in repeated test dates.
Furthermore, all hemodynamic, integrated MSNA, and action potential indices assessed
were without significant day-to-day variation (all P > 0.05).
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Table 2.1: Hemodynamic parameters at baseline and during maximal endinspiratory apnea

MAP (mmHg)
SBP (mmHg)
DBP (mmHg)
HR (beats min-1)
SV (mL)
CO (L min-1)
TPR (mmHg L-1 min-1)
PETO2 (Torr)
PETCO2 (Torr)

Baseline

Apnea

86 ± 8
120 ± 13
69 ± 8
55 ± 4
86 ± 12
4.7 ± 0.6
19 ± 2
103 ± 3
39 ± 3

97 ± 16†
134 ± 25*
78 ± 15†
62 ± 6†
81 ± 11*
5.0 ± 0.7
21 ± 3*
56 ± 3†
56 ± 4†

Values are mean ± SD. MAP, mean arterial pressure; SBP, systolic blood pressure;
DBP, diastolic blood pressure; HR, heart rate; SV, stroke volume; CO, cardiac output;
TPR, total peripheral resistance; PETO2, end-tidal partial pressure of oxygen; PETCO2,
end-tidal partial pressure of carbon dioxide. *Significantly different from baseline, P ≤
0.05; †Significantly different from baseline, P ≤ 0.01.
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Table 2.2: Integrated MSNA and action potential indices at baseline and during
maximal end-inspiratory apnea
Baseline

Apnea

Integrated MSNA
Burst Frequency (bursts/min)
Burst Incidence (bursts/100 heart beats)
Normalized Burst Amplitude (AU)
Total MSNA (AU)

15 ± 8
28 ± 16
24 ± 6
366 ± 220

48 ± 7†
77 ± 9†
58 ± 9†
2745 ± 478†

Action Potential Indices
AP Frequency (spikes/min)
AP Incidence (spikes/100 heart beats)
APs/Burst (spikes/burst)

174 ± 151
325 ± 293
11 ± 4

1083 ± 487†
1766 ± 829†
24 ± 12†

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; AU, arbitrary
units; AP, action potential. †Significantly different from baseline, P ≤ 0.01.
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Table 2.3: Hemodynamic parameters at baseline and during −80 mmHg lower
body negative pressure

MAP (mmHg)
SBP (mmHg)
DBP (mmHg)
HR (beats min-1)
SV (mL)
CO (L min-1)
TPR (mmHg L-1 min-1)

Baseline

LBNP

88 ± 8
121 ± 14
71 ± 9
56 ± 6
89 ± 19
4.9 ± 1.0
20 ± 4

88 ± 9
113 ± 14*
75 ± 8*
79 ± 14*
59 ± 19†
4.4 ± 1.0†
21 ± 4*

Values are mean ± SD. LBNP, lower body negative pressure; MAP, mean arterial
pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart
rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance.
*Significantly different from baseline, P ≤ 0.05; †Significantly different from
baseline, P ≤ 0.01.
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Table 2.4: Integrated MSNA and action potential indices at baseline and during
−80 mmHg lower body negative pressure
Baseline

LBNP

Integrated MSNA
Burst Frequency (bursts/min)
Burst Incidence (bursts/100 heart beats)
Normalized Burst Amplitude (AU)
Total MSNA (AU)

15 ± 7
26 ± 13
31 ± 12
472 ± 302

41 ± 15†
52 ± 12†
52 ± 4†
2138 ± 769†

Action Potential Indices
AP Frequency (spikes/min)
AP Incidence (spikes/100 heart beats)
APs/Burst (spikes/burst)

165 ± 83
296 ± 140
11 ± 2

839 ± 709†
1027 ± 703†
19 ± 9†

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; LBNP, lower
body negative pressure; AU, arbitrary units; AP, action potential. †Significantly
different from baseline, P ≤ 0.01.
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Table 2.5: Proportional and fixed bias outcomes for action potential detection
determined from the Bland-Altman method of differences during baseline,
maximal end-inspiratory apnea, and −80 mmHg lower body negative pressure
protocols

N = 5 males; r, Pearson product-moment correlation coefficient for the Bland-Altman
method of differences plots; PPB, P value for the Pearson product-moment correlation
coefficient for the determination of proportional bias; SE, standard error; CI,
confidence interval; PFB, P value for the one sample t-test on the mean differences
versus 0 for the determination of fixed bias; AP, action potential.
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Figure 2.1: Schematic representation of action potential (AP) detection and
classification.
MSNA, muscle sympathetic nerve activity.
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Figure 2.2: Representative sample of data from one subject collected at baseline,
during rebreathe, maximal end-inspiratory apnea, and recovery.
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Figure 2.3: Total detected clusters (A) and active clusters/burst (B) at baseline and
during maximal end-inspiratory apnea.
*Significantly different from baseline, P < 0.001.
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Figure 2.4: Histogram representing action potential (AP) content as a function of
normalized cluster number at baseline and during maximal end-inspiratory
apnea.
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Figure 2.5: Mean action potential cluster latency across participants as a function
of normalized cluster number at baseline and during maximal end-inspiratory
apnea.
Sample size for clusters in which not all 11 subjects are included are indicated in
parentheses. Sample sizes <11 at baseline represent subjects in whom these clusters
were not present at baseline but were recruited during apnea.
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Figure 2.6: Representative sample of data from one subject collected at baseline
and during −80 mmHg lower body negative pressure (LBNP) and recovery.
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Figure 2.7: Total detected clusters (A) and active clusters/burst (B) at baseline and
during −80 mmHg lower body negative pressure (LBNP).
*Significantly different from baseline, P < 0.01.
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Figure 2.8: Histogram representing action potential (AP) content as a function of
normalized cluster number at baseline and −80 mmHg lower body negative
pressure (LBNP).
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Figure 2.9: Mean action potential cluster latency across participants as a function
of normalized cluster number at baseline and −80 mmHg lower body negative
pressure (LBNP).
Sample size for clusters in which not all 11 subjects are included are indicated in
parentheses. Sample sizes <11 at baseline represent subjects in whom these clusters
were not present at baseline but were recruited during LBNP.

76

Discussion

2.4

The results of the current investigation reveal two novel findings which advance
our understanding of the neural coding patterns employed within the sympathetic
nervous system. First, we demonstrate the ability to recruit sub-populations of
previously silent (i.e., not present at baseline), larger amplitude, and faster conducting
sympathetic axons during periods of severe chemoreflex- and baroreflex-mediated
sympathoexcitation. We interpret this to be reflective of a reflex-independent
sympathetic neural recruitment strategy involving a latent sub-population of recruitable
neurons that are reserved for periods of severe stress. Second, our results demonstrate
the potential for reflex-specific changes in neural activation latency during periods of
severe sympathetic stress. Specifically, the action potential cluster latency profile was
shifted downwards during severe chemoreflex stress and upwards during severe
baroreceptor unloading. Of note, the deflections in the cluster latency response curve
were observed equally across all clusters, suggesting that this recruitment strategy was
applied to all action potentials and does not reflect slower axonal conduction. Rather,
this finding suggests variable synaptic delays as a second strategy to modify postganglionic sympathetic nerve activity. The combined data, observed in the same
individuals, supports the idea that both synaptic delay variations and high-threshold
sub-populations exist as recruitment strategies for post-ganglionic efferent sympathetic
outflow.
To date, available information on neural recruitment strategies within the
sympathetic nervous system has been largely inferred from the integrated neurogram.
For example, an early observation that larger integrated bursts exhibit shorter reflex
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latency led Wallin and colleagues to hypothesize that reductions in central synaptic
delays or variations in central pathways may occur and/or that there may exist
populations of latent sympathetic neurons with faster conduction velocities (Wallin et
al. 1994). More specific positioning of higher impedance electrodes enabled Macefield
and colleagues to isolate action potential discharge patterns of single sympathetic axons
within human peripheral nerves (Macefield et al. 1994). This approach revealed that,
when active, individual neurons generally fire only once per integrated burst (Macefield
et al. 1994), with the probability of multiple within-burst firing increasing during
periods of high sympathetic drive (Macefield & Wallin, 1999; Elam et al. 2002).
Results from these studies led to the idea that increased firing of already-active neurons
was an important mechanism by which burst strength is elevated during periods of
sympathetic stress (Macefield & Wallin, 1999).
Results from the current investigation, which studied action potential
recruitment from the multi-unit signal in both chemoreflex and baroreflex scenarios in
the same individuals, validate and extend these previous observations and provide
further insight into sympathetic neuronal recruitment strategies. First, evidence was
provided that sub-populations of previously dormant, larger amplitude, and faster
conducting sympathetic neurons are recruited during periods of high stress.
Importantly, the present data suggest that this appears to be a reflex-independent
strategy used within the sympathetic nervous system. These observations support the
earlier report that, in addition to higher firing rates of axons already recruited during
baseline, severe chemoreflex stress elicits activation of latent, higher-threshold, and
faster conducting (therefore, larger diameter) axons (Steinback et al. 2010). This
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discharge pattern was not observed during preliminary results using modest levels of
simulated orthostatic stress (i.e., −60 mmHg LBNP), whereby higher frequency firing
of action potential clusters already recruited at baseline was the primary determinant of
elevated efferent activity, with about 30% of participants demonstrating recruitment of
new, larger action potentials (Salmanpour et al. 2011a). Whereas orthostatic tolerance
or reserve varies across individuals, it remains likely that the threshold for recruitment
of this sub-population will also vary across individuals and with the level of stress. Our
current data indicate that more severe baroreceptor unloading (−80 mmHg LBNP) can
elicit recruitment of these latent axons. As such, it appears that during moderate levels
of stress, sympathetic activity is elevated through the multiple firing of already-active
neurons as previously hypothesized (Macefield & Wallin, 1999), whereas severe stress
stimulates the recruitment of latent sub-populations of larger axons to achieve the high
levels of sympathetic activity necessary. We therefore suggest that there may exist a
type of sympathetic reserve, whereby latent sub-populations of larger diameter, faster
conducting sympathetic neurons are reserved for severe sympathetic stress.
As previously established (Steinback et al. 2010; Salmanpour et al. 2011a), and
in support of observations from integrated MSNA analyses (Wallin et al. 1994), action
potential cluster latency was inversely related to action potential cluster amplitude,
whereby larger amplitude neurons exhibited shorter reflex latencies. This pattern was
observed both at baseline and during subsequent chemoreflex- and baroreflex-induced
sympathoexcitation. Interestingly, during severe chemoreflex stimulation, there was an
acute downward shift in the latency-size profile of all corresponding action potential
clusters (~ 53 ms; see Figure 2.5), such that the latency of all action potentials with
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similar peak-to-peak amplitudes was reduced during severe chemoreflex activation.
This systemic downward shift in the cluster latency profile was also demonstrated
during the Valsalva maneuver (Salmanpour et al. 2011b), and is consistent with
observed changes in mean reflex burst latency seen during several sympathoexcitatory
maneuvers (Fagius et al. 1987). The common pattern of this downward shift in latency
during both end-inspiratory apnea and Valsalva maneuver suggests a common
mechanism may be operating. Specifically, each maneuver elevates intrathoracic
pressure, thereby reducing venous return. Each also expresses a particular perceptual
stress related to individual volitional tolerance for the maneuver. While these two
observations are from different studies, they suggest a cardiac stimulus may have
contributed to the apneic outcomes of the current study. Alternatively, variations in
action potential latency during chemoreflex stress may be due to direct glutaminergic
activation of the rostral ventrolateral medulla from the nucleus tractus solitarius
(Koshiya et al. 1993), and/or faster conduction velocities within spinal descending
pathways specific to chemoreflex stimulation (Jänig & Szulczyk, 1979).
Conversely, we demonstrate that during −80 mmHg LBNP, the latency-size
profile of all corresponding action potential clusters was shifted upward (~31 ms; see
Figure 2.9), indicating that similarly sized post-ganglionic neurons were recruited with
a slightly slower latency during severe baroreceptor unloading, a pattern consistent with
that seen previously in a preliminary manner during −60 mmHg LBNP (Salmanpour et
al. 2011a). These data indicate that the sympathetic nervous system displays a unique
ability to modify acutely the reflex latency of all action potentials during severe
orthostatic stress. In as much as the conduction velocity of given axon is relatively
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fixed, these modifications in latency indicate malleability in the synaptic delays
between the brainstem and the recording electrode. One limitation of the multi-unit
recording approach is the inability to ensure that action potentials of the same size are
the same neurons with varying latencies during severe sympathoexcitation. However,
given the anatomical bundled distribution of axons in peripheral nerves (Tompkins et
al. 2013), it is unlikely that the recordings reflect completely different populations of
neurons. Regardless, all that can be concluded is that action potentials with similar
peak-to-peak amplitudes exhibit altered reflex latencies during chemoreflex- and
baroreflex-mediated sympathetic stress.
A potential limitation of the present study is that larger amplitude action
potentials observed during periods of severe sympathetic stress could theoretically be
the result of summation of two smaller-sized neurons firing concurrently, thereby
eliciting an artificially large action potential (Spickler & Kezdi, 1969; Andresen &
Yang, 1989). However, the likelihood for action potential summation is very low [~
0.3%; (Salmanpour et al. 2010)]. Further, such occurrences can be detected if the
resulting action potential is large and does not fit the latency-size pattern (Clamann &
Henneman, 1976) so that it is automatically removed from the analysis. Furthermore,
the mean signal-to-noise ratio of 4.15 ± 0.5 in the current data sets are expected to
produce a correct detection rate of >90% and false detection rate of <3% (Salmanpour
et al. 2010). Another consideration is that larger amplitude action potentials could be
the result of firing of neurons in close proximity to the recording electrode tip.
However, the consistent pattern that these larger action potentials reflect shorter
latencies argues against that possibility. Finally, results from our test-retest repeatability
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analysis, although completed in a small sample of men (n = 5), suggest that indices of
action potential detection are reproducible across test dates. If larger amplitude action
potentials were the result of summation or proximity to the recording electrode, one
would expect action potential indices to differ in repeated test dates, when the physical
relationship between the microelectrode placement and sympathetic axons is likely to
differ.
Perspectives and Significance
The current data indicate the existence of neural coding patterns within the
autonomic nervous system and enhances our understanding of how the sympathetic
nervous system is activated during reflex-mediated stress. Specifically, there appears a
fixed reflex-independent recruitment strategy, whereby the large increases in
sympathetic outflow during severe chemoreflex and baroreflex stress are the result of
recruitment of latent sub-populations of larger, faster conducting sympathetic neurons.
In addition, it appears as though the sympathetic nervous system is able to acutely
modify synaptic delays or central processing times and/or pathways, such that reflex
latency of all action potentials are altered during severe sympathetic stress. Taken
together, the data provide a new perspective on sympathetic stress responses. This new
understanding opens opportunity to study how such axonal recruitment strategies may
affect neurotransmitter discharge and overall vascular responses, as well as the effect of
age and disease on the patterning of efferent sympathetic outflow.
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Chapter 3

3

Central vs. peripheral determinants of sympathetic
neural recruitment: insights from static handgrip
exercise and postexercise circulatory occlusion

(Published in Am J Physiol Integr Comp Physiol 311: R1013-R1021, 2016)

3.1 Introduction
Neural coding patterns represent a fundamental feature in the exchange and
processing of neural information. Recently, we have confirmed that neural coding
principals operate within the sympathetic nervous system (Steinback et al. 2010;
Breskovic et al. 2011; Salmanpour et al. 2011a,b; Badrov et al. 2015; Badrov et al.
2016). Specifically, increases in muscle sympathetic nerve traffic in response to acute
physiological stress are the result of increased firing of low-threshold axons (i.e., rate
coding), as well as the recruitment of latent sub-populations of larger-sized axons that
are otherwise silent at baseline (i.e., population coding) (Steinback et al. 2010;
Breskovic et al. 2011; Salmanpour et al. 2011a; Badrov et al. 2015; Badrov et al.
2016). Furthermore, it appears that synaptic delay variations exist as a third strategy to
alter autonomic outflow (Salmanpour et al. 2011b; Badrov et al. 2015; Badrov et al.
2016). These strategies have been confirmed in two fundamental reflexes; that is, the
arterial baroreflex, studied during −80 mmHg lower body negative pressure (LBNP)
(Salmanpour et al. 2011a; Badrov et al. 2015) and the Valsalva maneuver (Salmanpour
et al. 2011b), as well as the arterial chemoreflex, as inferred during maximal voluntary
apnea (Steinback et al. 2010; Breskovic et al. 2011; Badrov et al. 2015; Badrov et al.
2016). However, a persistent question remains, particularly with the apnea response, as
to whether or not these recruitment strategies are restricted to the perception of effort
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during severe stress scenarios (i.e., a central command phenomenon), or to the severe
reflex stress alone (i.e., a peripheral-reflex mechanism). Evidence from the Valsalva
maneuver and voluntary apnea data do not exclude a role for a central perception of
effort determinant, whereas the LBNP data suggest a dominant role for peripheralreflex mechanisms. Additionally, one feature that may especially relate to central versus
peripheral features is the ability to acutely modify reflex latency. That is, compared to
resting levels, neural activation latency was reduced during voluntary apnea (Badrov et
al. 2015; Badrov et al. 2016) and the Valsalva maneuver (Salmanpour et al. 2011b), but
increased during LBNP-induced baroreceptor unloading (Badrov et al. 2015). As such,
the exact central versus peripheral mechanisms of these sympathetic neural recruitment
strategies remain to be fully elucidated.
The homeostatic response to fatiguing exercise represents a unique reflex in
which the central and peripheral elements of the reflex can be studied separately as they
develop over time. Specifically, alterations in efferent neural outflow during exercise
are mediated through a highly coordinated and integrative system of reflexes involving
feed-forward signals emanating from higher brain centres (i.e., central command)
(Johansson, 1895; Krogh & Lindhard, 1913; Goodwin et al. 1972), as well as peripheral
feedback from type III and IV muscle sensory afferents within active skeletal muscle
(i.e., exercise pressor reflex) (Alam & Smirk, 1937; McCloskey & Mitchell, 1972;
Kaufman et al. 1983; Mitchell et al. 1983). The exercise pressor reflex elicits large
increases in muscle sympathetic nerve activity (MSNA) (Mark et al. 1985; Seals et al.
1988; Victor et al. 1988; Wallin et al. 1989; Saito et al. 1990; Seals & Victor, 1991;
Shoemaker et al. 2007), albeit after a workload-dependent delay of approximately 30 to
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60 seconds (Mark et al. 1985). Sympathetic activity remains elevated during postexercise circulatory occlusion (PECO), which suggests that the mechanism of activation
relates to muscle metabolism and a dominant metaboreflex component. Furthermore, a
marked increase in integrated sympathetic burst size characterizes this reflex, most
likely reflective of increases in the number (Ninomiya et al. 1993) and/or size
(Salmanpour et al. 2011a) of action potentials (AP) firing more or less at the same time.
Recently, Murai et al. (2006) examined the firing patterns of a single axon that was
present at baseline and sustained during static handgrip (SHG) exercise and found
elevations in total sympathetic activity, but no change in the probability of multiple
within-burst firing of that axon. Combined, the observations of no change in the
probability of a single axon firing, but the need for additional and/or larger axons to
account for larger bursts, suggests that latent axons are recruited in the large
sympathetic response to fatiguing exercise. Thus, fatiguing exercise and the muscle
metaboreflex represents a unique model to study the central versus peripheral features
of sympathetic neural recruitment, as it allows the opportunity to isolate the peripheralreflex component from the central component (Alam & Smirk, 1937).
Therefore, to study the varying roles played by central versus peripheral
elements in the neural coding strategies used by the sympathetic nervous system during
acute physiological stress, we used a multi-unit AP approach to examine sympathetic
outflow patterns during fatiguing SHG exercise and a period of PECO. The latter was
designed to maintain and isolate the muscle metaboreflex (i.e., peripheral-reflex
component) from the central command features of the reflex (Alam & Smirk, 1937).
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3.2

Methods

3.2.1 Participants
Six young healthy, normotensive males (25 ± 3 yrs, 179 ± 7 cm, 82 ± 6 kg; body
mass index = 26 ± 2 kg/m2) were studied after providing informed written consent.
Participants were recreationally active, non-smokers, and otherwise healthy with no
history of cardiovascular or respiratory disease. The study was approved by the Health
Sciences Research Ethics Board at Western University in London, Canada.

3.2.2 Experimental Protocol
Participants were tested following a 3-hour fast, a 12-hour abstinence from
caffeinated products and alcohol, and a 24-hour abstinence from strenuous exercise.
Testing was completed in the supine position. Participants performed two maximal
voluntary contractions (MVCs) with their non-dominant hand (left hand in all
participants), and the largest of the two was used to calculate relative handgrip intensity
for the ensuing SHG protocol. Following a 3-minute baseline rest period, participants
performed SHG exercise for five minutes at 20% MVC, which was followed
immediately by PECO for three minutes. PECO was initiated approximately five
seconds prior to exercise completion by rapidly inflating a pneumatic cuff (Hokanson
SC12D, D.E. Hokanson, Bellevue, WA) on the upper exercised arm to suprasystolic
levels (~200 mmHg). Throughout SHG, visual feedback of exercise intensity was
provided to aid participants in the maintenance of target force. Upon exercise
completion, and before PECO onset, participants assessed their level of perceived
exertion using the 20-point Borg Rating of Perceived Exertion Scale (Borg, 1970).
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3.2.3 Experimental Measures
Sympathetic neural recordings were obtained in the right peroneal nerve using
microneurography (Hagbarth & Vallbo, 1968) (662C-3; Bioengineering of University
of Iowa, Iowa City, IA). The methodology used in our laboratory have been described
previously in detail (Steinback et al. 2010; Salmanpour et al. 2011a; Badrov et al.
2015). Heart rate (HR) was determined throughout the study protocol from a standard
three-lead electrocardiogram. Mean arterial pressure (MAP) was obtained on a beat-tobeat basis using finger photoplethysmography (Finometer; Finapres Medical Systems,
Amsterdam, The Netherlands) on the nonexercised hand, which was calibrated to
manual sphygmomanometry values. The Finometer Modelflow algorithm was used to
calculate stroke volume (SV) and cardiac output (CO), and total peripheral resistance
(TPR) was calculated as MAP divided by CO. Data were collected using LabChart7
and PowerLab (ADInstruments, Colorado Springs, CO).

3.2.4 Data Analysis
Data were analyzed for the 3-minute baseline period, each minute of the 5minute SHG exercise, and for the 3-minute PECO period. Sympathetic bursts were
identified from the integrated MSNA neurogram if: 1) they exhibited pulse-synchrony;
2) they had a signal-to-noise ratio of at least 2:1 with respect to the previous period of
neural silence between bursts; 3) they presented with characteristic rising and falling
slopes; and 4) APs were visible in the corresponding raw and filtered neurograms. The
level of integrated sympathetic activity was assessed using burst frequency (bursts/min)
and burst incidence (bursts/100 heart beats; hb). Furthermore, burst amplitude, which
reflects both the size (Salmanpour et al. 2011a) and number (Ninomiya et al. 1993) of
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APs recruited within each burst, was assessed. However, due to the potential influence
of microelectrode placement on the amplitude of the integrated signal (Vallbo et al.
1979; Tompkins et al. 2013), burst amplitude was normalized within each individual to
the largest burst at baseline, which was assigned a value of 100 arbitrary units (AU).
Finally, total MSNA (product of burst frequency and normalized burst amplitude) was
determined.
Sympathetic APs were extracted from the filtered raw MSNA signal using
wavelet-based methodology, as first used by others (Diedrich et al. 2003; Brychta et al.
2007), and modified in our laboratory (Salmanpour et al. 2010). Briefly, a continuous
wavelet transform with a ‘mother wavelet’ (adapted from actual physiological
recordings of post-ganglionic sympathetic APs) was applied to the filtered raw MSNA
signal to extract sympathetic APs at their point of incidence. Extracted APs were
ordered based on their peak-to-peak amplitude, and histogram analysis was conducted
to separate APs into ‘clusters’ (i.e., bins of similarly-sized APs) (Scott, 1979). The AP
detection, extraction, and classification process, as well as the reliability and
repeatability of our AP detection technique has been described previously in detail, and
readers are directed to this previous work (Salmanpour et al. 2010; Steinback et al.
2010; Badrov et al. 2015). Next, within participants, cluster characteristics were
normalized to ensure that bin width, maximum bin center, and the total number of bins
would be identical across conditions (i.e., baseline to SHG to PECO). This
normalization procedure ensured that corresponding clusters across conditions contain
APs with similar peak-to-peak amplitudes. Therefore, an increase in total clusters
during SHG or PECO represents recruitment of sub-populations of previously silent,
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larger-sized AP families that were not present at baseline. Finally, the average signalto-noise ratio in the current study was 4.4 ± 0.6, and based on previous validation
analysis of our analytical technique (Salmanpour et al. 2010), this is expected to
produce a correct detection rate of >90% and a false positive rate of <3%.
Patterns of AP activity were expressed using AP frequency (APs/min).
Recruitment of sympathetic APs was quantified using the mean AP content per
integrated sympathetic burst (APs/burst), the number of total AP clusters, and the
number of active AP clusters per integrated sympathetic burst (clusters/burst). AP
cluster latency was calculated as the mean AP latency of all APs present within that
respective cluster, which was measured as the time delay between the R-wave of the
preceding cardiac cycle and the negative peak of the AP waveform. As the number of
total AP clusters varied between participants, the number of total clusters was
normalized to 10 clusters, each containing 10% ranges of the largest detected cluster,
which was given a value of 100% (i.e., 0-10%, 10-20%, etc.), when assessing the AP
cluster size-latency relationship (Badrov et al. 2015; Badrov et al. 2016).

3.2.5 Statistical Analysis
One-way repeated measures ANOVAs assessed the effect of time (i.e., baseline
to SHG to PECO) on each hemodynamic, integrated MSNA, and AP variable
(SigmaPlot 12.0; Systat Software Inc., San Jose, CA). Data were tested for normal
distribution using Shapiro-Wilk tests. Non-normally distributed data were assessed
using Friedman repeated measures ANOVAs on ranks. Significant main effects were
assessed using Tukey’s post-hoc analysis. Statistical significance was set at P < 0.05
and all data are presented as mean ± SD.
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3.3

Results
Figure 3.1 displays original recordings of HR, MAP, integrated MSNA, filtered

raw MSNA, and detected APs from one participant. On average, SHG exercise was
completed at 20 ± 1% MVC and participants reported a Borg scale rating of 17 ± 2 at
end exercise.
Figure 3.2 displays the mean and individual hemodynamic responses to SHG
and PECO and Table 2.1 provides the delta values on going from baseline to each
period of the SHG and PECO protocol. At baseline, MAP was 94 ± 7 mmHg, HR was
62 ± 5 beats/min, SV was 106 ± 17 mL, CO was 6.7 ± 1.4 L/min, and TPR was 15 ± 3
mmHg/L/min. When compared with baseline, MAP was increased by minute two of
SHG, and remained elevated throughout the duration of exercise and PECO (all P <
0.01). HR was elevated during the entire SHG period and remained elevated during
PECO (all P < 0.001), but at levels that were less than those observed during minutes
three to five of SHG (all P < 0.05). When compared with baseline, SV was unchanged
during SHG and PECO (all P > 0.05). CO was elevated throughout SHG and PECO (all
P < 0.05). Finally, compared with baseline, TPR was reduced throughout SHG and
PECO (all P < 0.05).
Figure 3.3 illustrates the mean and individual integrated MSNA responses to
SHG and PECO and Table 3.2 provides the delta values. At baseline, burst frequency
was 18 ± 13 bursts/min, burst incidence was 28 ± 20 bursts/100 hb, burst amplitude was
46 ± 13 AU, and total MSNA was 742 ± 519 AU/min. When compared with baseline,
burst frequency and burst incidence were increased by minute three of SHG exercise
and remained elevated for the duration of exercise and PECO (all P < 0.05).
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Furthermore, burst amplitude increased above baseline by minute four of SHG and
remained elevated at minute five and during PECO (all P < 0.01). Finally, total MSNA
increased by minute three of SHG, remaining elevated above baseline levels for the
duration of exercise and PECO (all P < 0.05).
Figure 3.4 outlines the mean and individual AP responses to SHG and PECO
and Table 3.2 provides the delta values. At baseline, AP frequency was 223 ± 271
APs/min, the mean AP content per burst was 10 ± 5 APs/burst, the number of active
clusters per burst was 5 ± 2, and the number of total clusters was 14 ± 6. When
compared with baseline, AP frequency increased by minute three of SHG and remained
elevated throughout SHG and PECO (all P < 0.05). The mean AP content per integrated
sympathetic burst increased by minute four of SHG and remained elevated at minute
five and PECO (all P < 0.05). Similarly, the number of active clusters per integrated
burst was elevated by minute four and stayed elevated throughout the remainder of
SHG and PECO (all P < 0.01). Finally, compared to baseline, the number of total AP
clusters was increased at minutes four and five of SHG, and remained elevated during
PECO (all P < 0.01).
At baseline, AP cluster latency decreased as a function of normalized cluster
number (i.e., as the peak-to-peak AP cluster amplitude increased), such that larger-sized
APs exhibited shorter reflex latency. The mean response was fitted using an exponential
function model (R2 = 0.73; P < 0.001). The same pattern was observed throughout SHG
exercise (HG1: R2 = 0.92; HG2: R2 = 0.93; HG3: R2 = 0.83; HG4: R2 = 0.69; HG5: R2=
0.91; all P < 0.01) and PECO (R2 = 0.65; P < 0.01). When compared with baseline, the
AP cluster size-latency profile for corresponding clusters was not shifted significantly
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upward or downward during the first three minutes of SHG exercise (HG1: mean = 8 ±
16 ms, range −12 to 28 ms; HG2: mean = 4 ± 17 ms, range −17 to 27 ms; HG3: mean =
−11 ± 18 ms, range −38 to 12 ms; all P > 0.05). However, compared with baseline, the
AP cluster-size latency profile was shifted downward for every corresponding cluster
during minutes four (mean = −32 ± 22 ms, range −5 to −61 ms; P < 0.05) and five
(mean = −49 ± 17 ms, range −27 to −77 ms; P < 0.05; Figure 3.5) of SHG exercise,
such that all similarly sized APs were recruited earlier during SHG. During PECO, the
AP cluster size-latency profile was not different than baseline levels (mean = −9 ± 12
ms, range −25 to 9 ms; P > 0.05).
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Table 3.1: Hemodynamic responses to SHG and PECO

Values are mean ± SD. SHG, static handgrip; PECO, post-exercise circulatory
occlusion; HG, handgrip; MAP, mean arterial pressure; HR, heart rate; SV, stroke
volume; CO, cardiac output; TPR, total peripheral resistance. *Significantly different
from baseline, P < 0.05.
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Table 3.2: Integrated MSNA and action potential responses to SHG and PECO

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; SHG, static
handgrip; PECO, post-exercise circulatory occlusion; HG, handgrip; BF, burst
frequency; BI, burst incidence; BA, burst amplitude; AU, arbitrary units; AP, action
potential. *Significantly different from baseline, P < 0.05.
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Figure 3.1: Representative sample of data collected from one subject at baseline
(BSL) and during static handgrip and postexercise circulatory occlusion (PECO).
HR, heart rate; BP, blood pressure; MSNA, muscle sympathetic nerve activity; AP,
action potential. *Denotes noise spikes not included in analysis.
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Figure 3.2: Hemodynamic responses to static handgrip (HG) and postexercise
circulatory occlusion (PECO).
Dashed lines represent individual data. Values are mean ± SD. MAP, mean arterial
pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral
resistance. *P < 0.05, significantly different from baseline (BSL).
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Figure 3.3: Integrated muscle sympathetic nerve activity (MSNA) responses to
static handgrip (HG) exercise and postexercise circulatory occlusion (PECO).
Dashed lines represent individual data. Values are mean ± SD. AU, arbitrary units; hb,
heartbeats. *P < 0.05, significantly different from baseline (BSL).
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Figure 3.4: Sympathetic action potential (AP) responses to static handgrip (HG)
exercise and postexercise circulatory occlusion (PECO).
Dashed lines represent individual data. Values are means ± SD. *P < 0.05, significantly
different from baseline (BSL).
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Figure 3.5: Action potential (AP) cluster latency as a function of AP cluster size at
baseline (BSL), minutes one to five of static handgrip (HG), and post-exercise
circulatory occlusion (PECO).
No significant upward or downward shift was seen in the AP cluster size-latency profile
during HG1 (range −14 to 36 ms; range represents individual data), HG2 (range −18 to
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35 ms), or HG3 (range −53 to 10 ms), whereas a significant downward shift in the
profile was observed during HG4 (range 4 to −136 ms) and HG5 (range −9 to −198
ms). Finally, no significant upward or downward shift was seen during PECO (range
−28 to 22 ms). *Significantly different from BSL, P < 0.05.
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3.4

Discussion
This study examined AP recruitment patterns during the SHG and PECO phases

of the exercise pressor response maneuver to gain insight into the role that central
command elements versus peripheral-reflex mechanisms have in AP recruitment and
sympathetic outflow patterns in humans. The major findings of the current study are as
follows: 1) In response to exercise pressor reflex activation, the sympathetic nervous
system increases efferent nerve discharge through increased firing of previously
recruited axons, and also through the recruitment of latent sub-populations of largersized, faster conducting axons. These larger and faster APs were present at the end of
the SHG period and persisted throughout the PECO phase. 2) The latency of all APs
was reduced towards the end of fatiguing SHG exercise, but not during the PECO
phase. The results suggest that central command features may play a specific role in
modifying the synaptic delay aspect of efferent sympathetic discharge timing, whereas
peripheral muscle chemoreflex mechanisms affect the recruitment of latent highthreshold APs.
Fatiguing SHG exercise elicits robust increases in muscle sympathetic outflow
through activation of mechanically- and metabolically-sensitive Type III and IV
sensory afferents (Kaufman et al. 1983; Mitchell et al. 1983), and perhaps modulatory
input from higher brain sites during more intense contraction (Victor et al. 1995). To
date, quantification of the integrated MSNA neurogram has formed the basis of
determining the sympathetic response to this reflex, with the finding that MSNA is
increased after an initial delay (Mark et al. 1985), the timing of which is most likely
influenced inversely by contraction intensity (Hashimoto et al. 1998). Indeed, in the
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current study, MSNA burst frequency and incidence were elevated after approximately
two minutes of SHG exercise completed at the relatively modest intensity of 20%
MVC.
Presently, using a multi-unit AP approach, we show for the first time that the
sympathetic nervous system responds to fatiguing SHG exercise by increasing the firing
of already recruited lower-threshold axons, and through the recruitment of subpopulations of previously silent (i.e., not present at baseline), higher-threshold and
faster conducting (and therefore, larger) axons. This is similar to patterns observed
previously during both baroreflex (Salmanpour et al. 2011a; Badrov et al. 2015) and
arterial chemoreflex (Steinback et al. 2010; Breskovic et al. 2011; Badrov et al. 2015;
Badrov et al. 2016) stimuli, and is supported by the concept that C-fiber diameter
variations (~0.5 to 2.0 µm) exist within the human peroneal nerve (Tompkins et al.
2013). Since these larger and faster APs became evident after three minutes of exercise,
and persisted throughout the PECO period, their recruitment appears to be related to
peripheral events within the muscle and, therefore, related to the metaboreflex. These
observations discount a role for central factors in eliciting the recruitment of these latent
fibres, at least in this reflex model. Interestingly, the different time-course of change
between integrated MSNA indices (i.e., increased after two minutes) and AP
recruitment (i.e., increased after three minutes) may lend important information as to
the order of discharge options used by the sympathetic nervous system. Specifically,
MSNA burst frequency increased before the number of APs per burst or total AP
clusters increased, which suggests that the first option for the sympathetic nervous
system is to increase firing frequency and the second option is recruitment of additional
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fibres, as previously hypothesized (Macefield & Wallin, 1999), and similar to the
ordered recruitment observed in the motor system (i.e., Henneman’s Size Principle)
(Henneman et al. 1965). This also supports the conjecture that these axons are reserved
for periods of high or severe physiological stress (Salmanpour et al. 2011a; Badrov et
al. 2015). In line with this, recruitment of new, larger axons was observed in all
individuals during −80 mmHg LBNP, but in only approximately 30% of these same
individuals during −60 mmHg LBNP (Salmanpour et al. 2011a). Taken together, it
appears as though a fixed, reflex-independent recruitment strategy exists within the
sympathetic nervous system, whereby sub-populations of larger neurons are recruited
during severe stress scenarios requiring high sympathetic outflow, albeit with some
interindividual variations. Furthermore, the current results suggest that peripheral-reflex
mechanisms play a dominant role in mediating this recruitment response. Whether this
conclusion applies across all reflexes will require additional study. However, central
command likely has a small role in LBNP, lending further support to the reflexive role
played by peripheral sensory mechanisms in AP recruitment.
In addition to the above described recruitment options, the sympathetic nervous
system also modifies efferent firing of lower-threshold axons through acute variations
of reflex activation latency (Salmanpour et al. 2011b; Badrov et al. 2015; Badrov et al.
2016). In further support of this, we show here that the AP cluster size-latency profile
was shifted downwards towards the end of fatiguing SHG exercise, such that during
minutes four and five of SHG, all APs expressed a shorter latency. Similar observations
have been made during the Valsalva maneuver (Salmanpour et al. 2011b) and during
maximal voluntary apnea (Badrov et al. 2015; Badrov et al. 2016). That this downward
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shift occurred during both peripheral chemoreflex activation (i.e., during volitional
apnea) (Badrov et al. 2015; Badrov et al. 2016) and muscle chemoreflex activation (i.e.,
during SHG) suggests perhaps that chemoreflex stress may be involved. However,
during isolation of the metaboreflex with PECO in the current study, the AP cluster
size-latency profile was shifted back toward baseline resting levels, indicating that the
muscle chemosensitive sensory afferents are unlikely to play a role in our observed
findings. Rather, the common pattern of a downward shift in the AP cluster size-latency
profile during the Valsalva maneuver (Salmanpour et al. 2011b), during maximal
voluntary apnea (Badrov et al. 2015; Badrov et al. 2016), and toward the end of
fatiguing SHG exercise here, suggests that a perceptual component (i.e., central
command) may be involved in this outcome. Specifically, each maneuver exhibits a
certain level of volitional stress that is related to individual tolerance and perception of
the maneuver. The exact mechanism(s)/source(s) for this change in AP latency cannot
be discerned from the current analysis and requires additional study. However, in as
much as conduction velocity of a given axon is relatively stable, our observations
suggest the possibility of variations in synaptic delays somewhere within the neural
pathway. Indeed, Macefield et al. (1994) noted that the AP latency of a single axon can
vary rather significantly (i.e., 358 ± 33 ms), demonstrating the potential for
considerable modification of synaptic delays and/or central processing times. The
functional significance of this systemic and coordinated shift to shorter reflex latency
remains unknown. However, the consistent observation of this downward shift in
latency during several sympathoexcitatory maneuvers suggests it may be a response
reserved for severe stress scenarios requiring high, and perhaps faster occurring,
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sympathetic outflow. Nonetheless, it appears that acute malleability of synaptic delays
and/or central processing times may represent a unique option available to alter efferent
sympathetic outflow during fatiguing SHG exercise, and this is perhaps mediated
through a central command phenomenon.
While the use of fatiguing SHG exercise and PECO offers a unique model to
study the central versus peripheral features of sympathetic neural recruitment, we
cannot conclude with certainty that the PECO phase represents solely peripheral (i.e.,
metaboreflex) feedback to the central nervous system, without any lingering central, or
perceptual, component. Indeed, the discomfort experienced during this period, and
retained pressor response, may sustain and/or modify residual centrally-determined
sympathetic patterns. In this sense, the lack of a control exercise recovery (i.e., no
PECO phase following SHG exercise) period, as performed by other groups (Crisafulli
et al. 2003; Mulliri et al. 2016), may represent a limitation of the current study.
However, data from these groups using a handgrip model without PECO supports the
concept that the occlusion phase represents selectively peripheral, metaboreflexmediated input, as the exercise pressor response is maintained during PECO, but absent
during the control recovery phase (Crisafulli et al. 2003). Furthermore, a ‘resting’
circulatory occlusion period (i.e., not preceded by exercise) had no effect on baseline
resting cardiovascular parameters, further discounting a role for central, or perceptual,
elements during our PECO phase in the current study.
In summary, alterations in efferent sympathetic neural outflow during fatiguing
exercise occur as a result of increased firing frequency and probability of lowerthreshold axons, as a result of recruitment of previously silent sub-populations of
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larger-sized, faster conducting axons, and perhaps through acute changes of synaptic
delays and/or central processing times. Taken together, it appears as though this
represents a generalized central neural coding response to severe stress within the
sympathetic nervous system. Our findings here, although in one reflex model, suggest a
role for central command features in mediating the synaptic delay aspect of sympathetic
discharge patterning, whereas peripheral-reflex mechanisms appear largely responsible
for recruitment of latent sympathetic fibres.
Perspectives and Significance
The current work and analytical technique complements traditional integrated
methodology, but provides a novel perspective on sympathetic discharge patterns
during exercise pressor reflex activation and, therefore, may offer new insights into
important unanswered concepts, such as 1) the influence of these neural coding patterns
on neurotransmitter release and end-organ vascular responses; 2) the apparent
decoupling between elevated sympathetic outflow and vascular resistance in the
inactive limb during metaboreflex activation (i.e., neurovascular transduction)
(Shoemaker et al. 2016); 3) the complex interplay between and neurocircuitry involved
in central command and perception of effort during exercise and the potential for
feedback-related central control (Williamson, 2010; Basnayake et al. 2012); and 4) the
exaggerated sympathetic responses to exercise (and in turn, limited exercise capacity)
observed in certain clinical pathologies (i.e., congestive heart failure) (Notarius et al.
2001; Murai et al. 2009).
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Chapter 4

4

Effects of aging and coronary artery disease on
sympathetic neural recruitment strategies during endinspiratory and end-expiratory apnea

(Published in Am J Physiol Heart Circ Physiol 311: H1040-H1050, 2016)

4.1 Introduction
Sympathetic nervous system dysregulation represents a hallmark of increasing
age and cardiovascular disease. This dysregulation has been well-studied at rest, where
aging and cardiovascular disease are characterized by a net elevation in baseline
sympathetic outflow (Seals & Esler, 2000; Grassi et al. 2015), which contributes to
numerous deleterious consequences, including cardiac and vascular damage and
remodeling, cardiac dysrhythmias, and an elevated risk of mortality (Pauletto et al.
1991; Barretto et al. 2009; Grassi et al. 2011). However, the mechanisms involved in
aberrant sympathetic control with aging and cardiovascular disease, such as the distinct
features of central recruitment strategies, are not known.
Normally, sympathetic neural control involves central integration of sensory and
cortical/sub-cortical signals within the brain stem and spinal cord (Barman & Gebber,
2000), synapses at the sympathetic ganglia (Jänig & McLachlan, 1992), efferent postganglionic nerve traffic, neurotransmitter release, and the subsequent vascular effect at
the end-organ (Shoemaker et al. 2016). These elements introduce multiple sites of
control in which sympathetic outflow can be coded and modified in response to acute
physiological perturbation. Data from direct single- and multi-fibre recordings of
central sympathetic outflow in young healthy individuals indicate that the sympathetic
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nervous system has options to increase the firing frequency and probability of lowthreshold axons (Macefield & Wallin, 1999; Salmanpour et al. 2011a), recruit latent
sub-populations of higher-threshold and faster conducting axons (Steinback et al.
2010b; Badrov et al. 2015), as well as acutely modify synaptic delays and/or central
processing times (Salmanpour et al. 2011b; Badrov et al. 2015). These patterns
illustrate unique properties of the central nervous system to fine-tune autonomic
homeostatic control.
Whether these neural coding strategies are affected by increasing age and
cardiovascular pathology normally associated with advancing age remains uncertain.
While recordings from single muscle vasoconstrictor axons reveal an increased firing
probability and frequency of single-units in cardiovascular disease (Greenwood et al.
1999; Macefield et al. 1999), the typical observation that a given neuron will fire
usually only once per sympathetic burst at rest appears unchanged in congestive heart
failure with reduced left ventricular ejection fraction (LVEF) (Macefield et al. 1994;
Macefield et al. 1999). Conversely, within-burst firing frequency of single axons at
baseline is increased in other states of chronic sympathetic arousal, such as obstructive
sleep apnea (Elam et al. 2002) and chronic obstructive pulmonary disease (Ashley et al.
2010), as well as in response to an acute physiological challenge (Macefield & Wallin,
1999; Elam & Macefield, 2001; Murai et al. 2006). However, information regarding the
several recruitment strategies available (i.e., recruitment of new axons) to the
sympathetic nervous system cannot be extracted from single-unit recordings, but
requires a multi-unit analysis model. Using multi-fibre recordings, we have documented
recruitment of new sub-populations of larger axons (Steinback et al. 2010b; Breskovic
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et al. 2011; Badrov et al. 2015), as well as modifiable synaptic delays (Badrov et al.
2015), in response to voluntary apnea-induced sympathoexcitation in young healthy
individuals. However, the ability to recruit latent neuronal sub-populations may be
diminished with healthy aging and cardiovascular disease (Maslov et al. 2012; Maslov
et al. 2014).
Therefore, the current study examined the hypothesis that cardiovascular disease
impairs sympathetic neural recruitment. Coronary artery disease (CAD) patients with
preserved LVEF completed maximal voluntary apneas, which served as a stimulus for
sympathoexcitation, and the response was compared to that of young healthy and older
healthy individuals to account for the concurrent effect of age.

4.2 Methods
4.2.1 Participants
Forty-two individuals participated in the current investigation after providing
informed written consent. Participants comprised three groups: 1) young healthy
individuals (YH; n = 14, 5 females), 2) older healthy individuals (OH; n = 14; 6
females), and 3) CAD patients (CAD; n = 14, 3 females). Participant characteristics are
summarized in Table 4.1. YH and OH participants were non-smokers, free of overt
disease, and non-medicated. CAD patients included those who were discharged from
hospital following an acute ST elevation (n = 7) or non-ST elevation (n = 7) myocardial
infarction (MI) as documented by their attending physician. In all instances, patients
presented with their first MI. Eleven patients underwent percutaneous coronary
intervention and four underwent coronary artery bypass grafting surgery. No CAD
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patients had a history of congestive heart failure, renal insufficiency, or diabetes
mellitus, and all had preserved LVEF at the time of study. Although all patients were on
anti-hypertensive medications, all presented with resting blood pressures within the
normal range (i.e., <140/90 mmHg). Six patients were former or current smokers at the
time of study. On average, testing took place 67 ± 37 days following hospital discharge.
Medication use in the CAD patients included beta-blockers (n = 13; 93%), angiotensin
converting enzyme inhibitors (n = 13; 93%), calcium channel blockers (n = 3; 21%),
diuretics (n = 1; 8%), statins (n = 13; 93%), and anti-platelets, including aspirin (n = 14;
100%). All experimental protocols were approved by the Health Sciences Research
Ethics Board at Western University.

4.2.2 Experimental Protocols
Participants arrived for testing having fasted and abstained from caffeine and
alcohol for 12 hours, and vigorous exercise for 24 hours. Data were collected in the
supine position during 1) a 1-minute baseline period and a subsequent end-inspiratory
(EI) apnea of maximal voluntary duration, and 2) a 1-minute baseline period and a
subsequent end-expiratory (EE) apnea of maximal voluntary duration. Both EI- and EEapnea were repeated twice, with each trial separated by three minutes of rest. EI- and
EE-apnea were used as stimuli to increase muscle sympathetic nerve activity (MSNA)
in order to study the neural recruitment strategies employed by the sympathetic nervous
system during reflex-mediated sympathoexcitation. Both EI- and EE-apnea elicit
marked increases in sympathetic outflow, albeit through different mechanisms.
Voluntary EI-apnea increases MSNA through a variety of factors including unloading
of the baroreceptors, chemoreflex activation, and an increased central drive-to-breathe

120

(Ferrigno et al. 1986; Somers et al. 1989; Hardy et al. 1994; Steinback et al. 2010a).
On the other hand, EE-apnea increases MSNA predominantly through chemoreflex
stimulation, as well as a lack of ventilatory restraint on sympathetic outflow, and
increased central drive-to-breathe (Somers et al. 1989; Hardy et al. 1994; Steinback et
al. 2010a).

4.2.3 Experimental Measures
Sympathetic neural recordings were obtained in the right peroneal nerve by
microneurography, using standard procedures originally defined by Hagbarth and
Vallbo (1968) and used frequently in our hands (Steinback et al. 2010b; Salmanpour et
al. 2011a; Badrov et al. 2015) (662C-3; Bioengineering of University of Iowa, Iowa
City, IA). Blood pressure was obtained throughout the experimental protocol using
finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The
Netherlands), which was calibrated to manual sphygmomanometry. Heart rate (HR)
was calculated from a standard three-lead electrocardiogram. Stroke volume (SV) and
cardiac output (CO) were acquired using the Finometer Modelflow algorithm and total
peripheral resistance (TPR) was calculated as the quotient of mean arterial pressure
(MAP) and CO. All data were collected and analyzed offline using LabChart6 and
PowerLab (ADInstruments, Colorado Springs, CO).

4.2.4 Data Analysis
For both the EI- and EE-apnea protocols, data were analyzed for the 1-minute
baseline period and during the second half of maximal voluntary apnea. MSNA was
analyzed from the integrated neurogram and from our technique to detect and extract
action potentials (APs) from the filtered raw MSNA signal (Salmanpour et al. 2010).
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Integrated MSNA was quantified using burst frequency and burst incidence [bursts per
minute and bursts per 100 heart beats (hb), respectively]. Furthermore, burst amplitude
(normalized to the largest burst at baseline, which was given a value of 100) and total
MSNA (product of normalized burst amplitude and burst frequency) were determined.
Individual APs were extracted from the filtered raw MSNA signal using
wavelet-based methodology, as first reported by others (Diedrich et al. 2003; Brychta et
al. 2007), and modified in our hands (Salmanpour et al. 2010). Our approach, described
in detail elsewhere (Salmanpour et al. 2010; Badrov et al. 2015), uses a continuous
wavelet transform constructed from real post-ganglionic sympathetic APs (Salmanpour
et al. 2010), that extracts APs at their point of occurrence, and classifies them according
to their peak-to-peak amplitude into clusters (i.e., bins) of similarly-sized APs using
Scott’s rule (Scott, 1979). To enable investigation into whether recruitment of new,
larger AP clusters occurred during apnea, a secondary analysis stage was introduced
whereby cluster characteristics were manipulated within each participant so that
minimum bin width, maximum bin center, and the total number of bins would be
identical across conditions. Therefore, corresponding clusters at baseline and apnea
contain APs with similar peak-to-peak amplitudes, while additional clusters during
apnea represent recruitment of latent sub-populations of larger-sized axons (i.e., not
present at baseline).
AP variables were quantified using AP frequency and AP incidence (APs per
minute and APs per 100 hb, respectively), as well as the mean AP content per
integrated sympathetic burst. Furthermore, the number of total AP clusters and the
number of active clusters per burst are presented. AP cluster latency was calculated as
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the average latency of all APs present within that cluster (as measured by the time delay
between the R-wave of the electrocardiogram of the preceding cardiac cycle and the
negative peak of the AP waveform). To adjust for the impact of interindividual
variations in total cluster number on calculations of changes in AP cluster latency, the
number of total clusters was normalized to 10 bins (i.e., 10% ranges of the largest
detected cluster, which was given a value of 100%) for this analysis step, as described
previously (Badrov et al. 2015).

4.2.5 Statistical Analysis
Mixed model ANOVAs (SigmaPlot 12.0; Systat Software Inc., San Jose, CA)
assessed the effect of group versus time (baseline vs. EI-apnea; baseline vs. EE-apnea)
on MSNA and hemodynamic variables. Bonferroni-corrected post hoc procedures were
used to evaluate specific differences between means. Regression analyses were used to
determine specific relationships between variables when applicable. For the EE-apnea
protocol, six participants (YH, n = 2; OH, n = 2; CAD, n = 2) were excluded as their
MSNA signal was obscured by motor-unit activation and/or a signal-to-noise ratio
(SNR) that was too poor to allow for adequate AP analysis. Statistical significance was
set at P < 0.05 and all data are means ± SD, unless otherwise stated.

4.3

Results
As noted above, some MSNA recordings lacked appropriate SNR or were

contaminated by motor-unit activation. Also, variations exist between individuals in the
duration of apnea, as well as within individuals in terms of the response and duration to
repeated apneas. To address these issues, Bland-Altman analyses assessed the

123

agreement between the first and second EI- and EE-apneas for all MSNA and AP
variables. Participants with SNR >3.7 (i.e., to allow for adequate AP detection) for both
apneas were included in the analysis (EI-apnea, n = 33; EE-apnea, n = 21). Briefly,
while the second EI- and EE-apnea were of longer duration (EI-apnea: 41 ± 17 vs. 36 ±
17 s; EE-apnea: 21 ± 10 vs. 19 ± 10 s; both P < 0.05), no differences existed between
the first and second sympathetic response to either EI- or EE-apnea (all P = NS), and all
MSNA and AP variables were without significant fixed or proportional bias (EI-apnea:
Total MSNA: 127 ± 139, mean difference ± SE; APs/burst: 0.6 ± 0.5; Clusters/burst:
0.1 ± 0.1; Total Clusters: 0.2 ± 0.5; EE-apnea: Total MSNA: −474 ± 315; APs/burst:
0.6 ± 0.7; Clusters/burst: 0.3 ± 0.2; Total Clusters: −0.5 ± 0.6). With no withinindividual differences between the first and second apnea, the average of the two EIand two EE-apneas were used in the final analysis. Re-examination of results with
removal of statistical outliers (i.e., those individuals with data points that were more
than 1.5 interquartile ranges below the first quartile or above the third quartile) did not
significantly alter the results; therefore, data from these individuals were retained in the
final analysis (Tukey, 1977). Finally, the mean SNR in the current study was 4.1 ± 0.5,
which is expected to produce a correct detection rate of >90% and a false positive rate
of <3% (Salmanpour et al. 2010).
Figure 4.1 displays representative recordings of the integrated MSNA
neurogram and detected APs from one YH individual, one OH individual, and one
CAD patient at baseline and during EI-apnea and EE-apnea.
Baseline versus End-Inspiratory Apnea. The duration of the second half of EIapnea was 46 ± 17 s (range 27 to 78 s) in YH, 35 ± 15 s (range 15 to 70 s) in OH, and
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28 ± 6 s (range 19 to 44 s) in CAD patients. In a pointwise contrast, CAD patients had a
lower EI-apnea duration compared to YH (P < 0.01). MAP, HR, and TPR exhibited
effects of time, whereby each increased during EI-apnea, while reductions in SV and
CO occurred (all P < 0.05; Table 4.2); however, no group differences existed in the
hemodynamic response to EI-apnea (all P = NS).
Table 4.3 outlines the integrated MSNA and AP indexes during EI-apnea and
their relative baseline values. Compared to YH, baseline burst frequency and burst
incidence were higher in OH and CAD (all P < 0.01), but no differences were observed
between OH and CAD (P = NS). Compared with baseline, all integrated MSNA
variables increased during EI-apnea in all groups (all P < 0.01). However, compared to
YH, the change in integrated MSNA was blunted in OH and CAD (all P < 0.01), with
no differences between OH and CAD (P = NS). Whereas EI-apnea resulted in increased
AP frequency and AP incidence in all groups (all P < 0.01), CAD patients had a
reduced ability to increase AP frequency and AP incidence compared to YH (both P <
0.01). No differences in the AP frequency and AP incidence response existed between
YH and OH (P = NS) or OH and CAD (P = NS).
Compared with baseline, the mean AP content per burst increased during EIapnea in YH (11 ± 8 to 17 ± 11 APs/burst; P < 0.01) and OH (10 ± 5 to 13 ± 7
APs/burst; P < 0.01), while no change occurred in CAD patients (10 ± 4 to 11 ± 5
APs/burst; P = NS; Figure 4.2a). The magnitude of response was reduced in both OH
and CAD compared to YH (P < 0.01), and further reduced in CAD versus OH (P <
0.01). When APs were binned according to their peak-to-peak amplitude, the number of
total clusters of APs increased in YH (9 ± 3 to 14 ± 4 total clusters; P < 0.01) and OH
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(13 ± 3 to 14 ± 3 total clusters; P < 0.01) during EI-apnea, but not in CAD patients (14
± 3 to 12 ± 3 total clusters; P = NS; Figure 4.2b). The ability to recruit new clusters of
APs was diminished in OH and CAD patients compared to YH (P < 0.01), and further
decreased in CAD versus OH (P < 0.01). Finally, the number of active clusters per
burst increased during EI-apnea in YH (4 ± 2 to 6 ± 2 clusters/burst; P < 0.01) and OH
(5 ± 1 to 6 ± 2 clusters/burst; P < 0.01), but not in CAD patients (5 ± 1 to 5 ± 1
clusters/burst; P = NS; Figure 4.2c). The magnitude of change was lower in OH and
CAD compared with YH (both P < 0.01), and further lowered in CAD compared with
OH (P < 0.01). When all subjects were pooled, EI-apnea duration correlated poorly
with the mean AP content per burst response (r = 0.207; P = NS) and the active clusters
per burst response (r = 0.277; P = NS) to apnea. EI-apnea duration correlated
moderately well with the total clusters response (r = 0.553; P < 0.01) to apnea;
however, when accounting for age and incidence of CAD, EI-apnea duration no longer
predicted the total cluster response to apnea (P = NS).
In all groups, at baseline (YH: R2 = 0.93; OH: R2 = 0.90; CAD: R2 = 0.77; all P <
0.01) and during EI-apnea (YH: R2 = 0.97; OH: R2 = 0.94; CAD: R2 = 0.91; all P <
0.01), a pattern emerged whereby AP cluster latency decreased as a function of
normalized cluster number (i.e., as peak-to-peak AP cluster amplitude increased). The
mean responses (Figure 4.3) were fitted using an exponential function model at baseline
and during EI-apnea. Interestingly, the cluster size-latency profile shifted downward for
every corresponding cluster during apnea in YH (range −8 to −48 ms; mean: −28 ± 15
ms; P < 0.01), OH (range −15 to −38 ms; mean: −32 ± 7 ms; P < 0.01), and CAD
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patients (range −5 to −58 ms; mean: −21 ± 17 ms; P < 0.01). No differences were found
in the magnitude of change between groups (all P = NS).
Baseline versus End-Expiratory Apnea. The duration of the second half of EEapnea was 20 ± 10 s (range 12 to 47 s) in YH, 22 ± 11 s (range 8 to 45 s) in OH, and 16
± 5 s (range 10 to 27 s) in CAD patients. No differences in duration were observed for
EE-apnea between groups (P = NS). Both MAP and TPR exhibited effects of time,
whereby values increased during EE-apnea; in contrast, reductions occurred in SV and
CO (all P < 0.05; Table 4.2). However, no group differences existed in the
hemodynamic response to EE-apnea (all P = NS).
Table 4.4 outlines the integrated MSNA and AP indexes during EE-apnea and
their relative baseline values. Once again, compared with YH, baseline burst frequency
and burst incidence were higher in OH and CAD (all P < 0.01), but no differences were
observed between OH and CAD (P = NS). Compared with baseline, all integrated
MSNA variables increased during EE-apnea in all groups (all P < 0.01). However,
compared with YH, the changes in burst frequency, burst amplitude, and total MSNA
were blunted in OH and CAD (all P < 0.01), while the change in burst incidence was
lower in CAD versus YH (P < 0.01). No differences were found between OH and CAD
for any integrated MSNA variable (all P = NS). Additionally, compared to baseline,
EE-apnea resulted in increased AP frequency and AP incidence in all groups (P <
0.05); however, CAD patients had a decreased ability to increase AP frequency and AP
incidence compared with YH (P < 0.01), while no differences existed between OH and
CAD (P = NS).
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Compared to baseline, the mean AP content per burst increased in YH (11 ± 6 to
20 ± 9 APs/burst; P < 0.01) and OH (11 ± 4 to 15 ± 8 APs/burst; P < 0.01) in response
to EE-apnea, but was unchanged in CAD patients (11 ± 6 to 13 ± 6 APs/burst; P = NS;
Figure 4.4a). The change in the mean AP content per burst was lower in OH and CAD
than in YH (both P < 0.01); however, no difference existed between OH and CAD (P =
NS). When APs were binned according to their peak-to-peak amplitude, the number of
total clusters of APs increased in YH (8 ± 4 to 14 ± 5 total clusters; P < 0.01), but was
unchanged in both OH (12 ± 3 to 13 ± 4 total clusters; P = NS) and CAD patients (13 ±
4 to 12 ± 2 total clusters; P = NS; Figure 4.4b). As such, the ability to recruit new
clusters of APs was diminished in OH and CAD compared with YH (both P < 0.01).
Finally, compared with baseline, the number of active clusters per burst increased
during EE-apnea in YH (4 ± 2 to 6 ± 2 clusters/burst; P < 0.01) and OH (5 ± 1 to 6 ± 2
clusters/burst; P < 0.01), but not in CAD patients (5 ± 1 to 6 ± 1 clusters/burst; P = NS;
Figure 4.4c). The magnitude of change was lower in OH and CAD compared with YH
(P < 0.01). When all subjects were pooled, EE-apnea duration correlated poorly with
the mean AP content per burst response (r = 0.029; P = NS), the active clusters per
burst response (r = 0.117; P = NS), as well as the total clusters response (r = 0.297; P =
NS) to apnea.
Similar to EI-apnea, a pattern emerged during baseline (YH: R2 = 0.76; OH: R2 =
0.85; CAD: R2 = 0.88; all P < 0.01) and EE-apnea (YH: R2 = 0.95; OH: R2 = 0.97; CAD:
R2 = 0.87; all P < 0.05), whereby AP cluster latency decreased as a function of
normalized cluster number (i.e., as peak-to-peak AP cluster amplitude increased). The
mean responses (Figure 4.5) were fitted using an exponential function model at baseline
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and during EE-apnea. Once again, the cluster size-latency profile shifted downward for
every corresponding cluster during apnea in YH (range −12 to −74 ms; mean: −35 ± 23
ms; P < 0.01), OH (range 0 to −47 ms; mean: −30 ± 14 ms; P < 0.01), and CAD
patients (range −31 to −87 ms; mean: −59 ± 17 ms; P < 0.01). No differences were
found in the magnitude of change between groups (all P = NS).
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Table 4.1: Participant characteristics
YH

OH

CAD

Age (y)

25±3

59±9*

61±10*

Height (cm)

173±8

168±7

169±9

Weight (kg)

74±13

68±11

86±15*†

Body Mass Index (kg/m2)

25±4

25±2

30±5*†

Systolic BP (mmHg)

113±13

121±16

120±21

Diastolic BP (mmHg)

69±10

74±10

66±9

HR (beats/min)

63±6

58±8

60±8

6.2±1.3

5.4±1.4

6.2±1.2

TPR (mmHg/L/min)

14±4

18±7

14±4

LVEF (%)

68±4

68±4

61±9

Burst Frequency (bursts/min)

18±8

34±9

*

41±7*

Burst Incidence (bursts/100 hb)

29±13

58±14*

69±11*

Total MSNA (AU)

989±380

1916±540*

2331±372*

Glucose (mmol/L)

5.1±0.6

5.2±0.4

5.6±0.7

Total Cholesterol (mmol/L)

3.6±1.0

4.3±0.6

3.2±0.6†

HDL Cholesterol (mmol/L)

1.2±0.2

1.5±0.3

1.0±0.1†

LDL Cholesterol (mmol/L)

2.0±1.0

2.4±0.6

1.7±0.5

Triglycerides (mmol/L)

0.9±0.3

0.9±0.4

1.0±0.3

HbA1C (%)

5.4±0.2

5.7±0.2*

5.8±0.3*

CO (L/min)

Values are the mean of the two baseline periods (mean ± SD). YH, young healthy;
OH, older healthy; CAD, coronary artery disease; BP, blood pressure; HR, heart rate;
CO, cardiac output; TPR, total peripheral resistance; LVEF, left ventricular ejection
fraction; hb, heart beats; MSNA, muscle sympathetic nerve activity; AU, arbitrary
units. HDL, high density lipoprotein; LDL, low density lipoprotein; HbA1C,
hemoglobin A1C. *Significantly different from YH, P < 0.01; †Significantly different
from OH, P < 0.01.
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Table 4.2: Hemodynamic responses to end-inspiratory and end-expiratory apnea
YH

OH

CAD

∆ MAP (mmHg)

9±5

6±8

8±8

∆ HR (beats/min)

2±9

3±10

2±4

∆ SV (mL)

−20±13

−22±12

−17±17

∆ CO (L/min)

−1.1±1.0

−1.2±0.9

−1.0±0.9

5±3

7±5

5±3

∆ MAP (mmHg)

11±4

8±6

7±5

∆ HR (beats/min)

4±11

0±9

0±3

∆ SV (mL)

−4±10

−12±8

−7±10

∆ CO (L/min)

0.1±0.5

−0.6±0.6

−0.5±0.5

2±2

5±4

3±2

End-Inspiratory Apnea

∆ TPR (mmHg/L/min)
End-Expiratory Apnea

∆ TPR (mmHg/L/min)

Values are mean ± SD. YH, young healthy; OH, older healthy; CAD, coronary artery
disease; MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO,
cardiac output; TPR, total peripheral resistance.

131

Table 4.3: Integrated MSNA and action potential indexes at baseline and during
maximal end-inspiratory apnea
Baseline

EI-Apnea

∆

17±8
35±9*
41±7*

41±8†
51±11†
53±8†

25±10
16±7‡
11±8‡

27±14
60±14*
70±10*

65±15†
82±13†
88±6†

38±18
22±14‡
18±10‡

57±8
57±6
57±5

100±25†
80±16†
69±13†

43±20
24±15‡
12±12‡

908±389
2002±614*
2357±415*

4144±1379†
4077±1211†
3624±811†

3236±1476
2075±1113‡
1267±700‡

189±222
372±226
410±180

691±480†
698±402†
584±279†

502±356
326±223
174±196‡

307±353
614±343
694±302

1081±757†
1136±681†
968±465†

774±581
522±461
274±305‡

Integrated MSNA Indices
Burst Frequency (bursts/min)
YH
OH
CAD
Burst Incidence (bursts/100 hb)
YH
OH
CAD
Burst Amplitude (AU)
YH
OH
CAD
Total MSNA (AU)
YH
OH
CAD
Action Potential Indices
AP Frequency (spikes/min)
YH
OH
CAD
AP Incidence (spikes/100 hb)
YH
OH
CAD

Values are mean ± SD. EI, end-inspiratory; MSNA, muscle sympathetic nerve
activity; YH, young healthy; OH, older healthy; CAD, coronary artery disease; hb,
heart beats; AU, arbitrary units; AP, action potential. *Significantly different from
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YH baseline value, P < 0.01; †Significantly different from baseline, P < 0.01;
‡

Significantly different from YH delta value, P < 0.01.
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Table 4.4: Integrated MSNA and action potential indexes at baseline and during
maximal end-expiratory apnea
Baseline

EE-Apnea

∆

19±7
33±9*
41±8*

42±12†
49±11†
51±5†

24±13
16±6‡
10±7‡

29±11
56±16*
70±11*

64±17†
83±13†
89±5†

34±20
27±14
18±13‡

57±7
56±9
58±5

124±55†
79±25†
81±19†

67±51
22±22‡
23±16‡

1006±381
1839±557
2372±425*

5147±2379†
3793±1170†
4103±996†

4141±2523
1953±1165‡
1731±762‡

216±207
370±191
447±262

852±491†
731±430†
662±301†

636±351
361±303
215±155‡

347±340
609±298
760±418

1278±669†
1219±738†
1162±531†

931±499
610±589
402±312‡

Integrated MSNA Indices
Burst Frequency (bursts/min)
YH
OH
CAD
Burst Incidence (bursts/100 hb)
YH
OH
CAD
Burst Amplitude (AU)
YH
OH
CAD
Total MSNA (AU)
YH
OH
CAD
Action Potential Indices
AP Frequency (spikes/min)
YH
OH
CAD
AP Incidence (spikes/100 hb)
YH
OH
CAD

Values are mean ± SD. EE, end-expiratory; MSNA, muscle sympathetic nerve
activity; YH, young healthy; OH, older healthy; CAD, coronary artery disease; hb,
heart beats; AU, arbitrary units; AP, action potential. *Significantly different from
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YH baseline value, P < 0.01; †Significantly different from baseline, P < 0.01;
‡

Significantly different from YH delta value, P < 0.01.
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Figure 4.1: Representative recordings of the integrated muscle sympathetic nerve
activity (MSNA) neurogram and detected action potentials (APs) from one young
healthy (YH) individual (A), one older healthy (OH) individual (B), and one
coronary artery disease (CAD) patient (C) at baseline and during end-inspiratory
(EI) and end-expiratory (EE) apnea.
HR, heart rate; MAP, mean arterial pressure; bpm, beats per minute.
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Figure 4.2: Action potential (AP) content per burst (A), total clusters (B), and
active clusters per burst (C) in young healthy (YH), older healthy (OH), and
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coronary artery disease (CAD) patients at baseline and during end-inspiratory
(EI) apnea.
Left panel; individual lines represent individual data. Right panel represents the
absolute delta change from baseline to EI-apnea. *Significantly different from baseline,
P < 0.01. †Significantly different from YH, P < 0.01. ‡Significantly different from OH,
P < 0.01.
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Figure 4.3: Action potential (AP) cluster latency as a function of normalized
cluster number (i.e., size) at baseline and during end-inspiratory (EI) apnea in
young healthy (YH; left panel), older healthy (OH; middle panel), and coronary
artery disease patients (CAD; right panel).
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Figure 4.4: Action potential (AP) content per burst (A), total clusters (B), and
active clusters per burst (C) in young healthy (YH), older healthy (OH), and
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coronary artery disease (CAD) patients at baseline and during end-expiratory
(EE) apnea.
Left panel; individual lines represent individual data. Right panel represents the
absolute delta change from baseline to EE-apnea. *Significantly different from baseline,
P < 0.01. †Significantly different from YH, P < 0.01.

141

Figure 4.5: Action potential (AP) cluster latency as a function of normalized
cluster number (i.e., size) at baseline and during end-expiratory (EE) apnea in
young healthy (YH; left panel), older healthy (OH; middle panel), and coronary
artery disease patients (CAD; right panel).
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4.4

Discussion
The novel findings of the current work are: 1) compared with young individuals,

the ability to increase within-burst firing frequency of already recruited sympathetic
fibres was reduced with aging and CAD; 2) the capacity of the sympathetic nervous
system to recruit sub-populations of previously silent and faster conducting fibres was
reduced with aging and lost in CAD; and 3) the ability to acutely modify synaptic
delays and/or central processing times appears preserved with aging and CAD. Taken
together, this work supports the hypothesis that cardiovascular disease impairs
sympathetic recruitment during apneic stress.
Voluntary apnea represents a robust stimulus for efferent sympathetic outflow
through various mechanisms including hypoxia and hypercapnia-induced
chemoreceptor activation, removal of the inhibitory influence of lung-stretch receptors,
and an increased central drive-to-breathe (Somers et al. 1989; Hardy et al. 1994;
Steinback et al. 2010a). Early work from single-unit recordings demonstrated that the
homeostatic adjustment to apnea involves an increased neural firing frequency and
probability, as well as an increase in the incidence of multiple within-burst firing of
single axons (Macefield & Wallin, 1999). Our previous work (Steinback et al. 2010b;
Breskovic et al. 2011; Badrov et al. 2015), and the results from the current study using
a multi-unit approach, are in agreement with this finding, at least in YH individuals.
Although both OH individuals and CAD patients achieved an elevation in total
sympathetic outflow through increased frequency and incidence of AP firing during
apnea, the ability to increase the number of APs per sympathetic burst was reduced with
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healthy aging and lost in CAD patients. Therefore, the impact of CAD appears to be
additive to normal age-related changes in central autonomic integration.
Previously, we observed recruitment of latent sub-populations of larger and
faster conducting sympathetic axons during periods of severe autonomic stress, elicited
via voluntary apnea (Steinback et al., 2010b; Breskovic et al. 2011; Badrov et al. 2015)
and by −80 mmHg lower body negative pressure (Salmanpour et al. 2011a; Badrov et
al. 2015). However, the current work extends this knowledge to pathological states with
known sympathetic dysregulation. In accordance with previous work (Maslov et al.
2012; Maslov et al. 2014), we show here that older individuals have a reduced capacity
to recruit these latent neural sub-populations compared with their young counterparts,
while the ability to do so is further reduced and perhaps lost all together in CAD. The
mechanism of this dysregulation is unknown. One possibility is that the elevation in
efferent sympathetic outflow at rest observed with healthy aging and cardiovascular
disease is, in part, mediated by the additional recruitment of these latent subpopulations, thereby reducing the residual capacity for further recruitment during acute
physiological stress. However, the capacity for neural recruitment was not hindered in
otherwise healthy, younger subjects with high baseline MSNA (~75 bursts/100 hb)
(Macefield & Wallin, 1999), discounting the possibility that a ceiling effect impairs the
ability to observe normal recruitment patterns. Furthermore, if these larger axons were
already recruited at rest, one may presume that older individuals and CAD patients
would have greater AP content per sympathetic burst during baseline resting conditions;
however, this was not the case in our study. These observations point to abnormal
central features of neural recruitment with healthy aging and perhaps more so with
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cardiovascular disease, rather than a loss of sympathetic reserve due to elevated resting
sympathetic outflow.
Synaptic delay variations and/or altered central processing times appear to exist
as a third recruitment strategy used by the sympathetic nervous system to modify
efferent sympathetic outflow in the face of physiological challenge (Salmanpour et al.
2011b; Badrov et al. 2015). The current observations replicate earlier observations
(Badrov et al. 2015), in that voluntary apnea caused an acute downward shift in the AP
cluster size-latency relationship in YH individuals, such that all APs with similar peakto-peak amplitudes were recruited with a shorter latency during the reflex-mediated
stress. Previous reports indicate that single axons display large latency variations at rest
(Macefield et al. 1994), and that reflex latency can change acutely with stress (Coote &
Macleod, 1974; Fagius et al. 1987). The multi-unit approach used here suggests that a
systemic and coordinated change in synaptic delay can occur as well. Interestingly, this
systemic downward shift in the AP cluster size-latency profile with apnea was
preserved with aging, as well as CAD, suggesting that, in contrast to actual recruitment,
the option for synaptic delay variations is preserved in these individuals. The location(s)
or source of the change in synaptic delay during apnea-induced stress remains
unknown, but may be due to the direct activation of the rostral ventrolateral medulla
from the nucleus tractus solitarius (Koshiya et al. 1993) specific to chemoreceptor
activation, and/or the presence of faster conduction velocities within spinal descending
pathways specific to chemoreceptor stimulation (~5.5 m/s) versus baroreceptor
activation (~3.3 m/s) (Jänig & Szulczyk, 1979).
Methodological Considerations
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Whether the recruitment impairment in OH individuals and CAD patients was
due to a smaller reflex stimulus, or to the pathology, cannot be determined specifically
from the current analysis. In the context of stimulus strength, variations in the apnea
stimulus may have influenced the between-group variations reported in the current
study. As mentioned above, the determinants of the apnea autonomic response are not
certain and may include the magnitude of chemoreflex stress, loss of lung-stretch
afferent activity, or an emotional drive to breathe (Somers et al. 1989; Hardy et al.
1994; Steinback et al. 2010a), and various factors influence the breakpoint for
voluntary apnea (Parkes, 2006). In this context, lack of arterial blood gas measures
represents a potential limitation of the current study. Although the apnea duration
varied within and amongst groups, they were each of maximal voluntary duration and
elicited near-maximal levels of burst probability; therefore, these represent maximal
sympathetic efforts. Furthermore, in the current study, EI- and EE-apnea duration
correlated poorly with indexes of AP recruitment. While apnea duration related
significantly to the total clusters response (r = 0.554) to EI-apnea (but not EE-apnea; r =
0.297), this was no longer the case when the effects of age and CAD were accounted
for. Therefore, at least in our data set, variations in apnea duration are an unlikely
determinant of the current observations.
Second, as is commonly practiced (Macefield et al. 1999; Murai et al. 2009;
Maslov et al. 2014), CAD patients were studied during their standard pharmacological
treatment, and no data exist regarding the effect of medications on sympathetic neural
recruitment strategies. However, medication use is a ‘life-long’ therapy for CAD
patients, increasing the relevance of studying these participants in the
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pharmacologically treated state. In addition, all OH individuals studied currently were
unmedicated and still displayed impaired central recruitment. If the pharmacological
treatment in CAD was causing the further detriment in recruitment observed in CAD
versus OH during EI-apnea, one would expect the same further detriment in recruitment
during EE-apnea; however, this was not the case. Taken together, these observations
provide evidence to the fact that anti-hypertensive medications are unlikely to be
playing a role in our observed findings.
Furthermore, CAD patients had greater body mass index (BMI) than their YH
and OH counterparts, and increased BMI has been known to alter baseline integrated
MSNA (Scherrer et al. 1994). Whether elevated BMI affects AP recruitment patterns
remains unknown; however, in the current study, BMI correlated poorly to all but one
indice of sympathetic recruitment, suggesting it did not play a role in our observed
findings. Nonetheless, when all subjects were pooled, BMI was correlated moderately
to the total cluster response to EI- (r = 0.441, P = 0.003) and EE- (r = 0.371, P = 0.026)
apnea. However, when accounting for age and incidence of CAD, BMI no longer
predicted the total cluster response to either apnea. In addition, these aberrant AP
recruitment patterns were observed within two to four months of the coronary event,
and their persistence will require additional study.
Finally, we acknowledge that the use of only one sympathoexcitatory reflex
limits the applicability of the apnea outcomes to other important reflexes, and therefore,
future study should assess responses to additional reflex stimuli (i.e., baroreflex,
metaboreflex, cold pressor test, etc.) to determine if the observed impairment in central
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recruitment with aging and cardiovascular disease is specific to apneic stress or a
generalized pattern across reflexes.
Summary
Autonomic nervous system dysregulation represents a hallmark of increasing
age and cardiovascular disease. Studied primarily under resting conditions, healthy
aging and cardiovascular disease are characterized by chronic sympathetic activation,
and this state has deleterious consequences for overall health and prognosis. For the
first time, the current data indicate that this sympathetic dysfunction extends to the
neural coding strategies used by the sympathetic nervous system to respond to acute
homeostatic challenge. Specifically, the sympathetic nervous system normally has
options to increase the firing of already-recruited axons, recruit latent sub-populations
of higher-threshold and faster conducting axons, and modify acutely synaptic delays in
response to autonomic arousal. The ability to acutely modify synaptic delays and/or
central processing times appears preserved with aging and CAD. However, the ability
to increase firing frequency and probability of low-threshold axons is reduced with
healthy aging and more so with CAD. Furthermore, the ability to recruit previously
silent sub-populations is reduced with increasing age and perhaps lost altogether with
CAD. As such, CAD augments the impact of age on recruitment strategies employed by
the sympathetic nervous system.
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Chapter 5

5

Ventilation inhibits sympathetic action potential
recruitment even during severe chemoreflex stress

5.1 Introduction
The chemoreflex represents a highly coordinated and integrative pattern of
response to systemic hypoxia and/or hypercapnia that ultimately regulates and defends
perfusion to critical organs and tissues within the body. As such, the homeostatic
challenges presented by central and/or peripheral chemoreceptor stimulation are
corrected through reflexive increases in ventilation, as well as autonomic circulatory
arousal (Guyenet, 2014). Indeed, the compensatory response to chemoreflex activation
involves large elevations in efferent sympathetic nerve outflow directed to skeletal
muscle (i.e., muscle sympathetic nerve activity; MSNA) and other vascular beds (Saito
et al. 1988; Malpas & Ninomiya, 1992a,b; Morgan et al. 1995; Leuenberger et al.
2005). Furthermore, the sympathetic response to voluntary apnea and/or pathological
apnea (i.e., obstructive sleep apnea) is large (Morgan et al. 1993; Hardy et al. 1994;
Leuenberger et al. 1995; Steinback et al. 2010b) and, in turn, has been linked to poor
clinical outcomes (Kara et al. 2003).
The mechanisms mediating the robust sympathetic response to apnea remain
uncertain and appear to be diverse. Indeed, one fundamental issue is the identification
of the specific roles played by the ventilatory response (or the lack thereof in the case of
volitional apnea) versus the chemoreflex activation itself. For example, voluntary apnea
potentiated the sympathetic response to isocapnic hypoxia, indicating the
sympathoinhibitory nature of ventilation (Somers et al. 1989a,b). Furthermore, the
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chemoreflex stimulus to typical 20- to 30-second apneas in untrained breath-hold
performers is rather unremarkable (Leuenberger et al. 2005; Heusser et al. 2009; Seitz
et al. 2013), yet the MSNA response is large; therefore, factors other than chemoreflex
stress must be involved in eliciting sympathetic activation. The possible factors
affecting the sympathoinhibitory effect of ventilation during chemoreflex stimulation
may include central pathways that coordinate respiratory drive with sympathetic
inhibition. Evidence for such pathways has been difficult to find in humans (St. Croix et
al. 1999), whereby MSNA is inhibited during inspiration (or at high lung volumes) and
increases during expiration (or at low lung volumes) (Eckberg et al. 1985; Seals et al.
1993); however, current evidence in the intact human argues against a significant role
played by central respiratory drive on the ventilatory modulation of MSNA (Seals et al.
1993; St. Croix et al. 1999). In contrast, such pathways can be induced in anesthetized
rodents (Numao et al. 1987; Haselton & Guyenet, 1989; Darnall & Guyenet, 1990),
leading Guyenet (Guyenet et al. 2010; Guyenet 2014) to speculate that species
differences exist. Nonetheless, current evidence suggests that the sympathetic response
to apnea has more to do with the lack of breathing rather than the chemoreflex stimulus
per se.
Yet, much remains uncertain regarding the interactions between chemoreflex
stress and ventilation on sympathetic neuro-circulatory control. For example, the degree
of chemoreflex stress may be an important caveat in understanding the role of
respiratory movements in sympathetic control. The central motor hypothesis has been
studied in humans mainly under normoxic and normocapnic conditions (St. Croix et al.
1999) or low levels of hypercapnia (Seals et al. 1993), raising the possibility that
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potentiation of central pathways associated with the drive-to-breathe and sympathetic
inhibition with breathing may be augmented with concurrent chemoreflex activation.
Observations arguing against this possibility are provided from our earlier study
(Steinback et al. 2010a), in which the very large sympathetic responses occurring
during prolonged apnea at functional residual capacity (FRC), performed by elite
breath-hold divers, were acutely inhibited by a two-breath rebreathe protocol performed
immediately following the apnea, despite a sustained chemoreflex stimulus. However,
the acute versus chronic effects were not studied, nor was it determined whether this
has to do with reduction of the emotional component of resisting the breathing
movements, the absence of lung-stretch during apnea, or the actual degree of
chemoreflex stimulus (Steinback et al. 2010a).
In addition, the mode of studying sympathetic nerve activity likely has an
impact on determinations of chemoreflex versus ventilatory control over sympathetic
nerve recruitment. Indeed, early work from single-unit action potential (AP) recordings
demonstrated that the sympathetic adjustment to apnea involves not only an increase in
neural firing probability, but also, a shift towards greater within-burst firing of single
axons (Macefield & Wallin, 1999). Therefore, the content and variability of
sympathetic APs within and between integrated bursts more accurately represents the
neural signal, and ultimately, reflects the neural discharge and recruitment patterns used
by the central nervous system to fine-tune sympathetic outflow. The need to study AP
behaviour becomes especially relevant when one considers that burst frequency,
reflecting the rate of discharge, and burst size, reflecting the number and/or size of
recruited APs (Ninomiya et al. 1993; Salmanpour et al. 2011), may be differentially
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regulated during chemoreflex stress, emphasizing increases in burst size (i.e., AP
recruitment) (Malpas et al. 1996; Lim et al. 2015). Using a multi-unit AP approach, we
have found that the central recruitment strategies used to alter sympathetic drive in
response to apneic stress involve both an increased firing of previously-recruited axons
and recruitment of sub-populations of larger, latent axons (Steinback et al. 2010b;
Breskovic et al. 2011; Badrov et al. 2015; Badrov et al. 2016a). However, whether
neural recruitment is restrained and/or inhibited in the presence of ventilation remains
unknown.
Therefore, the objective of the current investigation was to determine the
influence of ventilation on sympathetic AP recruitment during varying levels of high
chemoreflex stress. To do so, we studied sympathetic AP discharge during apnea at
FRC (i.e., absence of ventilation) and during asphyxic rebreathing (i.e., presence of
ventilation) in trained breath-hold divers. Trained breath-hold divers were studied
because of their unique ability to perform apneas for prolonged periods of time and
their capacity to endure high levels of chemoreflex stress (Heusser et al. 2009). We
tested the hypothesis that the sympathoinhibitory effect of ventilation on chemoreflexinduced sympathetic activation is limited to mild chemoreflex stress. If so, then it can
be expected that for similar levels of chemoreflex stimuli, the presence of ventilation
during rebreathing would restrain sympathetic AP recruitment as compared to apnea.
However, during more severe rebreathe-induced chemoreflex levels, the inhibitory
influence of ventilation would be overridden, such that AP recruitment would be similar
to that observed during apnea.
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5.2 Methods
5.2.1 Participants
Seven healthy individuals (1 female; 33±12 yr, 181±10 cm, 74±12 kg, body
mass index = 22±2 kg/m2) participated in the current investigation after providing
informed written consent. Participants were non-smokers without any history of
cardiovascular or respiratory disease. All studies were conducted at the University of
Split, adhering to the standards set by the latest revision of the Declaration of Helsinki,
and all experimental procedures were approved by the Research Ethics Board at the
University of Split School of Medicine in Croatia.

5.2.2 Experimental Protocol
All experiments were conducted following a 3-hour fast and a 12-hour
abstinence from caffeine, alcohol, and vigorous exercise. Participants voided their
bladder immediately prior-to study. All testing was completed in the supine position.
Participants were fitted with a mouthpiece (series 9060, Hans Rudolph, Kansas City,
MO) connected to a three-way valve, allowing them to breathe either room air, or
through a Y-connector (VacuMed, Ventura, CA) leading to two 3-litre breathing bags.
An infrared probe connected to a pulse oximeter (Poet II, Criticare Systems, Waukesha,
WI) was applied to the index finger to monitor arterial oxygen saturation (i.e.,
hemoglobin saturation; HbSat). Respiratory gases were analyzed using an infrared
carbon dioxide sensor and optical oxygen detector fed from a damped micro-vacuum
sampling pump (ML206 Gas Analyzer, ADInstruments, Colorado Springs, CO) and
calibrated using ambient air pressure values, which were converted to online
measurements of oxygen (PO2) and carbon dioxide (PCO2) partial pressures. End-tidal
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values for PO2 (PETO2) and PCO2 (PETCO2) were acquired using peak parameters
software (LabChart7; ADInstruments, Colorado Springs, CO).
Participants completed three protocols in random order, each separated by five
minutes of recovery. Prior-to the onset of each protocol, participants expired into the
breathing bags to fill them with air for an ensuing rebreathing period. The first protocol
(i.e., apnea protocol) assessed the impact of high levels of chemoreflex stress on
sympathetic axonal recruitment in the absence of ventilation. Specifically, following
three minutes of baseline data collection, the three-way valve was turned at endexpiration to begin an initial period of rebreathing, in an attempt to maximize the
severity of chemoreflex stimulation incurred during the ensuing apnea period
(Usselman et al. 2013; Badrov et al. 2015). This initial rebreathe period continued until
PETO2 reached 70 Torr, at which point participants performed an end-expiratory apnea
at FRC until they achieved ~85% of their self-perceived ‘maximal’ tolerance for the
maneuver. Upon cessation, participants breathed twice into and out of the breathing
bags for the measurement of end-apnea PETO2 and PETCO2. Average apnea duration in
the current study was 89±18 seconds. The second protocol (i.e., rebreathing protocol)
assessed the impact of chemoreflex stress on sympathetic axonal recruitment in the
presence of ventilation. Specifically, following three minutes of baseline data
collection, the three-way valve was turned to initiate rebreathing and participants were
instructed to rebreathe until, once again, they achieved ~85% of their self-perceived
‘maximal’ tolerance for the maneuver. Finally, a third protocol (FRC-RBRALT protocol;
n=6) was completed in which baseline data were collected for two minutes, followed by
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alternating 30-second periods of FRC apnea and rebreathing until ~85% maximal
tolerance.

5.2.3 Experimental Measures
Multi-unit recordings of MSNA were obtained from the right peroneal nerve by
microneurography (Hagbarth & Vallbo, 1968) (662C-3; Bioengineering of University
of Iowa, Iowa City, IA), using standard methodology described in detail elsewhere
(Badrov et al. 2015). Heart rate (HR) was determined from a standard three-lead
electrocardiogram. Continuous beat-to-beat blood pressure was obtained throughout all
protocols using finger photoplethysmography (Finometer; Finapres Medical Systems,
Amsterdam, The Netherlands), the values of which were calibrated to manual
sphygmomanometry values taken at baseline. Stroke volume (SV) and cardiac output
(CO) were determined using the Finometer Modelflow algorithm (Wesseling et al.,
1993) and total peripheral resistance (TPR) was calculated as the quotient of mean
arterial pressure (MAP) and CO. All data were collected using LabChart7 and
PowerLab data acquisition system (ADInstruments, Colorado Springs, CO).

5.2.4 Data Analysis
As a first aim, the study addressed the effect of the ‘absence or presence’ of
ventilation on sympathetic neural recruitment during similar (i.e., matched) levels of
chemoreflex stress. To address this aim, data were analyzed from the apnea protocol for
the 3-minute baseline period, the rebreathe period (i.e., until 70 Torr PETO2), and the
second half of the FRC apnea maneuver (i.e., FRCApnea). For the rebreathe protocol,
data were analyzed for the 3-minute baseline period, the initial rebreathe period (i.e.,
until 70 Torr PETO2), and during the period of continued rebreathe that corresponded to
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the same HbSat levels incurred during the second half of FRCApnea (i.e., RBRMatched).
Therefore, this represents the FRCApnea versus RBRMatched comparison at the same level
of chemoreflex stress, as inferred from the HbSat values (i.e., because PETCO2 could
not be measured in the FRCApnea component).
The second aim determined the influence of ventilation on sympathetic neural
recruitment at more severe levels of chemoreflex stress than that induced by FRCApnea.
Therefore, we compared data from the second half of the FRCApnea protocol, as above,
to data observed at the end of the continued rebreathe protocol (i.e., RBREnd). The
duration of data studied in the RBREnd period was matched to that of the last half of the
FRCApnea, used in the first aim. Therefore, this represents the FRCApnea versus RBREnd
comparison.
A third aim addressed the issue that the apnea or continued rebreathe protocols
always occurred at the end of each protocol, and therefore, this aim compared
alternating periods of FRC apnea with rebreathe during progressively increasing
chemoreflex stress. For the FRC-RBRALT protocol, as the number of alternating FRC
apnea and rebreathe periods differed between participants, the 2-minute baseline and
the final three FRC apnea and rebreathe periods for each participant were used for
analysis.
MSNA data were analyzed in two manners. First, the integrated neurogram was
quantified as per traditional methodology. Second, we studied the patterns of change in
APs from the filtered raw MSNA signal as per our approach detailed previously
(Salmanpour et al. 2010). Integrated sympathetic bursts were identified as exhibiting a
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pulse-synchronous burst pattern, having a signal-to-noise ratio of at least 2:1 with
respect to the previous period of neural silence, presenting with characteristic rising and
falling slopes, and having APs visible in the corresponding raw and filtered
neurograms. Integrated sympathetic activity was quantified using burst frequency (the
number of bursts per minute), burst incidence (the number of bursts per 100 heartbeats;
hb), burst amplitude (normalized to the largest burst recorded at baseline, which was
given a value of 100), and total MSNA (the product of normalized burst amplitude and
burst frequency).
For the analysis of sympathetic AP patterns, wavelet-based methodology was
used to detect and extract APs from the filtered raw MSNA signal (Salmanpour et al.
2010). Specifically, as described in detail previously (Steinback et al. 2010b;
Salmanpour et al. 2011; Badrov et al. 2015), a continuous wavelet transform was used,
in which a “mother wavelet” (adapted from actual physiological recordings of
postganglionic sympathetic APs) was applied to the filtered raw MSNA neurogram to
identify and extract APs at their point of occurrence. Next, extracted APs were ordered
based on their peak-to-peak amplitude into ‘clusters’ (i.e., bins of similarly-sized APs)
(Scott, 1979). Within participants, cluster characteristics were normalized within (i.e.,
baseline to rebreathe to maneuver) and between (i.e., FRCApnea vs. RBRMatched vs.
RBREnd) protocols to ensure that bin width, maximum bin center, and the total number
bins would be identical across conditions. This procedure ensured that corresponding
clusters within and between protocols contain APs with the same peak-to-peak
amplitude. Therefore, within protocols (i.e., baseline to rebreathe to maneuver), an
increase in the number of total clusters represents recruitment of latent sub-populations
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of larger-sized axons not present at baseline, whereas between protocols (i.e., FRCApnea
vs. RBRMatched vs. RBREnd), a greater number of total clusters represents further
recruitment of these latent sub-populations as compared to other protocols. Sympathetic
AP patterns were quantified using AP frequency (the number of APs per minute), while
sympathetic AP recruitment was expressed using the mean AP content per integrated
sympathetic burst (APs/burst), the number of active AP clusters per integrated
sympathetic burst (clusters/burst), and the number of total AP clusters (total clusters).
Based on previous validation analysis of our technique (Salmanpour et al. 2010), the
average signal-to-noise ratio in the current study (i.e., 4.8±0.6) is expected to produce a
correct AP detection rate of >90% and a false positive rate of <3%.

5.2.5 Statistical Analysis
All statistical analyses were performed using SigmaPlot 12.0 (Systat Software,
San Jose, CA). All data were normally distributed as confirmed by Shapiro-Wilk tests.
Two-way repeated measures ANOVAs assessed the effect of protocol (i.e., FRCApnea
vs. RBRMatched; FRCApnea vs. RBREnd) vs. time (i.e., baseline vs. rebreathe vs.
maneuver). For the FRC-RBRALT protocol, one-way repeated measures ANOVAs
assessed the effect of time (i.e., baseline vs. FRC vs. RBR). Bonferroni corrected posthoc procedures were used to assess specific differences between means, when
appropriate. Statistical significance was set at P<0.05 and all data are presented as
means ± SD.

163

5.3

Results
Figure 5.1 displays representative recordings of the integrated MSNA

neurogram and detected APs (and associated chemoreflex stimuli) from one individual
during the FRC apnea and rebreathing protocols.
FRCApnea vs. RBRMatched. Both FRCApnea and RBRMatched elicited large
reductions in HbSat (Table 5.1; P < 0.001) at end-maneuver. By design, HbSat levels
were similar (i.e., matched) between maneuvers (71 ± 6 vs. 71 ± 6%; P = NS).
Compared to baseline, PETCO2 (FRCApnea: +17 ± 2 Torr; RBRMatched: +19 ± 2 Torr; both
P < 0.001) increased, while PETO2 (FRCApnea: −68 ± 7 Torr; RBRMatched: −84 ± 7 Torr;
both P < 0.001) decreased, during FRCApnea and RBRMatched.
Integrated MSNA indexes during the baseline, rebreathe, and maneuver
periods of the FRCApnea and RBRMatched protocols are outlined in Table 5.2. Specifically,
compared to baseline, burst frequency (FRCApnea: +29 ± 7 bursts/min; RBRMatched: +12
± 9 bursts/min; both P < 0.01) and burst incidence (FRCApnea: +52 ± 16 bursts/100 hb;
RBRMatched: +14 ± 12 bursts/100 hb; both P < 0.05) increased during both maneuvers;
however, values of burst frequency and burst incidence were greater during FRCApnea
than RBRMatched (both P < 0.001). Similarly, burst amplitude (FRCApnea: +165 ± 85%;
RBRMatched: +69 ± 55%; both P < 0.01) increased above baseline levels during both
maneuvers, though levels were greater during FRCApnea (P < 0.001). As such, compared
to baseline, total MSNA was elevated during both maneuver periods (FRCApnea: +695 ±
397%; RBRMatched: +336 ± 481%; both P < 0.05); yet, once again, levels of total MSNA
were greater during FRCApnea (P < 0.001).
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Figure 5.2 presents the sympathetic AP discharge indexes during the baseline,
rebreathe, and maneuver periods of the FRCApnea and RBRMatched protocols. Specifically,
compared to baseline, AP frequency (FRCApnea: +1122 ± 534 APs/min; RBRMatched:
+328 ± 172 APs/min; both P < 0.05) increased during both maneuvers; however, AP
frequency was greater during FRCApnea compared to RBRMatched (1304 ± 534 vs. 511 ±
167 APs/min; P < 0.001). This increase in AP frequency was due to the elevated levels
of burst frequency, but also, an increase in the AP content per integrated sympathetic
burst (FRCApnea: +18 ± 7 APs/burst; RBRMatched: +7 ± 3 APs/burst; both P < 0.01)
during both maneuvers, as compared to baseline. The AP content per integrated
sympathetic burst, however, was greater during FRCApnea than RBRMatched (28 ± 9 vs. 18
± 4 APs/burst; P < 0.001). Furthermore, when APs were binned according to peak-topeak amplitude (i.e., into clusters), the number of total AP clusters increased during
FRCApnea (+10 ± 2 total clusters; P < 0.001), but not during RBRMatched (+1 ± 2 total
clusters; P = NS). As such, the number of total AP clusters was greater during FRCApnea
(P < 0.001). Finally, the number of active clusters per burst (FRCApnea: +4 ± 2
clusters/burst; RBRMatched: +2 ± 1 clusters/burst; both P < 0.01) was elevated above
baseline levels during both maneuvers, though levels were greater during FRCApnea than
RBRMatched (P < 0.01).
The hemodynamic responses to both maneuvers were consistent with the
sympathetic response patterns as shown in Table 5.1. Specifically, compared to
baseline, MAP (FRCApnea: +18 ± 9 mmHg; RBRMatched: +10 ± 7 mmHg; both P < 0.01)
increased during both maneuvers; yet, the pressor response was greater during FRCApnea
(P < 0.001). The greater pressor response was associated with a greater TPR during
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FRCApnea (P < 0.001). HR decreased during FRCApnea and increased during RBRMatched
(both P < 0.05), whereas reductions in SV were similar between maneuvers (P = NS).
Subsequently, compared to baseline, CO decreased during FRCApnea (P < 0.001), but
remained unchanged during RBRMatched (P = NS).
FRCApnea vs. RBREnd. By design, when rebreathing was allowed to continue
and analyzed at the end (i.e., RBREnd), the RBREnd maneuver elicited a larger reduction
in HbSat versus FRCApnea (56 ± 13 vs. 71 ± 6%; P < 0.001; Table 5.3). Similarly, larger
increases in PETCO2 (FRCApnea: +17 ± 2 Torr; RBREnd: +21 ± 3 Torr; both P < 0.001),
and larger decreases in PETO2 (FRCApnea: −68 ± 7 Torr; RBREnd: −94 ± 4 Torr; both P <
0.001), were observed during RBREnd compared to FRCApnea (Table 5.3; both P <
0.001).
Table 5.4 outlines the integrated MSNA indexes during the baseline, rebreathe,
and maneuver periods of the FRCApnea and RBREnd protocols. Compared to baseline,
burst frequency (FRCApnea: +29 ± 7 bursts/min; RBREnd: +32 ± 17 bursts/min; both P <
0.001) increased to similar levels during both maneuvers (P = NS), whereas burst
incidence (FRCApnea: +52 ± 16 bursts/100 hb; RBRMatched: +33 ± 17 bursts/100 hb; both
P < 0.001) increased to a greater extent during FRCApnea than RBREnd (P = 0.001). Burst
amplitude (FRCApnea: +165 ± 85%; RBREnd: +103 ± 46%; both P < 0.01) increased
above baseline levels during both maneuvers, though levels were greater during
FRCApnea than RBREnd (P < 0.05). Finally, compared to baseline, total MSNA was
elevated during both maneuver periods (FRCApnea: +695 ± 397%; RBREnd: +785 ±
903%; both P < 0.01); however, levels of total MSNA were not different during
FRCApnea and RBREnd (P = NS).
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Sympathetic AP discharge indexes during the baseline, rebreathe, and
maneuver periods of the FRCApnea and RBREnd protocols are displayed in Figure 5.3.
Compared to baseline, AP frequency (FRCApnea: +1122 ± 534 APs/min; RBREnd: +912
± 429 APs/min; P < 0.001) increased during both maneuvers; however, AP frequency
was not different during FRCApnea and RBREnd (1304 ± 534 vs. 1095 ± 423 APs/min; P
= NS). Once again, the increased AP frequency was due to the elevated burst
frequency, but also, an increase in the AP content per integrated sympathetic burst
(FRCApnea: +18 ± 7 APs/burst; RBREnd: +11 ± 5 APs/burst; both P < 0.001) during both
maneuvers, as compared to baseline. However, the AP content per integrated
sympathetic burst was greater during FRCApnea than RBREnd (28 ± 9 vs. 23 ± 5
APs/burst; P < 0.05). Furthermore, when APs were binned according to peak-to-peak
amplitude (i.e., into clusters), the number of total AP clusters increased during FRCApnea
(+10 ± 2 total clusters; P < 0.001) and RBREnd (+6 ± 4 total clusters; P < 0.001); yet,
total AP clusters was greater during FRCApnea (P < 0.01). Finally, the number of active
clusters per burst (FRCApnea: +4 ± 2 clusters/burst; RBREnd: +2 ± 1 clusters/burst; both P
< 0.001) was elevated above baseline levels during both maneuvers, whereby no
differences were observed during FRCApnea versus RBREnd (P = NS).
The hemodynamic responses to FRCApnea and RBREnd are shown in Table 5.3.
Compared to baseline, MAP (FRCApnea: +18 ± 9 mmHg; RBRMatched: +20 ± 12 mmHg;
both P < 0.001) increased similarly during both maneuvers (P = NS). However, this
pressor response was achieved differently for FRCApnea and RBREnd. Specifically,
compared to baseline, TPR increased during FRCApnea (P < 0.001), but not during
RBREnd (P=NS), whereas CO was increased during RBREnd (P < 0.01), but decreased
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during FRCApnea (P < 0.001). The latter was due to an increase in HR (P < 0.001)
during RBREnd versus no change during FRCApnea (P = NS), and a similar decrease in
SV during both maneuvers (both P < 0.001).
FRC-RBRALT. Figure 5.4 displays representative recordings of the integrated
MSNA neurogram and detected APs (and associated chemoreflex stimuli) from one
individual during the FRC-RBRALT protocol. HbSat levels were decreased versus
baseline during each of the final two FRC and RBR periods of the FRC-RBRALT
protocol (Table 5.5; all P < 0.001). Compared to baseline, PETCO2 was increased and
PETO2 decreased during each FRC and RBR period (Table 5.5; all P < 0.001). No
differences existed between corresponding periods of FRC and RBR for HbSat or
PETCO2 and PETO2 levels (all P = NS).
Table 5.6 displays the integrated MSNA indexes during baseline and FRC and
RBR periods of the FRC-RBRALT protocol. Specifically, compared to baseline, all
integrated MSNA variables were elevated during each FRC (all P < 0.001), but not
during any of the three RBR periods (all P = NS). As such, every corresponding FRCRBR period was associated with greater levels of integrated MSNA during FRC versus
RBR (all P < 0.001).
Sympathetic AP discharge indexes at baseline and during the FRC and RBR
periods of the FRC-RBR ALT protocol are shown in Figure 5.5. Compared to baseline, all
AP indices were increased during each FRC (all P < 0.001), but not during any RBR
period (all P = NS). Therefore, every corresponding FRC-RBR period was associated
with greater AP recruitment during FRC than RBR (all P < 0.001).
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Finally, the hemodynamic responses to the FRC-RBRALT protocol are provided
in Table 5.5. Compared to baseline, MAP increased during the final FRC and RBR
periods (both P < 0.001), whereas TPR increased during each FRC (all P < 0.001), but
not during RBR (all P = NS). HR was reduced during the final FRC versus the final
RBR (P < 0.001), whereas SV remained unchanged throughout the FRC-RBRALT
protocol (all P = NS). CO decreased during each FRC (P < 0.001), was above baseline
levels during the first RBR period (P < 0.001), but not in each of the final two RBR
periods (both P = NS).
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Table 5.1: Hemodynamic responses to FRCApnea and RBRMatched protocols

MAP (mmHg)
FRCApnea
RBRMatched
HR (beats/min)
FRCApnea
RBRMatched
SV (mL)
FRCApnea
RBRMatched
CO (L/min)
FRCApnea
RBRMatched
TPR (mmHg/L/min)
FRCApnea
RBRMatched
HbSat (%)
FRCApnea
RBRMatched
PETCO2 (Torr)
FRCApnea
RBRMatched
PETO2 (Torr)
FRCApnea
RBRMatched

Baseline

Rebreathe

Maneuver

87±3
87±3

89±3
88±2

105±9*†
97±6*

70±14
68±12

68±13
66±13

60±9*†
75±19*

97±20
96±19

90±18
91±19

84±18
86±24

6.6±1.3
6.4±0.9

6.0±1.0
5.9±0.8

5.0±0.7*†
6.1±0.9

13.5±2.3
13.7±1.7

15.1±2.1
15.2±1.9

21.6±3.3*†
16.1±2.8*

99.5±0.3
99.5±0.4

97.2±1.5
97.5±1.8

71.3±6.3
71.3±6.3

27±6
28±6

41±5*
40±6*

44±4*†
47±5*

118±5
117±7

66±5*
68±6*

50±5*†
33±3*

Values are mean ± SD. MAP, mean arterial pressure; HR, heart rate; SV, stroke
volume; CO, cardiac output; TPR, total peripheral resistance; HbSat, hemoglobin
saturation; PETCO2, end-tidal partial pressure of carbon dioxide; PETO2, end-tidal
partial pressure of oxygen. *Significantly different from baseline, P < 0.05;
†Significantly different from RBRMatched, P < 0.05. Effects of time were found for SV
and HbSat, whereby the maneuver periods were reduced versus baseline, both P ≤
0.001.
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Table 5.2: Integrated MSNA responses to FRCApnea and RBRMatched protocols

Burst Frequency (bursts/min)
FRCApnea
RBRMatched
Burst Incidence (bursts/100 hb)
FRCApnea
RBRMatched
Burst Amplitude (AU)
FRCApnea
RBRMatched
Total MSNA (AU/min)
FRCApnea
RBRMatched

Baseline

Rebreathe

Maneuver

17±5
16±7

17±6
17±6

46±8*†
28±7*

25±10
24±13

26±11
26±11

77±15*†
38±11*

50±10
51±4

53±9
63±15

127±32*†
87±33*

832±298
780±386

877±251
1019±307

5774±1572*†
2496±1434*

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; hb, heart beats;
AU, arbitrary units. *Significantly different from baseline, P < 0.05; †Significantly
different from RBRMatched, P < 0.001.
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Table 5.3: Hemodynamic responses to FRCApnea and RBREnd protocols

MAP (mmHg)
FRCApnea
RBREnd
HR (beats/min)
FRCApnea
RBREnd
SV (mL)
FRCApnea
RBREnd
CO (L/min)
FRCApnea
RBREnd
TPR (mmHg/L/min)
FRCApnea
RBREnd
HbSat (%)
FRCApnea
RBREnd
PETCO2 (Torr)
FRCApnea
RBREnd
PETO2 (Torr)
FRCApnea
RBREnd

Baseline

Rebreathe

Maneuver

87±3
87±3

89±3
88±2

105±9
106±11

70±14
68±12

68±13
66±13

60±9†
84±23*

97±20
96±19

90±18
91±19

84±18
87±23

6.6±1.3
6.4±0.9

6.0±1.0
5.9±0.8

5.0±0.7*†
7.0±1.1

13.5±2.3
13.7±1.7

15.1±2.1
15.2±1.9

21.6±3.3*†
15.5±2.1

99.5±0.3
99.5±0.4

97.2±1.5
97.5±1.8

71.3±6.3*†
51.9±13.1*

27±6
28±6

41±5*
40±6*

44±4*†
49±6*

118±5
117±7

66±5*
68±6*

50±5*†
23±5*

Values are mean ± SD. MAP, mean arterial pressure; HR, heart rate; SV, stroke
volume; CO, cardiac output; TPR, total peripheral resistance; HbSat, hemoglobin
saturation; PETCO2, end-tidal partial pressure of carbon dioxide; PETO2, end-tidal
partial pressure of oxygen. *Significantly different from baseline, P < 0.01;
†Significantly different from RBREnd, P < 0.01. An effect of time was found for
MAP, whereby the rebreathe and maneuver period were greater than baseline, both P
< 0.001. An effect of time was found for SV, whereby the maneuver period was
reduced versus baseline, P < 0.001.
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Table 5.4: Integrated MSNA responses to FRCApnea and RBREnd protocols
Burst Frequency (bursts/min)
FRCApnea
RBREnd
Burst Incidence (bursts/100 hb)
FRCApnea
RBREnd
Burst Amplitude (AU)
FRCApnea
RBREnd
Total MSNA (AU/min)
FRCApnea
RBREnd

Baseline

Rebreathe

Maneuver

17±5
16±7

17±6
17±6

46±8
47±15

25±10
24±13

26±11
26±11

77±15*†
57±15*

50±10
51±4

53±9
63±15

127±32*†
104±29*

832±298
780±386

877±251
1019±307

5774±1572
5170±2745

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; hb, heart beats;
AU, arbitrary units. *Significantly different from baseline, P < 0.05; †Significantly
different from RBREnd, P < 0.001. Effects of time were found for burst frequency
and total MSNA, whereby the rebreathe and maneuver periods were greater than
baseline, all P < 0.001.
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Table 5.5: Hemodynamic responses to the FRC-RBRALT protocol
MAP (mmHg)
HR (beats/min)
SV (mL)
CO (L/min)
TPR (mmHg/L/min)
HbSat (%)
PETCO2 (Torr)
PETO2 (Torr)

Baseline

FRC1

RBR1

FRC2

RBR2

FRC3

RBR3

88±3
63±6
97±23
6.0±1.1
15.1±2.6
99.5±0.5
28±7
114±12

92±3
57±7
88±21
5.0±0.9*
19.2±3.9*
95.3±2.3
40±3*
67±11*

88±3
63±7
88±21
5.4±0.9*
16.4±2.2
95.3±3.5
41±4*
69±11*

96±7
60±9
87±24
5.1±1.1*
20.0±4.0*
88.6±5.5*
44±4*
50±4*

96±6
66±11
87±24
5.6±0.8
17.6±3.0
88.7±6.9*
44±5*
50±10*

105±11*
58±10†
90±28
5.1±1.0*†
21.5±5.6*†
75.9±2.9*
47±5*
40±4*

101±10*
69±12
91±26
6.1±0.8
17.0±3.2
72.1±11.9*
48±7*
36±8*

Values are mean ± SD. FRC, functional residual capacity apnea; RBR, rebreathe;
MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output;
TPR, total peripheral resistance; HbSat, hemoglobin saturation; PETCO2, end-tidal
partial pressure of carbon dioxide; PETO2, end-tidal partial pressure of oxygen.
*Significantly different from baseline, P<0.001; †Significantly different from
corresponding RBR period, P<0.001.
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Table 5.6: Integrated MSNA responses to the FRC-RBRALT protocol

Values are mean ± SD. MSNA, muscle sympathetic nerve activity; FRC, functional
residual capacity apnea; RBR, rebreathe; BF, burst frequency; BI, burst incidence;
hb, heart beats; BA, burst amplitude; AU, arbitrary units. *Significantly different
from baseline, P < 0.001; †Significantly different from corresponding RBR period, P
< 0.001.
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Figure 5.1: Representative recordings of the integrated muscle sympathetic nerve
activity (MSNA) neurogram and detected action potentials (APs) (and associated
chemoreflex stimuli) from one individual during the functional residual capacity
(FRC) apnea and rebreathing protocols.
PO2, partial pressure of oxygen; PCO2, partial pressure of carbon dioxide; HbSat,
hemoglobin saturation. Highlighted (i.e., boxed) areas represent portions of the
maneuver used for analysis.
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Figure 5.2: Sympathetic action potential (AP) recruitment during baseline (BSL),
initial rebreathe (RBR), and maneuver (MAN) periods of the FRCApnea and
RBRMatched protocols.
*

Significantly different from BSL, P < 0.05; †Significantly different from RBRMatched, P

< 0.01.
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Figure 5.3: Sympathetic action potential (AP) recruitment during baseline (BSL),
initial rebreathe (RBR), and maneuver (MAN) periods of the FRCApnea and
RBREnd protocols.
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Significantly different from BSL, P < 0.05; †Significantly different from RBREnd, P <

0.01.
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Figure 5.4: Representative recordings of the integrated muscle sympathetic nerve
activity (MSNA) neurogram and detected action potentials (APs) (and associated
chemoreflex stimuli) from one individual during the alternating functional
residual capacity (FRC) apnea and rebreathe (RBR) protocol (i.e., FRC-RBRALT).
PO2, partial pressure of oxygen; PCO2, partial pressure of carbon dioxide; HbSat,
hemoglobin saturation. Highlighted (i.e., boxed) area represents the portion of the
maneuver used for analysis.
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Figure 5.5: Sympathetic action potential (AP) recruitment during baseline (BSL)
and alternating periods of apnea at functional residual capacity (FRC) and
rebreathe (RBR).
HbSat, hemoglobin saturation. *Significantly different from BSL, P < 0.001;
†

Significantly different from corresponding RBR, P < 0.001.
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5.4

Discussion
The current study was designed to study the dissociated influences of

chemoreceptor stimuli (i.e., hypoxia and hypercapnia) and ventilation on sympathetic
AP recruitment patterns during chemoreflex stress. First, we demonstrate that during
similar levels of (high) chemoreflex stress, the act of ventilation per se restrained the
increased firing of already-active, lower-threshold axons, and furthermore, inhibited the
recruitment of latent, higher-threshold axons that appeared during apnea. Second,
recruitment of previously-silent axons was observed during severe chemoreflex
stimulation induced by the continued rebreathe protocol; however, sympathetic AP
recruitment was still restrained as compared to apnea. Finally, during alternating
periods of apnea and rebreathe, the act of rebreathing between apneas was associated
with a rapid and complete withdrawal of sympathetic AP recruitment, despite the everincreasing chemoreflex stimulus. As such, it appears that the sympathoinhibitory effect
of ventilation during chemoreceptor activation extends to the central recruitment
strategies used by the sympathetic nervous system to respond to homeostatic stress,
whereby both the frequency of neural discharge and recruitment of latent axons are
restrained/inhibited in the presence of ventilation, even at excessive levels of
chemoreflex stress.
The sympathoexcitatory response to voluntary apnea is robust, and indeed,
includes a powerful stimulus for efferent sympathetic axonal recruitment (Steinback et
al. 2010b; Breskovic et al. 2011; Badrov et al. 2015; Badrov et al. 2016a).
Chemoreceptor activation is believed to form a primary mechanism driving this
response. Nevertheless, previous work demonstrates that the absence of ventilation
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during apnea acts to augment this sympathetic drive (Somers et al. 1989a,b; Steinback
et al. 2010a). Certainly, albeit indirectly, ventilation has been shown to be a powerful
within-breath modulator of sympathetic neural recruitment (Seals et al. 1990).
Specifically, during deep breathing, the typical observation of increased and decreased
MSNA during expiration and inspiration, respectively (Eckberg et al. 1985), was
extended to show that, over multiple breaths, MSNA inhibition during inspiration was
compensated for by augmented burst amplitude during expiration (Seals et al. 1990).
Therefore, the total MSNA response was not affected. Furthermore, since burst size
reflects AP content (Ninomiya et al. 1993; Salmanpour et al. 2011), ventilation affects
sympathetic AP synchronization and recruitment of additional and/or larger
sympathetic axons (Ninomiya et al. 1993; Salmanpour et al. 2011). Our current results
support the conjecture that ventilation modulates sympathetic postganglionic axonal
recruitment and extend this conclusion to include high/severe levels of chemoreflex
stress.
The current data illustrate, like never before, the unfailing ability of inhalation
to inhibit sympathetic activity across a wide range of chemoreflex stress, at least
acutely, and to inhibit AP recruitment even during what likely are the most severe cases
of chemoreflex stress that can be imposed voluntarily. Specifically, replicating earlier
studies (Steinback et al. 2010b; Badrov et al. 2015; Badrov et al. 2016a), the large
increases in neural outflow during apnea were associated with increases in the withinburst firing frequency of already-recruited sympathetic fibers, as well as the recruitment
of latent (i.e., not present at baseline) sub-populations of larger-sized axons. However,
for similar levels of hypoxia and hypercapnia, but in the presence of ventilation (i.e.,
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during RBRMatched), these neural recruitment patterns were not achieved. Indeed,
RBRMatched was associated with a lower firing frequency and a restrained increase in the
number of APs per integrated burst, such that, overall, sympathetic AP frequency
increased approximately 700% during FRCApnea, but only about 300% during
RBRMatched. Furthermore, the capacity of the sympathetic nervous system to recruit
latent neural sub-populations was inhibited during RBRMatched, despite the same
chemoreflex load, indicating the profound effect of ventilation on AP recruitment
patterns.
Nonetheless, the current data do support the idea that the sympathoinhibitory
effect of ventilation is less effective at more severe levels of chemoreflex stress.
Specifically, latent axons were recruited during the more severe chemoreflex stress
induced by the continued rebreathe protocol, despite the presence of ventilation (i.e.,
RBREnd). Interestingly, in this scenario (i.e., FRCApnea vs. RBREnd) the total integrated
MSNA response was similar between protocols but the underlying patterns of AP
recruitment differed by maneuver. These data highlight the importance of studying AP
behaviour and support the notion that these latent, higher-threshold axons, are reserved
for severe stress scenarios (Badrov et al. 2015).
The protocol alternating between FRC and rebreathing further enforces the
role of ventilation in AP recruitment, across many levels of progressive chemoreflex
stress. In this case, all occurrences of rebreathe, despite no relief of chemical drive,
were associated with an inhibition of sympathetic AP discharge to baseline levels.
Specifically, while each apnea was associated with increased within-burst firing of
lower-threshold axons and recruitment of latent, larger-sized axons, each subsequent
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period of rebreathe was accompanied by a total withdrawal of this sympathetic AP
recruitment. This withdrawal of sympathetic drive following the resumption of
breathing in the face of similar and/or elevated chemical drive is consistent with
findings from the integrated MSNA neurogram (Watenpaugh et al. 1999; Steinback et
al. 2010a; Seitz et al. 2013). For example, Steinback et al. (2010a) found that
sympathetic burst activity was silenced during brief periods of rebreathe following
apnea. Furthermore, Seitz et al. (2013) demonstrated an immediate inhibition of MSNA
following the break point of end-expiratory apnea, which was not influenced by
whether subjects inhaled room air or asphyxic gas upon the resumption of breathing.
Therefore, the present data support previous findings that indicate ventilation
per se is responsible for the sympathoinhibition across a wide range of chemoreflex
stress. However, acute periods of rebreathe following apnea were associated with
complete withdrawal of AP discharge, whereas when rebreathe was allowed to continue
(i.e., RBREnd protocol), sympathetic axonal recruitment did occur over time, albeit still
at lesser levels than apnea. These observations suggest that the sympathoinhibitory
influence of breathing may be robust acutely, but perhaps, less effective over time as
the chemoreflex load continues to extreme levels.
The mechanisms underlying the ventilatory restraint of sympathetic axonal
recruitment during high levels of chemoreflex stress remain unknown and cannot be
elucidated from the current results. Possible contributors include lung-stretch receptor
feedback (Somers et al. 1989b) and perceptual factors associated with the stress
experienced during prolonged breath-holding (Fowler, 1954; Heusser et al. 2009).
Stated differently, the volitional effort not to breathe coupled with the growing desire-
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to-breathe during voluntary apnea may result in a greater perception of stress than that
of rebreathing, thereby influencing sympathetic drive. Callister et al. (1992) have
shown that levels of perceived stress influence directly the sympathetic response during
cognitive challenge. However, stress-induced sympathetic responses related to such
prolonged breath-holds and chemoreflex duress produced by these elite breath-hold
competitors has not been quantified. However, components of the current observations
argue against a “stress” determinant of sympathetic drive during apnea. First, all
participants were instructed to engage in and continue each protocol until they achieved
~85% of their self-perceived ‘maximal’ tolerance for the maneuver. As such, the
FRCApnea and RBREnd protocols were ‘matched’ for levels of perceived stress, whereby
greater AP recruitment was still observed during apnea. Second, we deliberately studied
breath-hold divers who are uniquely trained to endure this level of stress and perform
these maneuvers often. Thus, the fact that these were not ‘maximal’ efforts, combined
with the participants’ familiarity with the maneuvers, likely suggests that levels of
perceived stress during voluntary apnea were not maximal. However, we acknowledge
that the perceptual levels of stress magnitude in sympathetic activation in the context of
apneas are not known. Finally, albeit in a volitional handgrip contraction and
metaboreflex activation model, we have found that a central perceptual component has
little to do with actual axonal recruitment, as opposed to the effects of peripheral-reflex
mechanisms (Badrov et al. 2016b). Therefore, we do not regard a specific role of
perceptual factors in the current results as important in the observations. Furthermore,
whether a baroreflex mechanism contributed to the divergent sympathetic recruitment
responses between conditions is unknown, but unlikely. Specifically, the differing AP
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recruitment responses persisted despite large and similar (or slightly greater during
apnea) increases in MAP during both maneuvers. Therefore, it is likely that resetting of
the arterial baroreflex occurred during both maneuvers (Muenter Swift et al. 2003), the
magnitude of which might be greater during apnea. Nonetheless, ventilation appears to
modulate sympathetic axonal recruitment during high and even severe chemoreflex
stress. The mechanisms mediating this restraint on sympathetic neural recruitment will
require additional study.
In summary, the present study demonstrated that the sympathetic axonal
recruitment strategies that are normally observed during apnea are largely restrained by
the act of ventilation per se, despite similar and/or greater levels of high, and even,
extreme, chemoreflex stress. Specifically, during severe levels of hypoxia and
hypercapnia, both the frequency of within-burst firing of already-active sympathetic
fibres and the recruitment of sub-populations of previously-silent, higher-threshold
axons are restrained in the presence of ventilation. Therefore, the robust increases in
sympathetic nerve activity seen during apnea are largely influenced by the lack of
breathing itself, rather than the increasing chemical drive, although the latter
undoubtedly plays a role (Hardy et al. 1994). Nonetheless, the pronounced sympathetic
neural recruitment in response to apnea, and in turn, the large systemic vascular
resistance and blood pressure response may lend important mechanistic insight into
observed relationship between obstructive sleep apnea and cardiovascular disease
(Kasai et al. 2012).

186

5.5

References

Badrov MB, Lalande S, Olver TD, Suskin N & Shoemaker JK (2016a). Effects of aging
and coronary artery disease on sympathetic neural recruitment strategies during
end-inspiratory and end-expiratory apnea. Am J Physiol Heart Circ Physiol 311,
H1040-H1050.
Badrov MB, Olver TD & Shoemaker JK (2016b). Central vs. peripheral determinants of
sympathetic neural recruitment: insights from static handgrip exercise and
postexercise circulatory occlusion. Am J Physiol Regul Integr Comp Physiol
311, R1013-R1021.
Badrov MB, Usselman CW & Shoemaker JK. (2015). Sympathetic neural recruitment
strategies: responses to severe chemoreflex and baroreflex stress. Am J Physiol
Regul Integr Comp Physiol 309, R160-R168.
Breskovic T, Steinback CD, Salmanpour A, Shoemaker JK & Dujic Z (2011).
Recruitment pattern of sympathetic neurons during breath-holding at different
lung volumes in apnea divers and controls. Auton Neurosci 164, 74-81.
Callister R, Suwarno NO & Seals DR (1992). Sympathetic activity is influenced by task
difficulty and stress perception during mental challenge in humans. J Physiol
454, 373-387.
Darnall RA & Guyenet P (1990). Respiratory modulation of pre- and postganglionic
lumbar vasomotor sympathetic neurons in the rat. Neurosci Lett 119, 148-152.
Eckberg DL, Nerhed C & Wallin BG (1985). Respiratory modulation of muscle
sympathetic and vagal cardiac outflow in man. J Physiol 365, 181-196.

187

Fowler WS (1954). Breaking point of breath-holding. J Appl Physiol 6, 539-545.
Guyenet PG (2014). Regulation of breathing and autonomic outflows by
chemoreceptors. Compr Physiol 4, 1511-1562.
Guyenet PG, Stornetta RL, Abbott SBG, Depuy SD, Fortuna MG & Kanbar R (2010).
Central CO2 chemoreception and integrated neural mechanisms of
cardiovascular and respiratory control. J Appl Physiol 108, 995-1002.
Hagbarth KE & Vallbo AB (1968). Pulse and respiratory grouping of sympathetic
impulses in human muscle nerves. Acta Physiol Scand 74, 96-108.
Hardy JC, Gray K, Whisler S & Leuenberger U (1994). Sympathetic and blood pressure
responses to voluntary apnea are augmented by hypoxemia. J Appl Physiol 77,
2360-2365.
Haselton JR & Guyenet PG (1989). Central respiratory modulation of medullary
sympathoexcitatory neurons in rat. Am J Physiol Regul Integr Comp Physiol
256, R739-R750.
Heusser K, Dzamonja G, Tank J, Palada I, Valic Z, Bakovic D, Obad A, Ivancev V,
Breskovic T, Diedrich A, Joyner MJ, Luft FC, Jordan J & Dujic Z (2009).
Cardiovascular regulation during apnea in elite divers. Hypertension 53, 719724.
Kara T, Narkiewicz K & Somers VK (2003). Chemoreflexes – physiology and clinical
implications. Acta Physiol Scand 177, 377-384.

188

Kasai T, Floras JS & Bradley TD (2012). Sleep apnea and cardiovascular disease: a
bidirectional relationship. Circulation 126, 1495-1510.
Leuenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C & Sinoway L (1995).
Surges of muscle sympathetic nerve activity during obstructive apnea are linked
to hypoxemia. J Appl Physiol 79, 581-588.
Leuenberger UA, Brubaker D, Quraishi S, Hogeman CS, Imadojemu VA & Gray KS
(2005). Effects of intermittent hypoxia on sympathetic activity and blood
pressure in humans. Auton Neurosci 121, 87-93.
Lim K, Burke SL, Moretti JL & Head GA (2015). Differential activation of renal
sympathetic burst amplitude and frequency during hypoxia, stress and
baroreflexes with chronic angiotensin treatment. Exp Physiol 100, 1132-1144.
Macefield VG & Wallin BG (1999). Firing properties of single vasoconstrictor
neurones in human subjects with high levels of muscle sympathetic activity. J
Physiol 516, 293-301.
Malpas SC, Bendle RD, Head GA & Ricketts JH (1996). Frequency and amplitude of
sympathetic discharges by baroreflexes during hypoxia in conscious rabbits. Am
J Physiol Heart Circ Physiol 271, H2563-H2574.
Malpas SC & Ninomiya I (1992a). Effect of asphyxia on the frequency and amplitude
modulation of synchronized renal nerve activity in the cat. J Auton Nerv Syst 40,
199-205.

189

Malpas SC & Ninomiya I (1992b). Effect of chemoreceptor stimulation on the
periodicity of renal sympathetic nerve activity in anesthetized cats. J Auton Nerv
Syst 37, 19-28.
Morgan BJ, Crabtree DC, Palta M & Skatrud JB (1995). Combined hypoxia and
hypercapnia evokes long-lasting sympathetic activation in humans. J Appl
Physiol 79, 205-213.
Morgan BJ, Denahan T & Ebert TJ (1993). Neurocirculatory consequences of negative
intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74,
2969-2975.
Muenter Swift N, Cutler MJ, Fadel PJ, Wasmund WL, Ogoh S, Keller DM, Raven PB
& Smith ML (2003). Carotid baroreflex function during and following voluntary
apnea in humans. Am J Physiol Heart Circ Physiol 285, H2411-H2419.
Ninomiya I, Malpas SC, Matsukawa K, Shindo T & Akiyama T (1993). The amplitude
of synchronized cardiac sympathetic nerve activity reflects the number of
activated pre- and postganglionic fibers in anesthetized cats. J Auton Nerv Syst
45, 139-147.
Numao Y, Koshiya N, Gilbey MP & Spyer KM (1987). Central respiratory driverelated activity in sympathetic nerves of the rat: the regional differences.
Neurosci Lett 81, 279-284.
Saito M, Mano T, Iwase S, Koga K, Abe H & Yamazaki Y (1988). Responses in
muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65,
1548-1552.

190

Salmanpour A, Brown LJ & Shoemaker JK (2010). Spike detection in human muscle
sympathetic nerve activity using a matched wavelet approach. J Neurosci
Methods 193, 343-355.
Salmanpour A, Brown LJ, Steinback CD, Usselman CW, Goswami R & Shoemaker JK
(2011). Relationship between size and latency of action potentials in human
muscle sympathetic nerve activity. J Neurophysiol 105, 2830-2842.
Scott DW (1979). On optimal and data-based histograms. Biometrika 66, 605-610.
Seals DR, Suwarno NO & Dempsey JA (1990). Influence of lung volume on
sympathetic nerve discharge in normal humans. Circ Res 67, 130-141.
Seals DR, Suwarno NO, Joyner MJ, Iber C, Copeland JG & Dempsey JA (1993).
Respiratory modulation of muscle sympathetic nerve activity in intact and lung
denervated humans. Circ Res 72, 440-454.
Seitz MJ, Brown R & Macefield VG (2013). Inhibition of augmented muscle
vasoconstrictor drive following asphyxic apnoea in awake human subjects is not
affected by relief of chemical drive. Exp Physiol 98, 405-414.
Somers VK, Mark AL, Zavala DC & Abboud FM (1989a). Contrasting effects of
hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J
Appl Physiol 67, 2101-2106.
Somers VK, Mark AL, Zavala DC & Abboud FM (1989b). Influence of ventilation and
hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J
Appl Physiol 67, 2095-2100.

191

St. Croix CM, Satoh M, Morgan BJ, Skatrud JB & Dempsey JA (1999). Role of
respiratory motor output in within-breath modulation of muscle sympathetic
nerve activity in humans. Cir Res 85, 457-469.
Steinback CD, Breskovic T, Frances M, Dujic Z & Shoemaker JK (2010a). Ventilatory
restraint of sympathetic activity during chemoreflex stress. Am J Physiol Regul
Integr Comp Physiol 299, R1407-R1414.
Steinback CD, Salmanpour A, Breskovic T, Dujic Z & Shoemaker JK (2010b).
Sympathetic neural activation: an ordered affair. J Physiol 588, 4825-4836.
Usselman CW, Luchyshyn TA, Gimon TI, Nielson CA, Van Uum SHM & Shoemaker
JK (2013). Hormone phase dependency of neural responses to chemoreflexdriven sympathoexcitation in young women using hormonal contraceptives. J
Appl Physiol 115, 1415-1422.
Watenpaugh DE, Muenter NK, Wasmund WL, Wasmund SL & Smith ML (1999).
Post-apneic inhalation reverses apnea-induced sympathoexcitation before
restoration of blood oxygen levels. Sleep 22, 435-440.
Wesseling KH, Jansen JR, Settels JJ & Schreuder JJ (1993). Computation of aortic flow
from pressure in humans using a nonlinear, three-element model. J Appl Physiol
74, 2566-2573.

192

Chapter 6

6

General Discussion

6.1

Overview
The SNS represents a fundamental system of control through which homeostatic

adjustments to physiological stress are achieved, occurring largely through the reflexive
regulation of blood pressure and blood flow. In turn, this process (i.e., neural control of
the circulation) is characterized by a highly integrative and finely-tuned system that is
layered with multiple levels of unique, albeit complex, control. Briefly, these include
post-ganglionic sympathetic nerve outflow, neurotransmitter release, and the end-organ
vascular response. Indeed, since the first human recordings of efferent sympathetic
nerve activity in the late 1960’s (Hagbarth & Vallbo, 1968), integrative physiologists
have been interested in the patterned nature of sympathetic neural discharge and, in
turn, its implication for, and role in, the neurovascular control complex. Stated
differently, the patterning of neural discharge reflects the strategies used by the CNS to
fine-tune sympathetic outflow, and ultimately, control systemic vascular resistance and
blood pressure, thereby maintaining homeostasis in the face of physiological
perturbation. As such, in the current dissertation, we investigated recruitment strategies
in efferent post-ganglionic sympathetic nerve activity with the hopes of gaining greater
insight into one of the complex mechanisms by which sympathetic neuro-circulatory
control is governed.

6.2

Major Findings
The series of studies contained herein investigated the neural coding patterns

employed by the SNS to alter efferent sympathetic outflow in response to homeostatic
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challenge, and further, the modifiers of, and mechanisms of control underlying these
recruitment strategies. Overall, these studies support the working hypothesis and
confirm that neural coding principles operate within the SNS. Specifically, these reflect
the ability to increase discharge frequency or rate of already-active, lower-threshold
axons (i.e., rate coding), recruit latent, higher-threshold neural sub-populations (i.e.,
population coding), as well as modify acutely synaptic delays and/or central processing
times (i.e., temporal coding) in response to reflex-mediated sympathoexcitatory stress.
A major finding of this series of studies was the ability of the SNS to recruit
sub-populations of previously silent (i.e., not active at baseline), larger amplitude, and
faster conducting sympathetic axons in response to severe physiological stress. In turn,
this recruitment option appears to be a fixed, reflex-independent recruitment strategy
available to the SNS, as this pattern was observed during severe chemoreflex- (i.e.,
Studies 1, 3, and 4), baroreflex- (i.e., Study 1), and metaboreflex- (i.e., Study 2)
mediated sympathoexcitation. These data of latent, but recruitable, higher-threshold
axons are consistent with rat work in which approximately 20% of post-ganglionic Cfibres are quiet at rest (Habler et al. 1994), and are further supported by the concept that
C-fibre diameter variations (~0.5 to 2.0 um) exist within the human peroneal nerve
(Tompkins et al. 2013). However, recruitment of latent axons was not observed during
preliminary studies using more modest levels of baroreceptor unloading (i.e., −60
mmHg LBNP) (Salmanpour et al. 2011a), or in the current dissertation, during low
levels of metaboreflex activation (i.e., the first three minutes of SHG exercise; Study 3).
In these low- to moderate- stress situations, sympathetic outflow was elevated primarily
through the increased firing of axons already-active at baseline. Therefore, it appears
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that the option to recruit latent neural sub-populations is reserved for severe stress
scenarios requiring high sympathetic drive. In this sense, original hypotheses from
Macefield and colleagues (Macefield & Wallin, 1999), in which they suggested that
recruitment of new axons may be a primary mechanism by which sympathetic
activation is achieved, are confirmed presently. However, it appears that a threshold for
recruitment of these latent sub-populations exists that varies with stress severity (i.e.,
reserved for severe stress). Therefore, during low- to moderate- levels of stress, the
SNS elevates sympathetic neural drive through increased firing of lower-threshold
axons (i.e., those already-active at baseline), whereas during severe stress scenarios,
latent sub-populations of higher-threshold sympathetic axons are also recruited to help
achieve the high levels of sympathetic outflow necessary to maintain cardiovascular
homeostasis. As such, the SNS operates on a principle of ordered recruitment, similar to
that of the skeletal motor system during the generation of ever-increasing muscular
contraction force (i.e., Henneman’s size principle) (Henneman et al. 1965).
Furthermore, results from Study 2 suggest that peripheral-reflex mechanisms play a
dominant role in mediating this recruitment option. Specifically, latent, higherthreshold axons were present (i.e., recruited) towards the end of fatiguing SHG
exercise, and importantly, persisted throughout the PECO phase (i.e., in the absence of
central, volitional factors). However, this important finding pertains to a metaboreflexmodel, and, therefore, whether this conclusion applies across all reflexes will require
future study. Yet, central factors likely play a small and insignificant role during LBNP
(i.e., Study 1), lending further support to the concept that peripheral sensory
mechanisms are responsible for mediating this recruitment strategy. Nonetheless, the
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present studies confirm the presence of neural coding patterns in the SNS, reflecting
both rate- and population coding strategies in response to acute reflex-mediated
sympathoexcitatory stress.
Another major and novel finding of this series of studies is that, in addition to
actual recruitment, the SNS exhibits a third strategy to alter efferent sympathetic
outflow in response to physiologic stress; that is, the ability to modify acutely synaptic
delays and/or central processing times. Specifically, the AP cluster size-latency profile
was shifted acutely downward during maximal voluntary apnea (i.e., Studies 1 and 3)
and towards the end of fatiguing SHG exercise (i.e., minutes four and five; Study 2),
such that the latency of all corresponding APs with similar peak-to-peak amplitudes
(i.e., AP clusters) was reduced during severe stress. Stated differently, lower-threshold
axons were recruited with a shorter latency during reflex-mediated stress. In line with
these observations, a similar systemic downward shift in the AP cluster size-latency
profile was found during the Valsalva maneuver (Salmanpour et al. 2011b). These
findings suggest the possibility of a neural short-cut somewhere within the neural
reflex-arc; however, the exact mechanism(s) and/or source(s) of these synaptic delay
changes cannot be discerned from the current analyses and will require future study.
Interestingly, in contrast to voluntary apnea (i.e., Studies 1 and 3) and SHG exercise
(i.e., Study 2), during −80 mmHg LBNP-induced baroreceptor unloading (i.e., Study 1),
the AP cluster size-latency profile was shifted acutely upward, such that all APs were
recruited with a slower latency during lower body suction. The physiological relevance
of this observation is unknown. Nevertheless, the common pattern of a systemic shift to
shorter reflex latency during maximal voluntary apnea (i.e., Studies 1 and 3), the
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Valsalva maneuver (Salmanpour et al. 2011b), and towards the end of fatiguing SHG
exercise, but not during PECO (i.e., Study 2), suggests that central, perceptual factors
may play a role in mediating the synaptic delay component of sympathetic neural
discharge. Furthermore, just like for that observed in the recruitment of latent neural
sub-populations, it seems that a threshold level of stress (or perception of stress) exists
for this recruitment option; that is, despite central, volitional factors being active
throughout all five minutes of SHG (i.e., Study 2), a downward shift in the AP cluster
size-latency profile was not observed until minutes four and five of exercise, when
levels of perceived stress were likely quite high. Nonetheless, in line with early theories
from Wallin et al. (1994), it appears that acute malleability of synaptic delays and/or
central processing times exists as an option available to the SNS to alter sympathetic
drive.
Furthermore, findings from Study 3 provide the first insight into the malleability
of these sympathetic neural recruitment strategies with increasing age and
cardiovascular disease. Importantly, it was demonstrated that the sympathetic
dysregulation commonly observed at rest with age and cardiovascular disease extends
to the neural coding patterns used by the SNS to respond to acute physiologic stress.
Specifically, while the ability to acutely modify synaptic delays and/or central
processing times appears preserved, both the ability to increase within-burst firing
frequency of already-recruited axons, and importantly, the capacity of the SNS to
recruit latent sub-populations of higher-threshold axons are reduced with healthy aging
and perhaps lost altogether with CAD. Therefore, aging, and even more so,
cardiovascular disease, impairs sympathetic axonal recruitment during apneic stress.
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However, future study is needed to assess recruitment responses to additional reflex
stimuli (i.e., baroreflex, metaboreflex, cold pressor test, etc.) to determine if the
presently observed impairment in neural discharge patterns with aging and
cardiovascular disease is specific to the apnea maneuver itself, or whether it represents
a generalized impairment across reflexes.
Finally, results from Study 4 suggest that, while voluntary apnea appears to
provide the most robust stimulus for sympathetic neural recruitment (Steinback et al.
2010), the response is largely due to the lack of ventilation itself. That is, increased
firing of already-active axons, and also, the recruitment of latent, higher-threshold
axons, is largely restrained/inhibited by the act of breathing, despite similar and/or
greater levels of severe chemoreflex stress. Therefore, the lack of ventilation per se,
rather than the increasing chemical drive, appears largely responsible for the robust
increases in sympathetic nerve activity observed during apnea.

6.3

Perspectives and Significance
The findings of the studies contained herein enhance our understanding of how

the SNS is activated during reflex-mediated physiological stress, and, importantly,
provide a novel perspective on sympathetic neural recruitment that may offer additional
insight into the complex nature of sympathetic neurovascular control in health and
disease. For example, the patterning of sympathetic neural discharge likely exerts
important influences on neurotransmitter release which, in turn, likely affects the endorgan homeostatic response. Indeed, the pattern of nerve discharge frequency appears to
affect neurotransmitter release, whereby ATP is dominantly released during low
frequency nerve activation (Todorov et al. 1994), followed by NE release at higher
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frequencies (Stjärne & Brundin, 1977), and finally, NPY release at even higher
frequencies (Pernow et al. 1989). However, the effect of increased firing probabilities
and recruitment of latent axons on neurotransmitter release patterns and the end-organ
vascular response (i.e., ‘neurovascular transduction’) remains to be determined. Yet, it
appears reasonable that these recruitment strategies may code for and/or combine to
elicit different functional responses within the end-organ, that, in turn, optimize the
ability of the SNS to buffer acute homeostatic perturbation. Indeed, efforts from the
integrated MSNA neurogram have demonstrated that total burst activity, likely
reflective of the integration and details of these sympathetic axonal recruitment patterns
(i.e., increased firing probability, latent neural sub-populations, synaptic delays, etc.),
influence directly the magnitude of decrease in leg vascular conductance (Fairfax et al.
2013). Nonetheless, the exact role(s) of these recruitment strategies available to the
SNS in the overall sympathetic neuro-circulatory control complex remains to be
discovered.
Furthermore, the data from this dissertation suggest that there are implications
of these recruitment strategies for cardiovascular disease, which, by extension, may
provide novel mechanistic insight into the aberrant sympathetic control seen in certain
cardiovascular-related pathologies. For example, findings of exaggerated sympathetic
and pressor responses to exercise in certain pathologies like hypertension (Delaney et
al. 2010) and chronic heart failure (Notarius et al. 2001; Murai et al. 2009) point to
abnormal central features of sympathetic neural recruitment. Yet, how these
observations integrate with the current observations of diminished recruitment in CAD
patients remains to be investigated. Nonetheless, the current analytical technique may
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offer a novel and innovative approach in the understanding of the mechanisms
contributing to abnormal sympathetic discharge patterns in humans. Certainly, these
important issues warrant further study.

6.4

Conclusion
In conclusion, the series of studies contained within this dissertation confirm the

presence of neural coding patterns in efferent post-ganglionic sympathetic nerve
activity, and further, offer novel insight into the recruitment strategies used by the SNS
to respond to homeostatic challenge. Specifically, in response to acute physiological
stress, the SNS has options to increase the firing frequency of already-active, lowerthreshold axons, recruit latent sub-populations of larger-sized, higher-threshold axons,
as well as modify acutely synaptic delays and/or central processing times. The
recruitment of latent neuronal sub-populations represents a reflex-independent strategy
within the SNS that is reserved for severe stress scenarios requiring high sympathetic
outflow, and further, is likely mediated via peripheral-reflex sensory mechanisms.
However, it appears that the capacity of the SNS to recruit these latent axons is reduced
with aging and perhaps lost altogether in cardiovascular disease. In contrast, the
synaptic delay component of efferent nerve discharge is reflex-specific, is influenced by
central, perceptual factors, and appears preserved with increasing age and
cardiovascular disease.
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